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The project investigates the reactions of selected aromatic nitrogen compounds with selected 
di- and interhalogens in order to obtain crystalline N···I halogen-bonded complexes 
according to the equation: 
       
where reactant A is a pyridine derivative (3,5-difluoropyridine, 3,5-dichloropyridine,  
2,6-dichloropyridine, 2,6-dimethoxypyridine, 4-methoxypyridine, 3-fluoropyridine,  
2-fluoro-3-iodopyridine, 2-fluoro-4-iodopyridine, 2-fluoro-5-iodopyridine, 2-cyanopyridine) 
or a heterocyclic compound (quinoxaline, 2-chloroquinoline, 1,10-phenanthroline). Reactant 
B represents iodine monochloride, iodine monobromide or iodine, while AB is the product. 
All the reactions were carried out in 1:1 molar ratio in ethanol as a solvent, starting at room 
temperature and subsequently cooling the reaction mixture down to 0 °C.  
Products can be classified into two groups, the first one (the majority of samples) consists of 
N···I halogen-bonded complexes with the crystals that form almost instantaneously after the 
reagents are mixed. These crystals are stable at the room temperature and have a relatively 
high melting point. 
The second group includes pyridinium ion-polyhalogen ion complexes and reactant 
polymorphs. The formation of these crystals requires placing the reaction mixture in the 
freezer for more than 12 hours or cooling the reaction mixture down to -45 °C or
 
-75 °C. 
All the crystalline products were characterised by ATR-FTIR spectroscopy, UV-Visible 
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1.1 Introduction  
 
The halogen bond (XB), which is analogous to a hydrogen bond (HB), is a highly directional 
non-covalent interaction between an electrophilic area of a covalently bonded halogen atom 
X, in a molecule designated as R-X, and another electronegative atom, or electron donor, 
signified by Y. Hence, the halogen bond formed by this interaction is commonly seen as 
RX···Y.
 1
 (Figure 1.1) It is important to note that X can also have multiple covalent bonds or 
even non-covalent interactions which can create a multitude of different chemical compounds 
with different states. 
Due to their high electronegativity, halogen atoms in halo-organics are classically considered 
as sites of high electron density. Bearing in mind such consideration, it is generally accepted 
that halogen atoms can interact by functioning as electron donor sites (i.e., nucleophiles). The 
ability of halogen atoms to serve as hydrogen bond acceptors was documented as early as the 
1920’s.
2
 Halogen molecules (frequently iodine, bromine, chlorine and even fluorine) or alkyl 
and aryl halides tend to form complexes with Lewis bases. This tendency had already been 
noted as early as two hundred years ago
3
 and more recently an enormous number of stable 











1.1.1 Historical Perspective 
The first historical account of halogen bonding was seen in J.L. Gay-Lussac’s laboratory in 
France. In 1813 J.J. Colin 
5
 had synthesized H3N···I2 and made several reports of his 
findings, including one which formed a liquid due to the combination of dry iodine and 
ammonia in gas form.
1
 However, the actual molecular composition was not formalized until 
the work of Guthrie in 1863, when he obtained the same product as Colin by adding dry 
iodine to concentrated ammonium nitrate.
6
 In addition, Rhoussopoulos prepared quinoline-
iodoform adduct in 1883,
3
 thus demonstrating that the halocarbons behave like dihalogens 
when forming Lewis base adducts. All the mentioned adducts contained iodine, which is not 
surprising since iodine is the best halogen bond donor, so only near to the end of the 19
th
 
century, I. Remsen and J.F. Norris were the first to report comparable adducts with bromine 
and chlorine.
7
 However, the first halogen bonding adduct for fluorine was not documented 






 century, the development of characterisation techniques contributed to a 
better understanding of the nature of XB. In the early 1950s, Benesi and Hildebrand 
confirmed the existence of I2-aromatic adducts using UV-Vis spectroscopy.
9
 Following that 
discovery, Mulliken reported formation of analogous complexes with ethers, thioethers and 
carbonyl derivates.
10
 In late 1950s Hassel and his co-workers at the University of Oslo 
pioneered the study of crystalline complexes of dihalogen molecules with Lewis bases by X-
ray diffraction. Specifically, the structure of the bromine-1,4-dioxane and bromine-benzene 
adducts were found to have a chain of ―halogen molecule bridges‖.
11
 (Figure 1.2)  In 1968, 
Bent
12
 published a comprehensive review of the structural chemistry of donor-acceptor 
adducts-the most notable details being how in all complexes, distances between the halogen 
atom and the electron donor were smaller than the sum of their van der Waals radii; as well as 
4 
 
how both the atoms lay nearly at 180 degrees, which both are unique features of XB. His 
claims were confirmed by Parthasarathy and Desiraju who made a statistical analysis of 
Cambridge structural database (CSD) deposited structures.
13
 
In 1992 Politzer and Murray
14
 showed that the electron density of covalently bound halogen 
atoms is anisotropic by calculating the surface electrostatic potential, which led to an 
introduction of a ζ-hole concept.
4,8,15-21
 Even though a variety of properties for this 
phenomenon were well known, the scientific community had to agree on a unified name for 
this type of interaction. 
 
Figure (1.2) Ball-stick representation of Br2···dioxane (top)  
and Br2···benzene (bottom) adducts
1,8 
 
1.1.2 Halogen bond nomenclature 
The hydrogen bond was used as a role model for naming the halogen bond interactions. The 
problem of a variety of names for the same electrophilic interaction of covalently bonded 
halogen atoms was also discussed in a review by Bent in 1968. The term halogen bond was 
possibly coined by Zingaro and Hedges
22
 to describe the obtained solution complexes of 
halogens or interhalogens and phosphine oxides and sulphides. It was further used by Martire 
et al.
23
 in 1976 and in a review by Dumas, Gomel and Guerin in 1986.
24
 On the contrary, 
during the same period of time, Klemperer et al. used the term ―anti-hydrogen bonding‖ to 
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classified the interactions of covalently bonded halogen atoms and hydrides as ―inverse 
hydrogen bonding‖. To avoid any further disputes, leading researchers in the field decided to 







1.2 Definition of the Halogen Bond  
 
A symposium dedicated to the XB was organized in the context of the 238th National 
Meeting of the American Chemical Society (Washington, DC, Aug 16, 2009), and had the 
influential role to allow for the emerging consensus on some features of the interaction to be 
acknowledged. At the edge of a two centuries long process, the IUPAC definition of the XB 
finally registered the agreement reached by the scientific community.
16
 The IUPAC project 
2009-032-1-100 was initiated in 2009 with the mission to provide a unified theoretical frame 
to interactions involving halogens as electrophilic species and to finally classify them in a 
distinct system. The definition of the halogen bond by the IUPAC recommendation in 2013 
is:  
“A halogen bond occurs when there is evidence of a net attractive interaction between 
an electrophilic region associated with a halogen atom in a molecular entity and a 








 proposed that: ―The existence of a halogen bond may be evident by 
experimental or theoretical, or even both.‖ Some features that are useful as signs for the 
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halogen bond are mentioned below. The more the number of features met, the more 
consistent the description of an interaction as a halogen bond is.  
In a typical halogen-bonded complex R–X···Y: 
• ―The interatomic distance between X and the appropriate nucleophilic atom of Y tends to be 
less than the sum of the van der Waals radii.‖ 
• ―The length of the R–X covalent bond usually increases relative to the unbounded R–X.‖ 
• ―The angle R–X···Y tends to be close to 180°, i.e., the halogen bond acceptor Y approaches 
X along the extension of the R–X bond.‖ 
• ―The halogen bond strength decreases as the electronegativity of X increases, and the 
electron withdrawing ability of R decreases.‖ 
• ―The forces involved in the formation of the halogen bond are primarily electrostatic, but 
polarization, charge transfer, and dispersion contributions all play an important role. The 
relative roles of the different forces may vary from one case to the other.‖ 
• ―The analysis of the electron density topology usually shows a bond path (a ―bond path‖ 
and a ―bond critical point‖ are defined as ―Within the topological electron distribution 
theory, the line resulting from the addition of two gradient paths of the electron density 
function emanating from the bond critical point located between each two neighbouring 
atomic basins‖ and ―Within the topological electron distribution theory, a (3, –1) critical 
point (the point of the gradient field of the electron density within a given neutral 
configuration in which ∇ρ(r,q) = 0) which is a local maximum in two directions and is a local 
minimum in the third, i.e. a saddle point in the three directions‖) connecting X and Y and a 
bond critical point between X and Y.‖ 
• ―The infrared absorption and Raman scattering observables of both R–X and Y are 
influenced by halogen bond formation; new vibrational modes associated with the formation 
of the X…Y bond are also observed.‖ 
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• ―The UV–vis absorption bands of the halogen bond donor usually transform to shorter 
wavelengths.‖ 
• ―The X···Y halogen bond usually affects the nuclear magnetic resonance (NMR) 
observables (e.g., chemical shift values) of nuclei in both R–X and Y, both in solution and in 
the solid state.‖ 
• ―The peaks have binding energies related to X with the X-ray photoelectron spectrum 
(XPS) of the compound moving to energies that are lowered in comparison with un-bonded 
X.‖ 
 
1.5 General Aspects and Nature of Halogen Bonding 
1.5.1 Halogen bond donors 
 
Halogen bond donors are halogen atoms iodine, bromine, chlorine and fluorine. XB donor 
ability increases in order F<Cl<Br<I. Even though following this trend astatine (At) should 
have the best properties as XB donor, it is omitted from the list because it is a rare and  
radioactive element with isotopes of a short half-life (the longest-living isotope 
210
At has a 
half-life of 8.1 hours)
27
, therefore very little is known about its chemistry and no halogen 
bond complexes are recorded so far.
15
   
When halogen atoms are covalently bonded, their electron density redistribution occurs, and 
the electrostatic potential becomes anisotropic; a similar behaviour is shown by any other 
element. This was suggested theoretically and confirmed later by the experimental studies. In 
covalently bonded halogen atoms, the atomic radius of the halogen atom along the R−X bond 
axis is shortened, while the radius perpendicular to this axis is prolonged. The expanse of 
positively charged electrostatic potential occurs at the terminus of the R−X covalent bond. 
Halogen atom shape becomes more ellipsoidal with the shorter radius always along the 





 which was further proven experimentally through a detailed analysis of the 
Cambridge Structural Database 
30




Figure (1.3) Schematic representation of ―polar flattening‖ on a  
covalently bonded halogen atom
18
 
1.5.2 The concept of ―ζ-hole‖ 
 
Bearing in mind that the anisotropic nature of the electrostatic potential in the Cl, Br, and I 
systems, together with the electronegative nature of these halogens, can result in amphilic 
behaviour, accordingly, the halogen atoms serve as electron-deficient areas when they 
interact at the pole (electrophilic end), and still again can also serve as electron-rich sites 
when interacting at the equator (nucleophilic segment).
34,35
 As a result, a region of partially 
negative electrostatic potential (δ
-
) emerges perpendicular to R−X axis and a region of a 
partially positive electrostatic potential (δ
+
) develops along the R−X covalent bond on the 
outermost portion of the halogen surface. This positive region has been denoted by Politzer et 
al.
28
 as a ―ζ-hole‖ because it can be seen as a local deficit of electron charge opposite a ζ-
bond. The ζ-hole is surrounded by a belt which has a negative electrostatic potential and is 
orthogonal to the bond responsible for ζ-hole formation. This model elegantly explains the 
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interaction pattern of covalently bonded halogen atoms, and their directional preferences, i.e., 
linear interactions with nucleophiles and lateral interactions with electrophiles. The presence 
of a positive ζ-hole accounts for the electrophilic behaviour of halogen atoms, while the 
focused nature of the ζ-hole accounts for the direction of interaction with the lone pair on the 
XB acceptor atoms thus determining its orientation.
 36-40
 Practically, the positive potential on 
the R-X axis increases moving from F to I, i.e. proportional to the polarizability of the 
halogen atom. (Figure 1.4) The ζ-hole concept,
28
 offers a sophisticated explanation of the 
electrophilic behaviour of the halogen atoms. Although this concept is still widely used, there 
are evident examples of halogen-bonded complexes whose features cannot be rationalized 
based merely on the concept of the ζ-hole, and the outline of the behaviour of the XB 




Figure 1.4 The molecular electrostatic potential (in Hartrees) at the isodensity surface with 
0.001 electrons Bohr
-3






1.5.2 Halogen bond acceptors 
 
Amines and pyridine derivatives are two examples of typical nitrogen-atoms-containing 
organic compounds, which show a more powerful halogen bond formation than do typical 
oxygen and sulphur complexes.
 53,
 The efficiency of the sulphur and oxygen atoms as halogen 
bond acceptors characteristically depend on the behaviour of the halogen bond donors. 
Halogen bond acceptors that are sterically inhibited are of lower efficacy. In addition, if there 
is an increase in the electron density on the electron-pair donor this encourages its Lewis 
basicity and favours halogen bond creation. A good example of this is the formation of XBs 




 Furthermore, the halogen bond 
acceptor aptitude of sp
2
-hybridized oxygen atoms increases in solution from acetone, to 
dimethyl sulfoxide, to hexamethylphosphortriamide.
57,58
 Oxygen atoms show lesser affinity 
as XB acceptors in comparison to nitrogen atoms, nevertheless the opposite is true when 
pyridine derivatives and the corresponding N-oxides are considered.
53,54
  
Another example is seen when neutral species are compared to anions, as the latter show a 
better XB acceptor activity hence signifying the potential of anions in structural chemistry 
directed by halogen bonds.
1,8
 The strength of the XB with an anion is directly correlated to 
how much dissociated an ion pair is, i.e. the more charge is transferred from the anion to the 
antibonding orbital (ζ*) of the XB donor, the stronger will be the anion XB. Halide anions 
form most of the common halogen-bonded adducts. Polyhalide anions can work as XB 
acceptors.
15
 The association course is largely determined by the solvation energies of the 
starting anions and their adducts in addition to the strength of the resultant halogen bond.
59,60 
Compared to hydrogen bonds, XB is a more directional interaction, and long interactions are 
less directional than short ones because the ζ hole is localized exactly on the elongation of 
the covalent bond(s) the halogen atom is involved in.1 This anisotropic spreading of electron 
density over the halogen atom results in the angle of the covalent and halogen bond over the 
11 
 
halogen atom in R-X···Y to be about 180°. Moreover, n-electron donors (for example ethers 
and amines) also function as halogen bond acceptors with the interaction favourably 
manifesting itself along the axis of the donated lone pair of electrons.
15,16
 In XBs involving 
pyridine fragments, the C-X bond is practically on the same plane as the pyridine ring. The 
precise nature of the halogen-bonding interaction is still debated. Transfer of electron density 
from the Lewis basic site (electron donor, halogen-bond acceptor) to a Lewis acidic site 
(electron acceptor, halogen-bond donor) does occur, however, the bonding contributions of 




1.5.3 Halogen Bond Characteristics: Energy and Geometry  
 
The binding mode of XBs causes the X···Y distances to be smaller than the sum of the van 
der Waals radii of the atoms involved, thus, the stronger the halogen bond, the shorter the 
X···Y distance. When the assumption is made the halogen bond is formed as the result of 
electron donation from Y to the ζ-antibonding R-X moiety, the formation of a halogen bond 
should slightly elongate the covalent R-X bond.
 62,63
  
Halogen bond strength is comparable to the more well-known intermolecular interactions 
such as the hydrogen bond. 
8,15
 HB and XB interactions show analogous drifts in energetic 
and geometric properties. This common property of XB and HB stems from the fact that 
halogens serve as electrophiles XB just as the hydrogen atoms do in HB. The main similarity 
between the two non-covalent interactions is the role of the electrophilic site on the halogen 
and hydrogen atoms, respectively; the inherent difference is that atoms of groups 17 and 1 are 
involved. 
Yet, XB interactions can be more sensitive to secondary interactions. Broadly speaking, the 
term halogen bonding generally covers a huge variety of noncovalent interactions whose 




 The significant strength of some halogen 
12 
 
bonds enables them to prevail over hydrogen bonding when interacting with other molecules. 
For instance, the construction of intermolecular hydrogen bonds between dissolved species 
are noticeably repressed if a relatively strong halogen bond donor is supplemented as a co-
solute.
65
 Several hydrocarbon complexes comprising two nitrogen atoms show more affinity 
to co-crystallize with halogen bond donors rather than with hydrogen bond donors on 
competitive co-crystal formation, as seen experimentally.
18
 This capacity of XBs to be an 




In comparison to hydrogen atoms, halogen atoms are much bigger and more polarizable; 
accordingly, XBs are more affected by steric effects than are HBs.
69-79 
Strength of a halogen bond can be controlled in several ways. The simplest is to change the 
halogen atom used as a donor. One system that this has been particularly well documented is 
that involving 3-halocyanoacetylene role, when the N···X distances (2.932 Å for iodo-, 2.978 
Å for bromo-, and 2.984 Å for chloro- complexes) are considered as the halogen bonds 
strength indicators in the adducts.
53,54,80
 
Moreover, the strength of halogen bonds can be finely-adjusted by altering the halogen atom 
and the motif to which it is covalently bound; increased halogen-bond donor strength can be 
achieved by increasing the electron-withdrawing ability of the substituent. 
This results in a positive charge for Cl, Br, and I while the electrostatic potential stays 
negative for the F atom. The extent of the positive field increases in response to the presence 
of electron-withdrawing neighbouring groups. Experimental outcomes verify that it is 
conceivable to fine-adjust the strength of the halogen bond in any halocarbon by altering the 







Figure (1.5) Computed electrostatic potentials on 0.001 au molecular surfaces of 
 (a) iodobenzene, and (b) pentafluoroiodobenzene. Colour range (kcal/mol): red, >20;  
yellow, 20-10; green, 10-0; blue, negative.  
Black hemispheres denote the positions of the halogen VS,max.
82
 
Haloheteroarenes and haloarenes (e.g. mono- or poly- halo substituted pyridine and benzene) 
are characteristically good XB donors. The halogen atom shows an even better donor nature 
whenever the heteroaromatic ring gains a positive charge. This effect has been effectively 
used to regulate the packing of bromo- and iodo-substituted tetrathiafulvalene by-products, 
which are also molecular conductors.
 83,84
  
In polyhaloalkanes, both steric as well as electronic effects result in the n-electron donors 
approaching from the front-side of the C-X covalent bond rather than the back-side attack; 
accordingly, these complexes commonly form halogen bonds. Tetrabromo-, triiodo-, and 
tribromomethane have been used broadly to produce halogen-bonded adducts,
85
 whereas 




Furthermore, the strength of the XB increases as the electron-withdrawing nature of the atom 











Strength and directionality of the halogen bonding is determined by the summation of charge-
transfer, electrostatic, dispersion, and polarization interactions following the Pauli exclusion 
principle. A diversity of theoretical approaches have been advocated for the breakdown of the 
binding energy into the different contributions.
37,44,48-50,89
 On the other hand, there is no 
universal agreement on this approach. In fact, some other studies, take the view that ―the total 
binding energy is a physical observable while the various proposed components have just a 
conceptual significance, are not uniquely defined, and are not independent from each 
other‖.
15,90-92 
Another important application of halogen bonding is in crystal engineering. This 
encompasses forming cocrystals with detailed preferred characteristics, such as the spatial 
orientations and/or component separation. Such implications open the door to limitless future 
possibilities in material design and development.
4,15,93-96
  
1.7 Applications of halogen bonds in crystal 
engineering 
 
An XB interaction is symbolized by an X···Y interaction between a halogen-bond donor (X) 
and an acceptor (Y), in which the internuclear distance is less than the sum of their van der 
Waals radii. The XB interaction is typically co-linear with the R−X covalent bond, as a 
matter of fact, the angle between constituents is usually at least 175° in the gas phase.
61
 This 
directionality of the interaction, as well as easily tuneable strength properties make XB a very 
useful tool in crystal engineering.  
A tecton is defined as ―a molecular building block that possesses the structure and molecular 
recognition features to predictably self-assemble into crystalline networks‖.
8
 Halogen atoms 
when their ζ hole is amplified by the presence of electron-withdrawing adjacent species can 
effectively behave as the ―sticky sites‖ that dictate the association of the molecules. This is 
15 
 
shown better with the behaviour of polyhalocarbons, which regularly act as XB tectons. The 
directionality of halogen bonds permits the supramolecular construction to be predicted from 
the assembly of the preliminary molecules. 
Another important term used in crystal engineering is denticity. IUPAC defined it as: ―the 
number of donor groups in a single ligand that bind to a central atom in a coordination 
complex‖.
97
 In supramolecular chemistry it refers to the number of donor or acceptor groups 
in a single tecton that are interacting via HB or XB. A tecton could be monodentate or 
polydentate (sometimes also referred as multidentate). Most commonly, the number of 
binding on polydentate tectons ranges from two (bidentate, e.g. ethylenediamine) to six 
(hexadentate, e.g. ethylenediaminetetraacetic acid (EDTA)), although even the cases of 







1.7.1 One-dimensional architectures 
Halogen bonds tend to be linear, based upon the R-X bond axis of the halogen bond donor 
and the axis of the lone pair of electrons of the heteroatom in the halogen bond donor. When 
a pyramidal tridentate halogen bond donor interacts with a monodentate halogen bond 
acceptor, pyramidal units with four building blocks are created, whereas linear units with 
three building blocks are formed when a linear bidentate halogen donor interacts with a 
monodentate halogen acceptor. 
If both the halogen bond donor and acceptor are bidentate, formation of one dimensional 
chains will be the result. Linear endless self-assembled chains are formed by donors  and 
acceptors with parallel and coaxial sites(e.g. 1,4-dihalobenzenes for the former and 4,4’-
bipyridine(4,4’-bipy) for the latter).
15
 (Figure 1.6a) On the other hand, a stepped chain pattern 
can be observed if the binding sites are not collinear even though they are parallel (e.g. α,ω-
diiodoperfluoroalkanes and 4,4’-bipy).
15
(Figure 1.6b) The self-formed chains adopt a 
―herringbone‖ structure if the binding sites axes in the elements are not parallel (Figure 1.6c) 
the angles of the axes in the binding sites strongly dictate the angles along the chain. Angled 
geometry structuring of the halogen bond donor, the halogen bond receptor or both is 
manifested in many models. Probably the simplest examples of tuning the angle of the 
―herringbone‖ structure is varying the positions of XB donor sites, for example, 1,2- and 1,3-
dihaloperfluorobenzenes, 60° and 120°, respectively. Halide anions often perform as 






Figure (1.6) One-dimensional halogen bond architecture types, 
linear- (a), stepped (b) and herringbone infinite chain (c) pattern;  
XB donors (grey), XB acceptors (black), adapted from8  
1.7.2 Two-dimensional architectures 
 
The two-dimensional architectures are manifested when one or both of the interacting 
components have three or more XBs. A commonly observed design is the system 
(honeycomb assembly),
1,8
 which is the result of self-assembling of halide anions with 
dihalocarbons. (Figure 1.7a) Halides behave as tridentate halogen bond acceptors that inhabit 
the nodes whereas the dihalocarbon components work as bidentate halogen bond donors that 
join the nodes. A ridged 2D honeycomb design is created as planar geometrical layout over 
the nodes. 
On the other hand, the design can be produced from the self-assembly of tridentate halogen 
bond donors-acceptors complexes.
1,8
 (Figure 1.7b) 
Tridentate components self-assemble with other (bi and tri) dentate complexes to produce 
two dimensional architectures. For example, ribbons are created when a tri dentate halide 
anions join a bidentate dihalocarbons.
15




Figure (1.7) Two-dimensional halogen bond architecture types, 





1.7.3 Three-dimensional architectures 
 
Interaction of a tetradentate module will result in the formation of either two dimensional or 
three-dimensional architectures. An example of two dimensional architectures are systems 
resulting from a tetradentate halogen bond acceptor self-assembled at the nodes and linking 
linear bidentate halogen bond donors. 
On the other hand, an example of three-dimensional architecture is the adamantoid networks. 
They are produced by the self-assembly of dissimilar constituents. An example of such a 
network is the homocrystal of a self-complementary tetradentate structural block that 
comprises 2 halogen bond donor sites as well as 2 halogen bond acceptor sites.(Figure 1.8a) 
Another pattern for the formation of three dimensional architectures is the self-assembly of 
tetradentate halogen bond acceptors, which are situated at the nodes, with bidentate halogen 
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bond donors (Figure 1.8b), that manifest a ―spacing‖ role and by the interchange of 
tetradentate halogen bond donors and acceptors at the nodes of the network.(Figure 1.8c) The 
aforementioned XB two and three-dimensional systems described above are porous structures 




Figure (1.8) Three-dimensional adamantoid halogen bond architecture types, 
self-assembled (a), tetradentate XB donors and bidentate XB acceptors (b) and ), tetradentate 







1.8 Graph-set motif nomenclature  
 
Even though this thesis is focused on preparation and structural studies of halogen bonded 
complexes, hydrogen bonds have also been observed in several systems. Hydrogen bonds can 
form a variety of motifs, which could be unequivocally described by graph-set motif 
nomenclature. Therefore, it is necessary to define and clarify this terminology. Graph-set 
motif nomenclature consists of a letter which represents the type of motif (R refers to the 
ring, C stands for a chain, while S is used for an intramolecular and D for a discreet hydrogen 
bond) and a set of numbers that describe the number of hydrogen bond donors (subscript), 
acceptors (superscript) and a number in brackets which corresponds to a total number of 











a)  N1=D 
b)    N1= C (7) 
c)  N1= S(6) S(5); N2= S
1
2 (9) 




Figure(1.10): Examples of graph-set motifs, a) discreet-, b) chain-,  
c) intramolecular-, d) ring hydrogen bond motif, adapted from
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1.9 Characterisation techniques  
 
The electromagnetic (EM) spectrum consists of the whole range of frequencies of 
electromagnetic radiation, each of which can be considered as a wave or particle (photon) 
travelling at the speed of light. The frequency and wavelength of electromagnetic radiation 
vary over many orders of magnitude, so the EM spectrum could be divided according to the 
type of atomic or molecular transition that causes the emission or absorption of photons (e.g. 
X-ray, UV, IR, microwave) (Table 1.1). Every molecule is capable of absorbing 
characteristic frequencies of EM radiation. During this process, energy is transferred to the 
molecule and the intensity of the incident EM radiation is decreased. The difference in 
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intensities at specific wavelengths offers a possibility to study a variety of aspects of 
molecular structure. (Table 1.1) Those differences in the beam attenuation occur following 
the absorption law. The scientific field that studies the interaction of matter and light is called 
spectroscopy.
99
 It is divided by the range of EM spectrum that is utilised, in this work 
ultraviolet-visible (UV-VIS) and infrared (IR) spectroscopy, X-ray diffraction 
characterisation techniques are used. 
Table 1.1 The electromagnetic spectrum and the corresponding transitions
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1.9.1 Ultraviolet-visible (UV-VIS) spectroscopy  
 
UV-VIS spectroscopy utilises the wavelengths from 200 to 1500 nm. In this range, electron 
excitation from low-energy molecular or atomic orbital to a higher-energy orbital occurs. The 
energy of the incoming photon must be the same as the energy difference of the orbital 
energies, for excitation to happen. Moreover, except the electronic transitions that are 
observed in UV-VIS range of the EM spectrum, molecules exhibit two other radiation-
induced types of transitions (vibrational and rotational) that occur alongside the electron 
excitation. Vibrational transitions occur because a molecule has a multitude of quantised 





 The absorption law, more familiar as the Beer-Lambert law (A= εlc), is used to 
quantitatively determine the amount of light attenuation. Absorption of light is specific for 
each wavelength and it depends on the path length (l) over which absorption occurs, the 
concentration (c) and type of the absorbing molecules. Dependence on the type of the 
molecules is defined through the molar absorptivity constant of the compound (ε). This 
constant is unique for each compound and the wavelength at which the molecule is observed. 
The transmittance (T) of the solution is the fraction of the incoming radiation (P0) transmitted 
by the absorbing solution (T=P/P0). Transmittance is expressed as a percentage. The 





A spectrometer is a spectroscopic instrument that converts the radiant intensities into 
electrical signals. UV-VIS spectrometers exist in two main design types, single and double-
beam instruments. Double-beam instruments offer an advantage when compared to the 
single-beam spectrometers because reflection and scattering could occur at the sample holder 
walls, which cause the loss in the light intensity. To compensate for these effects, in the 
double-beam instruments the intensity of the beam transmitted through a cell containing the 
analyte solution is compared with one that traverses an identical cell containing a ―blank‖ 
sample, which is just a solvent in a majority of the cases. However, due to the compact 
design, lower cost and maintenance, single-beam instruments are widely used. The reflection 
and scattering problems in a single beam are addressed by collecting the blank spectrum first, 
and then deducting it computationally from the sample spectrum. The main components of a 
single-beam UV-VIS instrument are the source, monochromator, beam splitter, sample 
holder, detector and a signal amplifier.
100





Figure (1.11): Scheme of a double-beam UV-VIS spectrometer,  
adapted according to the ref
100
 
As a light source usually a deuterium and tungsten lamps are used. Deuterium lamp produces 
a continuum spectre in a range from 160 to 380 nm, while the tungsten lamp produces light in 
the range from 240 to 2500 nm. This limited range of EM spectrum is then passed through a 
monochromator which filters the incident continuous spectra to a single wavelength. The 
beam with the filtered wavelength passes through the solution of interest and then a detector. 
The output from the detector is amplified, and the logarithm of the blank-sample ratio is 
computed and displayed on the computer as a spectrum.
99,100
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1.9.2 Infrared (IR) Spectroscopy 
 
The range of the electromagnetic radiation from 33 to 12000 cm
-1
 is called the infrared region 
and it is utilised in spectroscopy mainly for the qualitative identification of molecular 
structure by observing various vibrating properties. This part of the spectrum could be 
divided into well-defined regions based on the types of vibrations that could be observed:  
 Far-Infrared (400-33 cm
-1
): molecular skeleton and crystal lattice vibrations, molecules 
containing heavy atoms, 
 Mid-Infrared (4000-400 cm
-1
): the most utilised for organic compounds analysis  
 Near Infrared (12820-4000 cm
-1
): overtones; mainly for quantitative analysis 
The simplest modes of vibration that are infrared active are stretching and bending modes. 
(Figure 1.12) Stretching modes can be divided into symmetric and asymmetric while bending 
modes can be separated into four different types. Scissoring and rocking are in-plane modes 
while wagging and twisting are out-of-plane modes.  
  
Figure (1.12): Molecular vibration modes,  





To perform the structural analysis by IR spectroscopy the molecule under investigation must 
be infrared active, (i.e. it must absorb IR radiation). When the radiant energy matches the 
energy of a specific molecular vibration, absorption occurs. A compound that is infrared 
active must change its dipole moment when vibrating. Molecules with a permanent dipole 
moment (H2O and CO) are infrared active, while molecules like Cl2 and N2 molecule do not 
possess a permanent dipole moment, so they are not infrared active. In the case of alkenes 
(C=C) and alkynes (C≡C) if the bond is symmetrically substituted then no band would be 
observed in the IR spectrum. In the other hand, if the bond is asymmetrically substituted, a 
corresponding stretching frequency will be present. Samples in all phases (solid, liquid and 
gas) could be characterised, but for each phase, a specific sample holder is required. 
Fourier Transform Infrared (FTIR) instrument components: 
Infrared spectrometers use optical devices for dispersing and focusing electromagnetic 
radiation of IR frequency which is passed through the sample and any changes in absorbance 
measured against a reference beam. FTIR spectrometers consist of an IR source, 
interferometer, sample cell or chamber and a detector. A scheme of an FTIR instrument is 
shown below (Figure 1.13). 
IR source  
Common IR sources are silicon carbide rods which are heated by the electric current to 
approximately 1300 K. IR radiation passes through an aperture which controls the amount of 
radiation that reaches the sample, and therefore, the detector.  
Interferometer  
The interferometer is the essential piece of optical equipment, without which the 
contemporary FTIR system would not exist. The interferometer consists of a beam splitter, a 
fixed mirror, and a moving mirror. The beam splitter is made of a material which transmits 
half of the incident radiation and reflects the other half. IR radiation from the source is 
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separated by the beam splitter and into two beams. One part is transmitted through the beam 
splitter to the fixed mirror while the other one is reflected in the moving mirror. Both fixed 
and moving mirror reflect the radiation to the beam splitter where the two beams interfere 
and produce an interferogram. Both, the moving and the fixed mirror are flat highly reflective 





There are two classes of infrared detectors; thermal and photonic detectors. Photonic detector 
exhibits faster response times and higher sensitivity in comparison to their thermal 
counterparts. The materials used in these detectors are semiconductors with narrow band 
gaps. The incident IR radiation causes electronic excitations between the ground and first 





Figure (1.13): FTIR instrument scheme,  





 Attenuated Total Reflectance (ATR)  
IR instruments that utilise an ATR stage simplify the procedure and shorten the time required 
the sample preparation, while still resulting in a good quality spectrum. The IR radiation in 
the classic IR spectrometer is passed through the sample and the radiation which is 
transmitted is measured. ATR measures the changes which occur in an internally totally 
reflected IR beam that it is in direct contact with a sample (Figure 1.14). The IR beam enters 
the crystal (at a particular angle of incidence) that is made of a material with a high refractive 
index. The crystal has to be made of a material with a higher refractive index than the sample. 
The IR beam is internally reflected and it results in the production of an evanescent wave 
which can extend beyond the crystal surface and into the sample. Depending on the angle, 
type of the crystal and the sample, evanescent wave penetrates the sample to a depth from 0.5 
to 2 µm. When the IR radiation is absorbed by the sample a change in the evanescent wave 
occurs, i.e. the wave is attenuated. The attenuated energy is then transferred back to the IR 
beam in the crystal and is measured by the detector. The most common materials to be used 
as ATR crystals are zinc selenide (ZnSe) and Germanium (Ge) and diamond. Instruments 
which use diamond as the ATR crystal material exhibit greater durability and robustness, than 










1.9.3 X-ray diffraction 
 
In spectroscopic characterisation techniques, the difference in absorption or emission of 
radiation is measured while the wavelength of the incident light is varied. On the other hand, 
by using diffraction techniques, characterisation is based on the scattering of EM radiation on 
the sample. For the crystalline materials, X-ray part of the spectrum is ideal for the diffraction 
since its wavelengths (0.1-10 nm) coincide with the scale of chemical bonds and atom sizes. 
Apart from X-ray, diffraction of electrons and neutrons on crystals is observed, as well. 
Single-crystal X-ray diffraction is a non-destructive characterisation technique that provides 
detailed information about the internal lattice of crystalline substances (unit cell dimensions, 
bond-lengths and angles, details of site-ordering). The interaction of the incident rays with 
the sample produces constructive interference by the Bragg's Law (nλ=2d sinθ), where θ is 
the glancing angle of X-rays of a specific wavelength (λ), d is the interplanar spacing of the 
crystal and n (integer number) represents the order of reflection. (Figure 1.15) Bragg’s law 
relates the EM wavelength to the diffraction angle and the lattice spacing in a crystalline 
sample. Diffracted X-rays are then counted by the detector and further processed. By 
changing the geometry of the incident rays, the orientation of the central crystal and the 









Samples should be optically clear and unfractured crystals ideally from 200-550 μm in any 
direction. If no suitable specimen could be found, crystals can be broken off a larger sample 
and the best fragment selected. During a standard characterisation experiment, the crystal is 
mounted using a small drop of oil on a nylon loop, which is then cooled so the oil solidifies. 
The loop is attached to a metal pin, which is further mounted onto a goniometer head. The 
goniometer head containing the sample is then attached to the diffractometer. Samples are 
then centred by all three (X, Y and Z) directions. Subsequently, a preliminary set of frames is 
collected to determine the unit cell. This set of data is then used to select the reduced 
primitive cell, the appropriate crystal system and corresponding Bravias lattice, and to 
calculate and refine the orientation matrix.
101-103 
After the refined cell and orientation matrix have been determined, intensity data is collected. 
Generally, the data is collected from 4 to 55 2θ degrees for Mo-anode. A complete data 
collection requires from 2-24 hours, based on the specimen (collection could be constrained 
depending on the symmetry of the material to shorten the collection time) and the type of the 
diffractometer.  
The collected data from the X-ray analysis needs interpretation and refinement to obtain the 
sample crystal structure. Miller indices (hkl) are assigned to collected reflections, to indicate 
its position in the collected diffraction pattern. The pattern is related to lattice and the unit 
cell in real space as a reciprocal Fourier transform. After the data collection step, the phase 
problem has to be solved to determine the set of phases, which needs to be further combined 
with the structure factors to calculate the electron density of the analysed material from which 
the crystal structure obtained. There are several procedures present to solve the phase 
problem. The usual method currently is to use direct methods, where phases are assigned 
initially to strong reflections and then iterated until a refined fit is produced. The obtained 
data is further refined by least-squares. The final solution of the crystal structure contains a 
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Single-crystal X-ray diffractometer 
The principal components of a single-crystal X-ray diffractometer are an X-ray source, a 
goniometer with a sample holder and a detector. (Figure 1.16) 
X-ray sources 
X-rays could be generated in a cathode ray tube or by a synchrotron. For the laboratory use 
X-rays are generated in a cathode ray tube by heating a filament to produce electrons, which 
are then accelerated towards a target by applying a voltage. When accelerated electrons are of 
sufficient energy to displace inner shell electrons of the target material, X-ray spectra 
characteristic of the target (usually copper or molybdenum) is produced. These spectra 
consist of several specific wavelengths, usually Kα and Kβ. To be more specific, Kα further 
has Kα1 and Kα2. Kα1 is of a shorter wavelength and twice as intense as Kα2. Filtering or 
crystal monochromators are required to produce monochromatic radiation necessary for 
diffraction. Kα1and Kα2 are very close in wavelength, therefore a weighted average is used. 
Molybdenum is generally used as anode material for single-crystal diffraction, MoKα = 
0.7107Å. These X-rays are then collimated to make a more concentrated beam and directed 
to the crystal sample mounted on a goniometer.
101-103
 
Goniometer-sample holder  
Goniometers are instruments that allow objects to be rotated into precise angular positions. 
Modern single-crystal diffractometers use 4-circle goniometers. They are noted as 2θ, χ, φ, 
and Ω. These notations define the relationship of the incident monochromatic X-rays, the 
crystal lattice and a detector. Incident radiation could be either, transmitted reflected of 
scattered. A beam stop is located directly opposite the collimator to block transmitted rays 
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and prevent the detector damage. Diffracted rays at the correct orientation for the 




When the geometry of the incident X-rays impinging the sample satisfies the Bragg Equation, 
constructive interference occurs. A detector records and processes this X-ray signal and 
converts it to a count rate which is then processed by a computer. Previously photographic 
films and pixel detectors were used, but in contemporary single-crystal diffractometers, CCD 

































2-fluoro-5-iodopyridine Apollo Scientific 
2-cyanopyridine Acros Organics 
4-methoxypyridine T C I 
2-chloroquinoline Alfa Aesar 
1,10-phenanthroline Alfa Aesar 
Quinoxaline Apollo Scientific 
Iodine monochloride Acros Organics 
Iodine Fisher Chemical 
Iodine monobromide Acros Organics 
Methanol Fisher Chemical 
Ethanol Fisher Chemical 





For solid starting materials the aromatic nitrogen compounds (0.007 mol) A were dissolved in 
ethanol (3 mL) and added to a round-bottomed flask. If the starting material was a liquid, it 
was placed directly in a round-bottomed flask. ICl, IBr, I2 1.20 g (0.007 mol), 1.55 g (0.007 
mol), 1.90g (0.007 mol) respectively B was dissolved in 4 mL of ethanol and cooled to 0 °C 
for 30 min and added dropwise to compound A. Crystals were formed immediately for some 
products while for the other products it was necessary to place the samples in a freezer at -20 
°C for at least 12 hours before a precipitate was formed. If no crystals were formed on 
cooling the samples were left in a fume hood for the solvent to evaporate. If no suitable 
crystalline material was obtained using these procedures the fine product powder was 
dissolved in the minimum amount (2 mL) of solvent (dichloromethane, methanol) and cooled 




2.3 -Instrumentation  
2.3.1 IR analysis 
ATR FT-IR spectra were recorded on the crystalline samples using Thermo-Scientific 
NICOLET iS 10 FT-IR Spectrometer with a diamond crystal. Background spectra were 




the crystalline sample was loaded onto the 
IR sample stage crystalline sample was added until the transmittance of key signals was 
lower than 90 percentages and 16 scans were collected from 600-4000 cm
-1 
with the spectral 




2.3.2 UV-Visible analysis 
 
UV-Visible spectra were recorded on the solutions of the samples using a Thermo-Scientific, 
EVOLUTION 220- UV-Visible spectrophotometer and were recorded from 300-800 nm.
  
The liquid samples were placed in 1 cm pathlength quartz cell. 
2.3.3 XRD analysis 
 
X-ray intensity data for all crystals were collected and analysed by Drs R. H. Jones and C 
Hawes at -150 °C (123 K) using a Bruker D8 QUEST diffractometer equipped with a 
PHOTON 50 CMOS area detector using Mo Kα radiation, λ = 0.71073 Å
. 
The raw area 
detector data frames were reduced and corrected for absorption effects using the Bruker 
APEX3 and SADABS programs. Structures were solved using a variety of methods 
(programs SIR92, SUPERFLIP)
104, 105




2.4 –Experimental data  
2.4.1 Experimental conditions 
 
3,5-difluoropyridine-ICl 
3,5-difluoropyridine (0.862 g) (0.007 mol) was placed in a round bottom flask. ICl (1.210 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl solution 
was then added dropwise to the 3,5-difluoropyridine solution. Yellow crystals were formed 
immediately. The precipitate was filtered using a Hirsh funnel and stored in a freezer. Weight 
(1.58 g) Yield (76%); m.p. 107-109 °C. 
3,5-dichloropyridine-ICl 
3,5-dichloropyridine (1.125) g (0.007 mol) was mixed with ethanol (3 mL). ICl (1.210 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl solution 
was then added dropwise to the 3,5-dichloropyridine solution. Dark yellow crystals were 
formed immediately. The precipitate was filtered using a Hirsh funnel and stored in a freezer. 
Weight 1.17g Yield (50%) m.p. 140-143 °C. 
2,6-dichloropyridine-ICl  
2,6-dichloropyridine (1.125) g (0.007 mol) was mixed with ethanol (3 mL). ICl (1.210 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl solution 
was then added dropwise to the 2,6-dichloropyridine solution. Orange crystals were formed 
immediately. The precipitate was filtered using a Hirsh funnel and stored in a freezer. Weight 







2,6-dimethoxypyridine (1.042 g) (0.007 mol) was placed in a round bottom flask. ICl (1.210 
g) (0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl 
solution was then added dropwise to the 2,6-dimethoxypyridine solution. Yellow crystals 
were formed immediately. The precipitate was filtered using a Hirsh funnel and stored in a 
freezer. Weight (1.33 g) Yield (59%); m.p. 136-138 °C. 
4-methoxypyridine-ICl 
4-methoxypyridine (0.818 g) (0.007 mol) was placed in a round bottom flask. ICl (1.210 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl solution 
was then added dropwise to the 4-methoxypyridine solution. Dark orange crystals were 
formed immediately. The precipitate was filtered using a Hirsh funnel and stored in a freezer. 
Weight (1.52 g) Yield (74%); m.p. 165-168 °C. 
3-fluoropyridine-ICl  
3-fluoropyridine (0.727 g) (0.007 mol) was placed in a round bottom flask. ICl (1.210 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min and added 
dropwise to the 3-fluoropyridine, which had also been cooled. Yellow crystals were formed 
immediately. The precipitate was filtered using Hirsh funnel and placed in a freezer. Weight 
(1.15 g). Yield (59%); m.p. 106-109 °C. 
2-fluoro-3-iodopyridine-ICl  
2-fluoro-3-iodopyridine (1.672 g) (0.007 mol) was mixed with ethanol (3 mL). ICl (1.210 g) 
was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl solution was then 
added dropwise to the 2-fluoro-3-iodopyridine solution. No precipitate was formed 
immediately; the solution was placed in a freezer overnight. Brown crystals were formed and 





2-fluoro-4-iodopyridine (1.672 g) (0.007 mol) was mixed with ethanol (3 mL). ICl (1.210 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl solution 
was then added dropwise to the 2-fluoro-4-iodopyridine solution. No precipitate was formed 
The solution was placed in the freezer overnight. However, no precipitate was formed. The 
solution was placed in a fume hood for a few days until orange crystals were formed. These 
were filtered using a Hirsh funnel and stored in a freezer. Weight (1.23 g) Yield (42%); m.p. 
136-138 °C. 
2-fluoro-5-iodopyridine-ICl  
2-fluoro-5-iodopyridine (1.672 g) (0.007 mol) of was mixed with ethanol (3 mL). ICl (1.210 
g) (0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl 
solution was then added dropwise to the 2-fluoro-5-iodopyridine solution. Light orange 
crystals were formed immediately. These were filtered using Hirsh funnel and stored in a 
freezer. Weight 1.78 g Yield (62%); m.p. 133-135 °C. 
2-cyanopyridinium-ICl2
- 
2-cyanopyridine (0.780 g) (0.007 mol) was mixed with ethanol (3 mL). ICl (1.210 g) (0.007 
mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl solution was 
then added dropwise to the 2-cyanopyridine solution. Brown crystals were formed 
immediately. These were filtered using a Hirsh funnel and stored in a freezer. Weight (1.31 g) 
Yield (66%); m.p. 94-96 °C. 
1,10-phenanthroline-ICl  
1,10-phenanthroline (1.351 g) (0.007 mol) was mixed with ethanol (3 mL). ICl (1.210 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl solution 
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was then added dropwise to the 1,10-phenanthroline solution. Yellow crystals were formed 
immediately. These were filtered using a Hirsh funnel and stored in a freezer. Weight (0.96 g) 
Yield (37%); m.p. 214-217 °C. 
Quinoxaline-ICl  
Quinoxaline (0.976 g) (0.007 mol) was mixed with ethanol (3 mL). ICl (1.210 g) (0.007 mol) 
was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The ICl solution was then 
added dropwise to the quinoxaline solution. No precipitate formed immediately, the solution 
was allowed to warm to room temp. and stirred more than half an hour. To this solution, 5 
mL of hexane was added. Light Brown crystals were formed, and were filtered using a Hirsh 
funnel and subsequently stored in a freezer. Weight (1.35 g) Yield (61%); m.p. 109-111 °C. 
2-chloroquinoline-ICl  
2-chloroquinoline (1.227 g) (0.007 mol) was mixed with dichloromethane (5 mL). ICl (1.210 
g) (0.007 mol) was dissolved in 4 mL of dichloromethane and cooled to 0 °C for 30 min. The 
ICl solution was then added dropwise to the 2-chloroquinoline solution. Brown crystals were 
formed immediately. The precipitate was filtered using a Hirsh funnel and stored in a freezer. 





3,5-difluoropyridine (0.862 g) (0.007 mol) was placed in a round bottom flask. IBr (1.551 g) 
(0.007 mol) was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The IBr solution 
was then added dropwise to the 3,5-difluoropyridine solution. No precipitate was formed 
immediately; the solution was placed in a freezer overnight. Brown crystals were formed. 
The precipitate was filtered using Hirsh funnel and stored in a freezer Weight (1.55 g) Yield 
(64%); m.p. (No melting point could be recorded as this was below room temperature). 
3,5-dichloropyridine-IBr 
3,5- dichloropyridine (1.125 g) (0.007 mol) was mixed with ethanol (3 mL). IBr (1.551 g) 
(0.007 mol) was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The IBr solution 
was then added dropwise to the 3,5-dichloropyridine solution No precipitate was formed 
immediately; the solution was placed in a freezer overnight. Dark brown crystals were 
formed. The precipitate was filtered using Hirsh funnel and stored in a freezer. Weight (1.21 
g) Yield (45%), m. p(No melting point could be recorded as this was below room 
temperature).  
2,6-dichloropyridine-IBr 
2,6-dichloropyridine (1.125 g) (0.007 mol) was mixed with ethanol (3 ml). IBr (1.551 g) 
(0.007 mol) was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The IBr solution 
was then added dropwise to the 2,6-dichloropyridine solution. Brown crystals were formed 
immediately. The precipitate was filtered using Hirsh funnel and stored in a freezer. Weight 





2,6-dimethoxypyridine (1.042 g) (0.007 mol) was placed in a round bottom flask. IBr (1.551 
g) (0.007 mol) was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The IBr 
solution was then added dropwise to the 2,6-dimethoxypyridine solution. Brown crystals 
were formed immediately. The precipitate was filtered using Hirsh funnel and stored in a 
freezer. Weight (0.44 g) Yield (20%); m.p. 52-55°C. 
4-methoxypyridine-IBr 
4-methoxypyridine (0.818 g) (0.007 mol) was mixed with ethanol (3 ml). IBr (1.551 g) 
(0.007 mol) was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The IBr solution 
was then added dropwise to the 4-methoxypyridine solution. Brown crystals were formed 
immediately. The precipitate was filtered using Hirsh funnel and stored in a freezer. Weight 
(1.31 g) Yield (55%); m.p. 38-40°C. 
3-fluoropyridine-IBr 
3-fluoropyridine (0.727 g) (0.007 mol) was placed in a round bottom flask. IBr (1.551 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooling to 0 °C for 30 min and dropwise to 
3-fluoropyridine. Brown crystals was formed immediately. The precipitate was filtered using 
Hirsh funnel and placed in a freezer. Yield (30%); m.p. 58-61°C. 
2-fluoro-3-iodopyridine- IBr 
2-fluoro-3-iodopyridine (1.675 g) (0.007 mol) was mixed with ethanol (3 mL). IBr (1.551 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The IBr solution 
was then added dropwise to the2-fluoro-3-iodopyridine solution. Dark brown needle crystals 
were formed immediately. The precipitate was filtered using Hirsh funnel and stored in a 





2-fluoro-4-iodopyridine (1.67g) (0.007mol) was mixed with ethanol (3 mL). IBr 1.551 g 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The IBr solution 
was then added dropwise to the 2-fluoro-4-iodopyridine solution. Brown needle crystals were 
formed immediately. The precipitate was filtered using Hirsh funnel and stored in a freezer. 
Yield (52%); m.p. 88-91 °C. 
2-fluoro-5-iodopyridine- IBr  
2-fluoro-5-iodopyridine (1.67g) (0.007mol) was mixed with ethanol (3 mL). IBr 1.551g 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The IBr solution 
was then added dropwise to the2-fluoro-5-iodopyridine solution. Brown needle crystals were 
formed immediately. The precipitate was filtered using Hirsh funnel and stored in a freezer. 
Yield (52%); m.p. 96-99 °C. 
2-Cyanopyridine- IBr 
2-cyanopyridine (0.787g) (0.007mol) was mixed with ethanol (3 mL). IBr 1.551g (0.007 mol) 
was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The IBr solution was then 
added dropwise to the2-cyanopyridine solution. Brown crystals were formed immediately. 
The precipitate was filtered using Hirsh funnel and stored in a freezer. Yield (42%); m.p. 94-
96 °C.  
1,10-Phenanthroline- IBr 
1,10-Phenanthroline (1.351 g) (0.007mol) was mixed with ethanol (3 mL). IBr (1.551 g) 
(0.007mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min.  The IBr solution 
was then added dropwise to the1,10-Phenanthroline solution. Light brown crystals were 
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formed immediately. The precipitate was filtered using Hirsh funnel and stored in a freezer. 
Weight (1.44 g)Yield (49%); m.p.191-194°C. 
Quinoxaline-IBr (yellow) 
Quinoxaline (0.976 g) (0.007 mol) was mixed with ethanol (3 mL). IBr (1.551 g) (0.007 mol) 
was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The IBr solution was then 
added dropwise to the Quinoxaline solution. No precipitate was formed immediately; the 
solution was placed in the freezer for in excess of 12 hours. Brown crystals were formed. The 
precipitate was filtered using a Hirsh funnel and stored in a freezer. Weight (1.14 g) Yield 




2-chloroquinoline (1.227 g) (0.007 mol) was mixed with ethanol (3 mL). IBr (1.551 g) (0.007 
mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The IBr solution was 
then added dropwise to the2-chloroquinoline solution. No precipitate was formed 
immediately, the solution was placed in a freezer overnight, with brown crystals being 
formed. The precipitate was filtered using Hirsh funnel and stored in a freezer Weight (1.04 





3,5-difluoropyridine (0.862 g) (0.007 mol) was placed in a round bottom flask. I2 (1.905 g) 
(0.007 mol) was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The I2 solution 
was then added dropwise to the 3,5-difluoropyridine solution. Brown crystals were formed 
immediately. The precipitate was filtered using Hirsh funnel and stored in a freezer. Weight 
(1.04g) Yield (37%); m.p. 125-128°C. 
3,5-dichloropyridine-I2 
1.125 g (0.007 mol) of 3,5- dichloropyridine was mixed with ethanol (3 ml). I2 (1.905 g) 
(0.007 mol was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The I2 solution 
was then added dropwise to the 3,5-dichloropyridine solution. Dark brown crystals were 
formed immediately. The precipitate was filtered using Hirsh funnel and stored in a freezer. 
Weight (0.85) Yield (28%); m.p. 130-133°C. 
2,6-dichloropyridine-I2 
1.125 g (0.007 mol) of 2,6 - dichloropyridine was mixed with ethanol (3 ml). I2 (1.905 g) 
(0.007 mol) was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The I2 solution 
was then added dropwise to the 2,6-dichloropyridine solution. Orange crystals were formed 
immediately. The precipitate was filtered using Hirsh funnel and stored in a freezer. Weight 
(1.57 g), Yield (68%); m.p. 95-97 °C.  
2,6-dimethoxypyridine-I2 
1.042 (0.007 mol) of 2,6-dimethoxypyridine was placed in a round bottom flask I2 (1.905 g) 
(0.007 mol) was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The I2 solution 
was then added dropwise to the 2,6-dimethoxypyridine. Yellow crystals were formed 
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immediately. The precipitate was filtered using Hirsh funnel and stored in a freezer. Weight 
(0.63 g) Yield (21%); m.p. 68-70°C.  
4-methoxypyridine-I2  
0.818 g (0.007 mol) of 4-methoxypyridine was mixed with ethanol (3 ml). I2 (1.905 g) (0.007 
mol) was dissolved in 4 ml of ethanol and cooled to 0 °C for 30 min. The I2 solution was then 
added dropwise to the 4-methoxypyridine solution. No precipitate was formed immediately, 
the solution was placed in the freezer for more than 12 hours. Dark orange crystals were then 
formed, the precipitate was filtered using Hirsh funnel and stored in a freezer. Weight (0.49) 
Yield (24%); m.p. 91-93°C. 
3-fluoropyridine-I2 
0.727 g (0.007 mol) of 3-fluoropyridine was placed in a round bottom flask. I2 (1.905 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooling to 0 °C for 30 min and dropwise to 
3-fluoropyridine. No precipitate was formed immediately. The solution was placed in the 
freezer more than 12 hours. Brown crystals were then formed, the precipitate was filtered 
using a Hirsh funnel and stored in a freezer. Weight (0.80 g), Yield (30%); m.p. (No melting 
point could be recorded as this was below room temperature). 
2-fluoro-3-iodopyridine-I2 
2-fluoro-3-iodopyridine (1.672 g) (0.007 mol) was mixed with ethanol (3 mL). I2 (1.905 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The I2 solution 
was then added dropwise to the 2-fluoro-3-iodopyridine solution. No precipitate was formed 
immediately, the solution was placed in the freezer for more than 12 hours. However, no 
precipitate was formed, the solution was placed in a fume hood for a few days until brown 
crystals were formed. These were filtered using Hirsh funnel and stored in a freezer. Weight 




2-fluoro-4-iodopyridine (1.672 g) (0.007 mol) was mixed with ethanol (3 mL). I2 (1.905 g) 
was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The I2 solution was then 
added dropwise to the 2-fluoro-4-iodopyridine solution No precipitate was formed 
immediately, the solution was placed in the freezer more than 12 hours. Brown crystals were 
then formed, the precipitate was filtered using a Hirsh funnel and stored in a freezer. Weight 
(1.90 g) Yield (66%); m.p. 62-65 °C. 
2-fluoro-5-iodopyridine-I2 
2-fluoro-5-iodopyridine (1.672 g) (0.007 mol) was mixed with ethanol (3 mL). I2 (1.905 g) 
was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The I2 solution was then 
added dropwise to the2-fluoro-5-iodopyridine solution. No precipitate was formed 
immediately, the solution was placed in the freezer more than 12 hours. Brown crystals were 
then formed, the precipitate was filtered using Hirsh funnel and stored in a freezer. Weight 
(1.90 g) Yield (66%); m.p. 32-35 °C. 
2-cyanopyridine-I2 
0.787g (0.007 mol) of 2-cyanopyridine was mixed with ethanol (3 mL). I2 (1.905 g) (0.007 
mol was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The I2 solution was then 
added dropwise to the 2-cyanopyridine solution. No precipitate was formed immediately the 
solution was placed in the freezer for more than 12 hours. However, no precipitate was 
formed, the solution was placed in a fume hood for a few days until a brown non-crystalline 
precipitate was formed. This was dissolved in 3 mL of dichloromethane and cooled to -75°C. 
Brown crystals were then formed, these were filtered using a Hirsh funnel and stored in a 
freezer. Weight (0.75 g), Yield (27%); m.p. (No melting point could be recorded as this was 




1,10-phenanthroline (1.351 g) (0.007 mol) was mixed with ethanol (3 mL). I2 (1.905 g) 
(0.007 mol) was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The I2 solution 
was then added dropwise to the1,10-phenanthroline solution. No precipitate was formed 
immediately, the solution was placed in the freezer for more than 12 hours. Dark grey 
crystals were then formed, the precipitate was filtered using Hirsh funnel and stored in a 
freezer. Weight (1.06 g) Yield (32%); m.p. 137-139°C.  
Quinoxaline-I2 
Quinoxaline (0.976 g) (0.007 mol) was mixed with ethanol (3 mL). I2 (1.905 g) (0.007 mol) 
was dissolved in 4 mL of ethanol and cooled to 0 °C for 30 min. The I2 solution was then 
added dropwise to the Quinoxaline solution No precipitate was formed immediately, the 
solution was placed in the freezer for more than 12 hours. However, no precipitate was 
formed, the solution was then placed in a fume hood for a few days until reddish brown 
crystals were formed. These were filtered using a Hirsh funnel and stored in a freezer. Weight 
(1.02 g) Yield (35%); m.p. 126-129°C. 
2-chloroquinoline-I2 
2-chloroquinoline (1.227 g) (0.007 mol) was mixed with dichloromethane (5 mL). I2 (1.905 
g) (0.007 mol) was dissolved in (4 mL) of dichloromethane and cooled to 0 °C for 30 min. 
The I2 solution was then added dropwise to the2-chloroquinoline solution. No precipitate was 
formed immediately, the solution was placed in the freezer for more than 12 hours. Brown 
crystals were then formed, the precipitate was filtered using a Hirsh funnel and stored in a 




2.5 ATR-FTIR data. 
ATR-FTIR spectrum band positions for starting material are shown in Table 2.2 and for the 
ICl, IBr and I2 halogen bond complexes are shown in Table 2.3, while ATR-FTIR Spectra of 
both the starting material and for all products in is each of the corresponding chapters. 




Starting material C-Cl C-F C-N C=C C-H 
3,5-difluoropyridine  1042 1577 1476 3101 
3,5-dichloropyridine 728  1423 1555 3070 
2,6-dichloropyridine 737  1584 1654 3039 
2,6-dimethoxypyridine   1530 1545 3102 
4-methoxypyridine   1547 1616 3097 
3-fluoropyridine  1074 1576 1645 3054 
2-fluoro-3-iodopyridine  1109 1556 1579 3024 
2-fluoro-4-iodopyridine  1073 1578 1645 3056 
2-fluoro-5-iodopyridine  1075 1557 1579 3055 
2-cyanopyridine   1462 1578 3060 
1,10-phenanthroline   1502 1586  
Quinoxaline   1530 1630 3038 








Product C - Cl C-F C-N C=C C-H 
3,5-difluoropyridine-ICl  1082 1561 1437 3072 
3,5-dichloropyridine-ICl 700  1407 1535 3039 
2,6-dimethoxypyridine-ICl   1483 1548 3011 
4-methoxypyridine-ICl   1500 1604 3098 
3-fluoropyridine-ICl  1099 1557 1605 3036 
2-fluoro-3-iodopyridine-ICl  1036 1511 1585 3083 
2-fluoro-4-iodopyridine-ICl  1072 1540 1583 3082 
2-fluoro-5-iodopyridine-ICl  1041 1568 1592 3045 
2-cyanopyridine-ICl   1552 1587 3093 
1,10-phenanthroline-ICl   1496 1545 3052 
Quinoxaline-ICl   1494 1608  










Product C-Cl C-F C-N C=C C-H 
3,5-difluoropyridine-IBr  1152 1538 1610 3065 
3,5-dichloropyridine-IBr 1099  1551 1462 3054 
2,6-dichloropyridine-IBr   1556 1609 3050 
2,6-dimethoxypyridine-IBr   1544 1609 3003 
4-methoxypyridine-IBr   1560 1604 3015 
3-fluoropyridine – IBr  1114 1584 1603 3100 
2-cyanopyridine-IBr   1581 1604 3090 
1,10-phenanthroline-IBr   1563 1615  
Quinoxaline-IBr    1612 3038 








Product C-Cl C-F C-N C=C C-H 
3,5-difluoropyridine-I2  1382 1549 1437 3024 
3,5-dichloropyridine-I2   1407 1535 3039 
2,6-dimethoxypyridine-I2   1534 1608 3000 
4-methoxypyridine-I2   1560 1604 3090 
3-fluoropyridine-I2  1115 1585 1605 3086 
2-cyanopyridine-I2   1577 1600 3084 
1,10-phenanthroline-I2   1561 1612 3052 
Quinoxaline-I2   1557 1672  













The pioneering work on halogen bonding was performed on systems including dihalogens,
6,10
 
but the majority of the current halogen bond research involves organohalogen or inorganic 
halide XB donors. However, the dihalogens continue to attract interest.
106
 The majority of 




Dihalogens can be divided into two groups, homoatomic (X2), and heteroatomic (XY) which 
are also called interhalogens. As it was mentioned in the general introduction, due to the size 
and polarizability of the atoms, the XB donor ability for homoatomic dihalogens increases in 
order F2 < Cl2 < Br2 < I2. In systems where homonuclear dihalogens approach the 
nucleophilic region of XB acceptor, charge separation occurs. For simplicity, the X atom 
interacting with XB acceptor will be labelled as XI, while the X atom not included in 
interaction will be labelled as XII. On the XI end, there is an accumulation of positive charge, 
while the negative charge accumulates on the XII end. After the formation of an XB with a 
Lewis base, the negative charge on the XII makes it more likely to act as an acceptor of a 
different XB or HB, than as the XB donor. In addition to that, the initial X─X bond is 




Heteroatomic dihalogens (XY) are polar because of different atoms present in the molecule 
and this property impacts the XB donor features. The negative charge is located on the more 
electronegative halogen atom (Y) thus making the less electronegative halogen (X) the XB 
donor atom. For the iodine-containing heteronuclear dihalogens the XB donor ability is 
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stronger, the more difference in the electronegativity there is, causing the better charge 
separation. 
Iodine monochloride is a heteronuclear dihalogen that is observed as a solid in two 
polymorph forms that melt near room temperature, dark-red needles (α-form, m.p. 27.2 °C) 
and brown-red platelets (β-form, m.p. 13.9 °C). It is soluble in methanol, ethanol, ether, 
pyridine, acetone, and acetic acid, but hydrolyses when in contact with water.
111
 Iodine 
monochloride is prepared by reaction of gaseous iodine and chlorine in 1:1 ratio, the bond 
length of ICl in the gas phase was determined by microwave spectroscopy (2.3210 Å).
27  
In a study by Ouvrard et al. 141 halogen bond complexes based on homo- and heteronuclear 
dihalogens were studied
112
. These authors report that in these systems N, O, S, P, As and Se 
are observed to act as XB acceptors, while Cl, Br and I as XB donors. They concluded that 
for the studied systems, the mean R-X···Y bond angle is 176°, which is more linear by 11-
38° 
112
 than the corresponding O-H···Y HBs. Moreover, for the sp
2
- hybridized N bases the 
XB direction is very close to the axis of the nonbonding electron pair and the Y···X halogen 
bond length and the elongation of the dihalogen bond are significantly related to the donation 
strength of the Lewis base, but the Lewis acid strength (Br2 < I2 < IBr < ICl) does not rely on 
the softness of the base. In this introduction, only the complexes containing N···ICl will be 
















 2-Chloroquinoline iodomonochloride 2.432 2.446 179.93 
GANXAV
114
 3-Bromo-1-chloroiodopyridine 2.344 2.473 178.43 
GANXOJ
114
 1-Chloroiodo-4-(dimethylamino)pyridine 2.246 2.562 179.24 
PMTTIC
115
 Pentamethylenetetrazole iodine 
monochloride 
2.347 2.437 176.11 
PYRIIC10
116





2.327 2.554 178.64 
TAGNEV
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2.294  2.512 176.49 
 
It can be observed that 11 complexes containing N···I-Cl have been reported. The average 
N···I distance is 2.319 Å, while the value for I-Cl bond is 2.507 Å. A complex with refcode 
ZAVDAB
120120 has the shortest N···I value (2.228 Å) that indicates the strongest XB, and the 
most elongated I-Cl bond (2.651 Å) is observed in the same system, as well. All the N···I-Cl 




This chapter aims to prepare and characterise crystalline N···I halogen-bonded complexes 
formed by a reaction between the selected aromatic nitrogen compounds with iodine 
monochloride. The starting materials were chosen because of the large variety in their base 
strength. All the crystalline complexes are characterised by ATR-FTIR spectroscopy, UV-Vis 
spectroscopy and single-crystal X-ray diffraction. From the structures obtained by X-ray 
diffraction the halogen bond lengths and angles within the N···I unit are determined and 




3.3 Investigation of halogen bonded complexes 
3.3.1 3,5-difluoropyridine- ICl  
 
UV-Visible spectra for 3,5-difluoropyridine- ICl solution  
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 3,5-difluoropyridine absorbed at 303 nm and ICl absorbed at 341 nm. A 
new band appeared at 443 nm when the two above starting materials were mixed, which is 
not attributed to the 3,5-difluoropyridine or ICl. This new band supports the argument that the 
formation of the halogen bonded complex occurs. That means λmax for 3,5-difluoropyridine is 
shifted 140 nm toward higher wavelengths, which is called bathochromic shift or redshift,  
Figure (3.1.1). The starting material and the resulting complex are also characterised by 




Figure (3.1.1): UV-Visible spectra for the 3,5-difluoropyridine-ICl system:  
3,5-difluoropyridine (Blue), ICl (Orange) and 3,5-difluoropyridine-ICl (Green), the spectra 



























Figure (3.1.3): IR spectrum of 3,5-difluoropyridine-ICl. 
 
XRD measurements: 
1.Crystal Structure of 3,5-difluoropyridine-ICl  
Crystallographic data for 3,5-difluoropyridine are given in Table (3.1), and selected bond 
lengths and angles in Table (3.2). A Thermal ellipsoid plot of the structure together with the 





Figure (3.1.4): Thermal ellipsoid plot of 3,5-difluoropyridine-ICl. 
3,5-difluoropyridine crystallises in the monoclinic space group P21/m. The molecule thus 
possesses crystallographic mirror symmetry with I1, Cl1, N1, C4 and H41 lying in the mirror 
plane, Figure (3.1.5). 
 
Figure (3.1.5): Thermal ellipsoid plot of 3,5-difluoropyridine showing relationship to 
crystallographic mirror plane possessed by molecule. 
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The halogen bond distance between N and I is 2.358(6) Å (N···I-Cl angle is 178.60(1)), 
which is less than the sum of van der Waals radii of N and I (3.51 Å).
121
 The distance 
between I and Cl for the product is 2.470(2) Å, while the same distance for the iodine 
monochloride is 2.3210 Å.
27
  
Complexes are further interconnected via series of C-H···F and C-H···Cl hydrogen bonds, 
Figures (3.1.6, 3.1.7).  In the C–H···Cl hydrogen bond, H···Cl distance is (2.789 Å) and the 
C–H···Cl angle is (143.13°). The hydrogen bonding motif can be described by the graph set 
motif   
 (  ) shown in Figure (3.1.8). There is also C–H···F hydrogen bond present (2.641 





 The distance between C and F is 0.029 Å less than the 
summation of van der Waals radii and C–H···F angle is (129.67°). Graph motif present in 
this type of hydrogen bond is   
 ( ), while both hydrogen bonds are a part of   
 (  ) motif, 
Figure (3.1.8). In this figure, the orange contact refers to the halogen bond between N and I, 
while the red contacts refer to the hydrogen bonds between H and F, H and Cl. 
All the analogous complexes are in the single plane and they are linked via C-H···F HBs to 
complexes in the plane above and via C-H···Cl hydrogen bonds to complexes in the plane 
below, Figures (3.1.6, 3.1.7). The vertical distance between the two planes where complexes 
are linked via C-H···F HBs is 1.163 Å, while the distance between centroids of two adjacent 
molecules in these planes is 6.751 Å, Figure (3.1.9).  The vertical distance between the planes 
where complexes are linked via C-H···Cl HBs is 1.580 Å, while the distance between 




Figure (3.1.6): View showing planes consisting of 3,5-difluoropyridine –ICl complexes 
linked by C-H···F and C-H···Cl hydrogen bonds 
 
Figure (3.1.7) View showing vertical view on the planes consisting of 3,5-difluoropyridine –





Figure (3.1.8) View showing 3,5-difluoropyridine–ICl approximately along a-axis with the 




Figure (3.1.9) View showing the distance between the centroids  
of two 3,5- difluoropyridine –ICl molecules and the vertical distance between two adjacent 
planes where complexes are linked via C-H···F hydrogen bonds  
 
Figure (3.1.10) View showing the distance between the centroids  
of two 3,5- difluoropyridine –ICl molecules and the vertical distance between two adjacent 




Table (3.1) Crystallographic data for 3,5-difluoropyridine -ICl complex. 
Crystal data  
Chemical formula C5H3ClF2IN 
Mr 277.44 
Crystal system, space group Monoclinic, P21/m 
T/K 123 
a, b, c (Å) 4.1747 (1), 7.9188 (3), 11.5313 (4) 
β (°) 91.5981 (17) 
V/ (Å
3
) 381.06 (2) 
Z 2 




Crystal size / (mm) 0.33 × 0.12 × 0.06 
  
Data collection  
Diffractometer Bruker Kappa Apex2 
Absorption correction Multi-scan  
SADABS (Siemens, 1996) 
Tmin, Tmax 0.58, 0.76 
No. of measured, independent and 
observed [I > 2.0ζ(I)] reflections 















), S 0.029, 0.073, 1.08 
No. of reflections 1044 
No. of parameters 54 
No. of restraints 2 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3





Table (3.2): Selected interatomic contacts/ Å and /
o
 for the complex 3,5-difluoropyridine –
ICl. 
Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 Cl1 2.470(2) Cl1 I1 N1 178.691) 
I1 N1 2.358(6) I1 N1 C2 119.3(3) 
N1 C2 1.336(5) I1 N1 C2 119.3(3) 
N1 C2 1.336(5) C2 N1 C2 121.4(6) 
C2 C3 1.376(7) N1 C2 C3 119.4(5) 
C3 C4 1.381(6) C2 C3 C4 122.3(5) 
C3 F1 1.344(5) C2 C3 F1 118.7(4) 
C4 C3 1.381(6) C4 C3 F1 118.9(4) 
C2 C3 1.376(7) C3 C4 C3 115.2(4) 
C3 F1 1.344(5) H41 C4 C3 122.3(5) 
 N1 C2 C3 119.4(5) 





3.3.2 3,5-dichloropyridine- ICl  
 
 UV-Visible spectra of 3,5-dichloropyridine- ICl solution. 
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 3,5-dichloropyridine absorbed at 335 nm and ICl absorbed at 341 nm. 
When the two above starting materials were mixed a new band appeared at 444 nm, which is 
not attributed to starting materials. This new band confirms the formation of the halogen 
bonded complex. That means λmax for 3,5-dichloropyridine is shifted 109 nm toward higher 
wavelengths, Figure (3.2.1). Starting material and the resulting complex are also 





Figure (3.2.1): UV-Visible spectra of 3,5-dichloropyridine-ICl:  
3,5-dichloropyridine (Blue), ICl (Orange), 3,5-dichloropyridine-ICl (Green), the spectra were 



























 Figure (3.2.3): IR spectrum of 3,5-dichloropyridine-ICl 
XRD measurements for 3,5-dichloropyridine -ICl 
Crystal Structure of 3,5-dichloropyridine-ICl  
Crystallographic data for 3,5-dichloropyridine are given in Table (3.3), and selected bond 
lengths and angles in Table (3.4). A Thermal ellipsoid plot of the structure together with the 
numbering scheme used is given in Figure (3.2.4). 
 
Figure (3.2.4): Thermal ellipsoid plot of 3,5-dichloropyridine-ICl. 
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3,5-dichloropyridine-ICl crystallises in the orthorhombic space group Cmcm. The molecule 
possesses exact mm crystallographic symmetry. One mirror plane contains Cl1, I1, N1, C4 
and H41, whilst the mirror plane which is perpendicular to it comprises in addition to these 
atoms C2, C3, Cl2 and H21. Due to the presence of the two mirror planes at right angles to 
each other, there is only 
1
/4 of a molecule in the asymmetric unit, Figure (3.2.5).  
 
Figure (3.2.5): Thermal ellipsoid plot of 3,5-dichloropyridine-ICl showing relationship to 
crystallographic mirror plane possessed by the complex. 
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Table (3.3) Crystallographic data for 3,5-dichloropyridine -ICl complex. 
Crystal data  
Chemical formula C5H3Cl3IN 
Mr 310.35 
Crystal system, space group Orthorhombic, Cmcm 
T/K 123 
a, b, c/ (Å) 6.6920 (3), 14.8401 (6), 9.1150 (4) 
V/ (Å
3
) 905.21 (7) 
Z 4 




Crystal size/ (mm) 0.30 × 0.22 × 0.15 
Data collection  
Diffractometer Bruker Kappa Apex3  
Absorption correction Multi-scan  
SADABS (Siemens, 1996) 
Tmin, Tmax 0.38, 0.51 
No. of measured, independent and 
observed [I > 2.0ζ(I)] reflections 












), S 0.018, 0.046, 1.11 
No. of reflections 803 
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No. of parameters 39 
No. of restraints 6 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3





Table (3.4): Selected interatomic contacts/ Å and /
o
 for the complex 3,5-dichloropyridine–ICl. 
 
3,5-dichloropyridine and ICl are connected via halogen bond between N atom of the pyridine 
ring and I atom of  ICl. The distance of N···I interaction is 2.342 Å, which is less than the 
sum of van der Waals radii for N and I (3.51 Å).121 The second indication of halogen bond is 
the distance between I and Cl (2.487 Å) which is elongated compared to the bond distance of 
ICl in the gas phase (2.3210 Å).
27
 The 3,5-dichloropyridine-ICl molecular complex forms a 
chain running parallel with c-axis, Figure (3.2.6). These chains are connected by C-H···Cl 
hydrogen bonds, where chlorine from I-Cl moiety acts as a bifurcated acceptor. The distance 
between H and Cl atom in C-H···Cl hydrogen bond is 2.695 Å, which is shorter than the sum 
Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 Cl1 2.4872(9) Cl1 I1 N1 180 
I1 N1 2.341(3) I1 N1 C2 119.4(2) 
N1 C2 1.336(3) I1 N1 C2 119.4(2) 
N1 C2 1.336(3) C2 N1 C2 121.1(4) 
C2 C3 1.386(4) N1 C2 C3 120.1(3) 
C3 C4 1.384(4) C2 C3 C4 120.8(3) 
C3 Cl2 1.729(3) C2 C3 Cl2 118.7(2) 
C4 C3 1.384(4) C4 C3 Cl2 120.5(2) 
C2 C3 1.386(4) C3 C4 C3 117.1(4) 
C3 Cl2 1.729(3) N1 C2 C3 120.1(3) 
   C4 C3 C2 120.8(3) 
   C4 C3 Cl2 120.5(2) 
   C2 C3 Cl2 118.7(2) 
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of van der Waals radii of H and Cl (2.96 Å),
121
 and the C-H···Cl angle is 165.4(2)°. 
Moreover, the   
 (  ) graph set motif can be assigned to this hydrogen bond, Figure (3.2.7). 
Because a chlorine atom is larger than a fluorine atom and due to the lack of the equivalent of 
the C-H···F hydrogen bonds between the layers of chains on the side of the pyridine ring 
opposite to the N···I-Cl XB, the complexes are linked by C-H···Cl hydrogen bonds that are 
within the same plane, (Figures (3.2.8), (3.2.9)). This is the opposite to the 3,5-
difluoropyridine-ICl, where both types of hydrogen bonds linked the complexes in different 
planes. The lack of the equivavlent of C-H···F hydrogen bonds could also be observed by the 
increase in distance between the centroids of two adjacent pyridine rings within the plane 
(8.143 Å), which is significantly longer than the corresponding one in the 3,5-
difluoropyridine-ICl (6.751 Å), while the distance between two centroids of complexes 
linked via C-H···Cl is similar, 9.451 Å and 9.287 Å, respectively. (Figures 3.1.9, 3.1.10, 
3.2.9) The distance between two planes in 3,5-dichloropyridine-ICl is 3.346 Å, the distance 
between two centroids of the adjacent 3,5-dichloropyridine molecules between the planes is 
5.694 Å (Figure (3.2.9)). 
Also, it is observed that the distance of H···Cl interaction (2.789 Å) in  
the 3,5-difluoropyridine-ICl complex is longer than the distance of H···Cl (2.695 Å) in  
3,5-dichloropyridine-ICl. This is supported by shorter elongation of I-Cl bond in 3,5-
difluoropyridine-ICl (2.470 Å) than in 3,5-dichloropyridine-ICl (2.487 Å). The effect can be 
explained by a more charge transfer in the dichloropyridine complex leading to a greater 
negative charge on the chlorine, which leads to a stronger hydrogen bond. Additionally, only 
one type of hydrogen bonds present in dichloropyridine complex indicates that the electron 




Figure (3.2.6): Packing diagram of 3,5-dichloropyridine -ICl  
viewed parallel to the c-axis. 
 
Figure (3.2.7): Thermal ellipsoid plot of 3,5-dichloropyridine-ICl showing 




Figure (3.2.8): Stacking of two adjacent planes containing 3,5-dichloropyridine –ICl 
complexes. 
 






3.3.3 2,6-dichloropyridine- ICl  
 
 
Crystal Structure of 2,6-dichloropyridine 
Unfortunately, the crystals obtained are not of the halogen bonded complex but rather that of 
the starting material 2,6-dichloropyridine. ATR-FTIR spectrum is given in Figure 3.3.1 and 
crystallographic data for 2,6-dichloropyridine in Table (3.5), and selected bond lengths and 
angles in Table (3.6). A thermal ellipsoid plot of the structure together with the numbering 
scheme used is given in Figure (3.3.2)  
 




Figure (3.3.2): Thermal ellipsoid plot of 2,6-dichloropyridine. 
2,6-dichloropyridine crystallises in the monoclinic space group P21/m with Z=2. The 
molecule thus possesses exact crystallographic mirror symmetry with atoms N1, C4 and H41 
lying in mirror plane Figure (3.3.3). The individual bond lengths agree well with the values 




Figure (3.3.3): Thermal ellipsoid plot of 2,6-dichloropyridine showing relationship to 
crystallographic mirror plane possessed by molecule.  
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Table (3.5) Crystallographic data for 2,6-dichloropyridine. 
Crystal data  
Chemical formula (C5H3Cl2N) 
Mr 495.76 
Crystal system, space group Monoclinic, P21/m 
T/K 298 
a, b, c (Å) 3.870 (3), 14.845 (11), 5.441 (4) 
β (°) 97.49 (3) 
V/ (Å
3
) 309.9 (4) 
Z 2 




Crystal size /(mm) × ×  
Data collection  
Diffractometer Bruker Kappa Apex3 
Absorption correction – 
No. of measured, independent and 
observed [I > 2ζ(I)] reflections 
844, 320, 231  
Rint 0.062 













), S 0.063, 0.156, 1.11 
No. of reflections 320 
No. of parameters 40 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 0.25, −0.28 
 
Table (3.6): Selected interatomic contacts/ Å and /
o
 for the complex 2,6-dichloropyridine  
Atom1 Atom2 Length  Atom1 Atom2 Atom3 Angle 
Cl1 C1 1.738 (6) C2 N1 C2 115.4(2) 
N1 C2 1.323(7) N1 C2 C3 125.3(1) 
C2 C3 1.382(9) C2 C3 C4 116.8(1) 
C3 C4 1.383(7) C3 C4 C3 120.0(1) 
  Cl1 C2 N1 115.0(1) 
Cl1 C2 C3 119.7(1) 
 
Of the 2,6-dihalo- substituted pyridines only that of 2,6-difluoropyridine has been reported.
123
 
The ipso angle N1-C2-C3 angle 125.3°)
 
is slightly smaller to the average seen than in the 
case of the difluoro- compound (126°), which is presumably the result of the greater 
electronegativity of fluorine.
124
 The observed ipso C2-N1-C2 angle 115.4°
 
is identical to that 
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seen compared in the fluoro compound,115.4(7)°. Both of these angles at N do not differ 
significantly from that observed in pyridine itself 116.5°.
125
 
In the structure of 2,6-dichloropyridine, two different intermolecular interactions appear to be 





are aligned in the 101 direction to form linear chains, Figure (3.3.4). 
The main reason for obtaining starting material 2,6-dichloropyridine instead of the halogen 
bond complex could be due to the starting material 2,6-dichloropyridine containing two 
chlorine groups which cause an effect from two sides: 
Firstly, the two chlorine atoms that are moderately good electron-withdrawing groups thus 
act to decrease the electron density on N atom for pyridine ring. Secondly, the position of 
these two groups (ortho- position) acts to prevent ICl from attacking the N atom of the 
pyridine ring by the steric hindrance. 
 
Figure (3.3.4) View normal to the chain direction 
The other interactions are Cl···Cl halogen bonds 3.362 Å which are approximately in the 121 
direction, Figure (3.3.5). These are type I halogen bonds
125
 as the difference between the 2 
the C-Cl···Cl angle in the bond is 0° which is less than 15°
 






Figure (3.3.5) interactions are Cl···Cl halogen bonds which are approximately in the 121 
direction. 
The overall effect of these interactions is to produce layers in approximately the 101 plane, 
Figure (3.3.6) 
 
Figure (3.3.6) layers in approximately the 101 plane. 
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The closest distance of approach between an atom and that of atom in the layer above is 
typically 3.4-3.41 Å, Figure (3.3.6) whilst the centroid to centroid distance is 3.870 Å, Figure 
3.3.7 
 
Figure (3.3.7) View showing the distance between the centroids  
of two 2,6- dichloropyridine –ICl molecules   
86 
 
3.3.4 2,6-dimethoxypyridine- ICl  
 
UV-Visible spectra of the 2,6-dimethoxypyridine-ICl solution  
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 2,6-dimethoxypyridine absorbed at 316 nm and iodine monochloride 
ICl at 341 nm. A new band appeared at 446 nm when the two above starting materials were 
mixed which cannot be attributed to the 2,6-dimethoxypyridine or ICl. That means λmax for 
2,6-dimethoxypyridine is shifted 130 nm toward higher wavelengths. Figure (3.4.1) Starting 





Figure (3.4.1): UV-Visible spectra of 2,6-dimethoxypyridine –ICl system:  
2,6-dimethoxypyridine (Blue), ICl (Orange), 2,6-dimethoxypyridinium- ICl2
–
 (Green),the 

























Figure (3.4.3): ATR-FTIR spectrum of 2,6-dimethoxypyridinium- ICl2
–
 
XRD measurements for 2,6-dimethoxypyridinium - ICl2
– 
Crystal Structure of 2,6-dimethoxypyridinium- ICl2
–
  
Instead of the expected 2,6-dimethoxypyridine-ICl complex linked via the Cl-I···N halogen 
bond, the 2,6-dimethoxypyridinium- ICl2
–
 complex is observed. Crystallographic data for 2,6-
dimethoxypyridinium- ICl2
–
 are given in Table (3.7), and selected bond lengths and angles in 
Table (3.8) A Thermal ellipsoid plot of the structure together with the numbering scheme 









crystallises in the monoclinic space group P21/n. The 
structure unlike many of the other compounds studied possesses no exact crystallographic 
symmetry, and thus the asymmetric unit comprises of just a pyridinium cation and ICl2
– 
anion 
with a hydrogen bond between the pyridine ring and the ICl2
–
. The distance between the 





Table (3.7): Crystallographic data for 2,6-dimethoxypyridinium – ICl2
-
 complex.  
Crystal data  
Chemical formula Cl2I·C7H10NO2 
Mr 337.96 
Crystal system, space group Monoclinic, P21/n 
T/K 190 
a, b, c (Å) 7.2986 (3), 12.6919 (6), 12.6654 (6) 
β (°) 102.413 (2) 
V/ (Å
3
) 1145.81 (9) 
Z 4 




Crystal size / (mm) 0.29 × 0.23 × 0.19 
  
Data collection  
Diffractometer Bruker APEX-II CCD 
Absorption correction Multi-scan 
Tmin, Tmax 0.643, 0.747 
No. of measured, independent and 
observed [I > 2ζ(I)] reflections 















), S 0.028, 0.055, 1.08 
No. of reflections 5626 
No. of parameters 123 
No. of restraints 1 
H-atom treatment H atoms treated by a mixture of 
independent and constrained refinement 
Δρmax, Δρmin (e Å
−3




Table (3.8): Selected interatomic contacts/ Å and /
o




Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 Cl1 2.6041(5) Cl1 I1 Cl2 178.99(2) 
I1 Cl2 2.5176(5) C1 O1 C7 117.2(1) 
O1 C1 1.325(2) C5 O2 C6 117.7(1) 
O1 C7 1.440(2) C1 N1 C5 123.4(1) 
O2 C5 1.318(2) O1 C1 N1 112.0(1) 
O2 C6 1.443(2) O1 C1 C2 128.5(1) 
N1 C1 1.344(2) N1 C1 C2 119.5(1) 
N1 C5 1.350(2) C1 C2 C3 117.5(2) 
C1 C2 1.380(2) H2 C2 C3 121.3 
C2 C3 1.387(3) C2 C3 C4 122.7(2) 
C3 C4 1.376(3) H3 C3 C4 118.7 
C4 C5 1.383(2) C3 C4 C5 117.7(2) 
 
H4 C4 C5 121.2 
O2 C5 N1 111.8(1) 
O2 C5 C4 128.9(1) 
N1 C5 C4 119.2(1) 
 
Instead of a complex linked by a Cl-I···N halogen bond, this system crystallised as an ionic 
complex 2,6-dimethoxypyridinium- ICl2
– 
linked through the N-H···Cl hydrogen bond.  The 
formation of polyhalogen ions is discussed below. Based on mechanisms described in section 
(3.4 Discussion) that suggest the formation of polyhalogen ions occurs due to the hydrolysis, 
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it can be observed that hydrogen ions are formed as a byproduct of that reaction. These 
hydrogen ions can further protonate the nitrogen atom of the pyridine ring, thus enabling the 
formation of the crystalline halogen-bonded complex by balancing the charge in the crystal, 
as well. The distance between the iodine atom and the two chlorine atoms within the ion is 
different, with the distance between the iodine atom and Cl1 being 2.6041(5) Å and the 
distance between the iodine atom and Cl2 2.5177(6) Å. The difference in bond lengths is 
observed because of the N1-H1···Cl1 hydrogen bond, where the N1···Cl1 distance is 
3.224(1) Å, and the N1-H1···Cl1 angle is 166.90(2) °. This hydrogen bond causes the 
elongation of the bond between I1 and Cl1, while the I1-Cl2 bond is shorter because Cl2 is 
not included in any of the non-covalent interactions. 
 






Figure (3.4.6): View showing the distance between the centroids of  





3.3.5 4-methoxypyridine- ICl  
 
UV-Visible spectra for 4-methoxypyridine-ICl solution 
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M.  The base 4-methoxypyridine absorbed at 328 nm and iodine monochloride 
absorbed at 341 nm. A new band appeared at 359 nm when the two above starting materials 
were mixed which is not attributed to the 4-methoxypyridine or ICl. λmax for 4-
methoxypyridine was shifted 31 nm toward higher wavelengths (Figure 3.5.1). Starting 





Figure (3.5.1): UV-Visible spectra of 4-methoxypyridine -ICl:  
4-methoxypyridine (Blue), ICl (Orange), 4- methoxypyridine -ICl (Green), the spectra were 






























Figure (3.5.3): ATR-FTIR spectrum of 4-methoxypyiridine-ICl 
(Spectrum should be collected again prior to further publication of the data) 
 
XRD measurements for 4-methoxypyridine –ICl 
Crystal Structure of 4-methoxypyridine-ICl  
Crystallographic data for 4-methoxypyridine- ICl are given in Table (3.9), and selected bond 
lengths and angles in Table (3.10) A Thermal ellipsoid plot of the structure together with the 
numbering scheme used is given in Figure (3.5.4) 
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Figure (3.5.4): Thermal ellipsoid plot of 4-methoxypyridine-ICl. 
4-methoxypyridine-ICl crystallises in the monoclinic space group P21/n. The molecular 
complex possesses no exact crystallographic symmetry. Moreover, the unit cell consists of 
four complexes (Figure 3.5.5) and the asymmetric unit of one 4-methoxypyridine and one ICl 
molecule. They are connected through the N atom of the pyridine ring and I atom of the ICl 
moiety. The selected distances between the following atoms are atoms: N1 and I1 2.272(3) Å, 
I1 and Cl1 2.528(1) Å, N1 and C1, and C5 are 1.331(4) Å, 1.347(3) Å respectively, and of 
C3-O, and C6-O was 1.344(4) Å, 1.440(4) Å, respectively. 
Measured angles: N-I-Cl was 177.87(7) °, I-N-C1 and I-N-C5 was121.1(2º), 118.0(2) º 
respectively C3-O-C6 was 118.0(3) °. Table (3.10). 
4-methoxypyridine and ICl are connected by Cl–I···N halogen bond. The distance of  N···I 
interaction is 2.272(3) Å, which is shorter than the sum of N and I van der Waals radii (3.51 
Å).
121 Moreover, the distance between I and Cl (2.528(1) Å) which is an elongation 
compared to the ICl bond length in the gas phase (2.3210 Å).
27
 Also, I-Cl elongation and the 
N···I distance in this complex indicate that the halogen bond interaction is the strongest 
amongst the comparable complexes within this work (3,5-dichloropyridine-ICl, 3,5-
difluoropyridine). The central distance between two molecules with 4-methoxy groups facing 
99 
 
in opposite directions in 4.191 Å, while the distance between two adjacent molecules through 
the inversion centre is 6.551 Å, Figure (3.5.5) The complex units are not interconnected by 
hydrogen bonds like in the cases of 3,5-difluoro- and 3,5-dichloropyridine-ICl samples. Even 
though the ether oxygen atom could act as a hydrogen bond acceptor, there are no strongly 
polarised bonds (N-H, O-H) in the system that are necessary for such interactions.
 128
 
Additionally, the C-H···Cl hydrogen bonds, that linked mentioned complexes in chains, are 
not observed as well. Since the elongation of the I-Cl bond (2.528 Å) is more significant than 
in the previously mentioned complexes (2.470 Å and 2.487 Å, respectively), the large amount 
of electron density is transferred into XB interaction. Therefore, the additional hydrogen bond 
would require even more electron density redistribution, which could ultimately lead to I-Cl 
bond cleavage. 
 
Figure (3.5.5) View showing the distance between the centroids  
of two 4-methoxypyridine -ICl molecules.  
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Table (3.9) Crystallographic data for 4-methoxypyridine –ICl. 
Crystal data  
Chemical formula Cl2I·C7H10NO2 
Mr 337.96 
Crystal system, space group Monoclinic, P21/n 
T/K 190 
a, b, c (Å) 7.2986 (3), 12.6919 (6), 12.6654 (6) 
β (°) 102.413 (2) 
V/ (Å
3
) 1145.81 (9) 
Z 4 




Crystal size/ (mm) 0.29 × 0.23 × 0.19 
  
Data collection  
Diffractometer Bruker APEX-II CCD 
Absorption correction Multi-scan  
Tmin, Tmax 0.643, 0.747 
No. of measured, independent and 
observed [I > 2ζ(I)] reflections 















), S 0.028, 0.055, 1.08 
No. of reflections 5626 
No. of parameters 123 
No. of restraints 1 
H-atom treatment H atoms treated by a mixture of 
independent and constrained refinement 
Δρmax, Δρmin (e Å
−3





Table (3.10): Selected interatomic contacts/ Å and /
o
 for the complex 4-methoxypyridine -ICl 
I1—Cl1 2.5305 (4) C3—C4 1.3935 (19) 
I1—N1 2.2717 (12) C4—C5 1.3993 (18) 
N1—C2 1.3376 (17) C4—O7 1.3395 (19) 
N1—C6 1.3476 (17) C5—C6 1.371 (2) 
C2—C3 1.381 (2) C8—O7 1.4416 (19) 
Cl1—I1—N1 177.76 (3) C3—C4—C5 118.88 (13) 
I1—N1—C2 121.03 (9) C3—C4—O7 125.05 (12) 
I1—N1—C6 119.47 (9) C5—C4—O7 116.06 (12) 
C2—N1—C6 119.00 (13) C4—C5—C6 118.93 (13) 
N1—C2—C3 122.63 (13) C5—C6—N1 122.16 (12) 





3.3.6 3-fluoropyridine- ICl  
 
UV-Visible spectra for 3-fluoropyridine- ICl solution  
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M.  The base 3-fluoropyridine absorbed at 303 nm and iodine monochloride (ICl) 
absorbed at 341 nm. Two new bands appeared at 358 nm and 444 nm when the above-
mentioned starting materials were mixed. These bands are not attributed to the 3-
fluoropyridine or ICl. λmax for 3-fluoropyridine is shifted 55 nm and 141 nm, while for ICl. 
λmax was shifted 17 nm toward higher wavelengths (Figure 3.6.1). Starting material and the 





Figure (3.6.1): UV-Visible spectra of 3-fluoropyridine -ICl: 3-fluoropyridine (Blue), ICl 
(Orange), 3-fluoropyridine -ICl (Green), the spectra were collected using methanol as the 































UV-Visible spectra for 2-fluoro-3-iodopyridine ICl solution 
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 2-fluoro-3-iodopyridine displays two main absorption bands at 316 nm 
and 445 nm, while ICl absorbed at 341 nm. The new band appeared at 450 nm when the 
above-mentioned starting materials were mixed. That band is not attributed to the 2-fluoro-3-
iodopyridine or ICl. λmax for 2-fluoro-3-iodopyridine is shifted 134 nm toward higher 
wavelengths (Figure 3.7.1). Starting material and the resulting complex are also characterised 





Figure (3.7.1): UV-Visible spectra of 2-fluoro-3-iodopyridine -ICl: 2-fluoro-3-iodopyridine 
(Blue), ICl (Orange), 2-fluoro-3-iodopyridine –ICl (Green), the spectra were collected using 



































UV-Visible spectra for 2-fluoro-4-iodopyridine-ICl solution 
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 2-fluoro-4-iodopyridine displays the main absorption band at 351 nm, 
while ICl absorbed at 341 nm. The new band appeared at 446 nm when the above-mentioned 
starting materials were mixed. That band is not attributed to the 2-fluoro-4-iodopyridine or 
ICl. λmax for 2-fluoro-4-iodopyridine was shifted 95 nm toward higher wavelengths (Figure 
3.8.1). Starting material and the resulting complex are also characterised by ATR-FTIR, 





Figure (3.8.1) UV-Visible spectra of 2-fluoro-4-iodopyridine -ICl: 2-fluoro-4-iodopyridine 
(Blue), ICl (Orange), 2-fluoro-4-iodopyridine -ICl (Green), the spectra were collected using 































UV-Visible spectra for 2-fluoro-5-iodopyridine- ICl solution 
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 2-fluoro-5-iodopyridine displays two main absorption bands at 317 nm 
and 448 nm, while ICl absorbed at 341 nm. Two new bands appear at 346 nm and 442 nm 
when the above-mentioned starting materials were mixed. These bands are not attributed to 
the 2-fluoro-5-iodopyridine or ICl.  λmax at 317 nm for 2-fluoro-5-iodopyridine was shifted 29 
nm and the λmax at 448 nm for 2-fluoro-5-iodopyridine was shifted for 6 nm toward lower 
wavelengths (blue shift) (Figure 3.9.1). Starting material and the resulting complex are also 





Figure (3.9.1): UV-Visible spectra of 2-fluoro-5-iodopyridine -ICl: 2-fluoro-5-iodopyridine 
(Blue), ICl (Orange), 2-fluoro-5-iodopyridine –ICl (Green), the spectra were collected using 































3.3.10 2-Cyanopyridine ICl 
 
UV-Visible spectra for 2-Cyanopyridine- ICl solution 
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 2-cyanopyridine absorbed at 305 nm and iodine monochloride ICl 
absorbed at 341 nm. Two new bands appeared at 341 and 442 nm when the two above 
starting materials were mixed which is not attributed to the 2-cyanopyridine or ICl. λmax for 
2-cyanopyridine is shifted 137 nm toward higher wavelengths, Figure (3.10.1). Starting 






Figure (3.10.1): UV-Visible spectra of 2-cyanopyridine –ICl system:  
2-cyanopyridine (Blue), ICl (Orange), 2-cyanopyridinium - ICl2
-
 (Green), the spectra were 




























XRD measurements for 2-cyanopyridinium – ICl2
– 
Crystal Structure of 2-cyanopyridinium - ICl2
–
 
Crystallographic data for 2-cyanopyridinium - ICl2
–
 are given in Table (3.11), and selected 
bond lengths and angles in Table (3.12) A Thermal ellipsoid plot of the structure together 
with the numbering scheme used is given in Figure (3.10.4). 
 
Figure (3.10.4): Thermal ellipsoid plot of 2-cyanopyridinium - ICl2
–
. 
The complex crystallises in the monoclinic space group P21/c, with four complex units within 
the unit cell, Figure (3.10.5). There is no imposed crystallographic symmetry on this 
complex. The structure comprises of two 2-cyanopyridine molecules, which are linked by the 
proton of a hydrogen bond to form a [H(C7H4N2)2]
+ 
 ion, the charge of which is balanced by 
the ICl2
- 
anion. In this sample, instead of co-crystallising the starting materials, forming of 
pyridinium ions and ICl2
–
 could be observed. Hydrolysis of ICl is one of the mechanisms that 
suggest the formation of these ions, which will be discussed below. The selected distances 
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between atoms; Cl1-I is 2.5531(6), Cl2-I is 2.5540(6) Å, N1-H1is 0.919 Å, H1-N3 is 1.825 
Å, N1-Cl1 is 3.238 Å. 
Measured angles; Cl1-I-Cl2 is 179.68(2) °, C5-C6-N2 is 177.7(2) °, C11-C12-N4 is 178.84°, 
N1-C5-C6 is 116.3(2) °, N3-C11-C12 is 115.2(2) °, N1-H1-N3 is 176.84°, N1-Cl1-I is 
165.29°. 
There are two molecules of 2-cyanopyridine in the asymmetric unit (the molecule containing 
N1 atom is a pyridinium ion while the other one is neutral molecule) with an ICl2
–
. Because 
of the presence of a hydrogen bond N-H···N and lack of any interaction between the ICl2
– 
and the four N atoms, the two I-Cl distances in the ion are almost equal 2.5531(6) Å, 
2.5541(6) Å. This contrasts with the previous ICl2
–
 salt where preferential hydrogen bonding 
leads to a difference in the ICl distances. In an N1-H1···N3 hydrogen bond, the distance 
between N1 and N3 is 1.825 Å, (Figure 3.10.6) which less than the sum of Van der Waals 
radii (2.75 Å),
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 and the N1-H1-N3 angle is 176.84°. A distance of 4.015Å was observed for 
the centroid distance between two pyridine ring of 2-cyanopyridine – ICl2
–








Crystal data  
Chemical formula Cl2I·C6H5N2·H C6H4N2 
Mr 407.03 
Crystal system, space group Monoclinic, P21/c 
T/K 150 
a, b, c (Å) 9.6982 (18), 13.243 (2), 11.553 (2) 
β (°) 93.207 (6) 
V/ (Å
3
) 1481.5 (5) 
Z 4 




Crystal size / (mm) 0.25 × 0.2 × 0.14 
  
Data collection  
Diffractometer Bruker APEX-II CCD 
Absorption correction Multi-scan  
Tmin, Tmax 0.656, 0.747 
No. of measured, independent and 
observed [I > 2ζ(I)] reflections 















), S 0.022, 0.054, 1.13 
No. of reflections 4701 
No. of parameters 175 
No. of restraints 1 
H-atom treatment H atoms treated by a mixture of 
independent and constrained refinement 
Δρmax, Δρmin (e Å
−3





Table (3.12): Selected interatomic contacts /Å and /
o




Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 Cl1 2.5531(6) Cl1 I1 N1 177.76(3) 
I1 Cl2 2.5541(6) I1 N1 C2 121.03(9) 
N1 C1 1.333(2) I1 N1 C6 119.46(9) 
N1 H1 0.92(2) C2 N1 C6 119.0(1) 
N1 C5 1.352(2) N1 C2 C3 122.6(1) 
N2 C6 1.148(3) N1 C2 H21 117.8 
C1 C2 1.388(3) C2 C3 C4 118.4(1) 
C2 H2 0.95 C2 C3 H31 120.4 
C2 C3 1.385(3) C4 C3 H31 121.2 
C3 H3 0.95 C3 C4 C5 118.9(1) 
C5 C6 1.443(3) C4 C5 C6 122.4(2) 
N3 C7 1.335(2) N1 C6 C5 122.2(1) 
N3 C11 1.357(2)  
N4 C12 1.142(3) 
C7 C8 1.394(3) 
C8 C9 1.386(3) 
C9 H9 0.95 
C9 C10 1.394(3) 
C10 C11 1.387(2) 





Figure (3.10.5): Packing diagram of 2-cyanopyridinium -ICl2
–
  
approximately along to c axis 
 






Figure (3.10.7): View showing the distance between the centroids  
of two 2-cyanopyridinium -ICl2
–





UV-Visible spectra for 1,10-phenanthroline - ICl solution 
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 1,10-phenanthroline absorbed at 308 nm and iodine monochloride ICl 
absorbed at 341 nm. A new band appeared at 440 nm when the two above starting materials 
were mixed which is not attributed to the 1,10-phenanthroline or ICl. This new band confirms 
the formation of the halogen bonded complex. That means λmax for 1,10-phenanthroline is 
shifted 132 nm toward higher wavelengths, Figure (3.11.1). Starting material and the 





Figure (3.11.1): UV-Visible spectra of 1,10-phenanthroline –ICl system:  
1,10-phenanthroline (Blue), ICl (Orange), 1,10-phenanthroline - ICl (Green), the spectra were 

































UV-Visible spectra for Quinoxaline - ICl solution 
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M.  The base quinoxaline displays two main absorption bands at 323 nm and 460 
nm, while ICl absorbed at 341 nm. The new band appeared at 444 nm when the above-
mentioned starting materials were mixed. That band is not attributed to the quinoxaline or 
ICl. λmax at 323 nm for quinoxaline was shifted 121 nm toward lower wavelengths (blue shift) 
(Figure 3.12.1). Starting material and the resulting complex are also characterised by ATR-




Figure (3.12.1) UV-Visible spectra of quinoxaline –ICl system:  
quinoxaline (Blue), ICl (Orange), quinoxaline- ICl (Green), the spectra were collected using 

























Figure (3.12.3): ATR-FTIR spectrum of quinoxaline-ICl. 







UV-Visible spectra for 2-chloroquinoline - ICl solution  
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 2-chloroquinoline displays two main absorption bands at 319 nm and 
460 nm, while ICl absorbed at 341 nm. The new band appeared at 449 nm when the above-
mentioned starting materials were mixed. That band is not attributed to the 2-chloroquinoline 
or ICl. λmax at 319 nm for 2-chloroquinoline was shifted 130 nm toward higher wavelengths 
(redshift) and the λmax at 460 nm for 2-chloroquinoline is shifted for 11 nm toward lower 
wavelengths (blue shift) (Figure 3.13.1). Starting material and the resulting complex are also 





Figure (3.13.1): UV-Visible spectra of 2-chloroquinoline –ICl system:  
2-chloroquinoline (Blue), ICl (Orange), 2-chloroquinoline ICl (Green), the spectra were 





























Table 3.13: Distance between atoms /Å, measured angles /
 o 
, λ max /nm and melting point/°C 
for ICl complexes. 
Compound 
 




m. p. / °C 
3,5-difluoropyridine-ICl 2.358(6) 2.470(2) 178.69(1) 443 107-109 
3,5-dichloropyridine-ICl 2.341(3) 2.4872(9) 180.00 444 140-143 
2,6-dichloropyridine-ICl    442 91-93 
2,6-dimethoxypyridine-ICl2
-
  2.6041(5), 
2.5176(5) 
 446 136-138 
4-methoxypyridine-ICl 2.2717(12) 2.5305(4) 177.76(3) 359 165-168 
3-fluoropyridine-ICl    358 106-109 
2-fluoropyridine-3-iodopyridine-ICl    438 135-137 
2-fluoropyridine-4-iodopyridine-ICl    445 136-138 
2-fluoropyridine-5-iodopyridine-ICl    438 133-135 
2-cyanopyridine –ICl2
-
  2.5531(6), 
2.5541(6) 
177.76(3) 442 94-96 
1,10-phenanthroline-ICl    440 214-217 
Quinoxaline-ICl    439 109-111 





3.4 Discussion  
 
Prepared complexes can be separated into two main groups, the ones characterised by single-
crystal X-ray diffraction, UV-VIS and ATR-FTIR spectroscopy, and the ones characterised 
just by the latter two techniques. The former group can further be separated based on the 
observed structural properties, (A) complexes with N···I-Cl halogen bond, (B) ionic 
complexes containing polyhalogen ions and (C) crystals of the starting materials. The first 
group contains three complexes (3,5-difluoropyridine-ICl, 3,5-dichloropyridine-ICl and 4-
methoxypyridine-ICl). Halogen bond geometrical properties of these compounds are 
compared with the selected literature data in Table 3.14. The complexes are chosen because 
in all of them an sp
2
 N atom is halogen bonded to the iodine atom of the ICl moiety. It could 
be noticed that the nomenclature system in Table 3.0.1 is not uniform, therefore all the 
literature complexes will be labelled in a consistent way for better clarity. Since in the 




 two interactions are present, they 
are labelled as (1) and (2) shown in Figure (3.14.1). In addition, for the pyridine-ICl complex, 
instead of values reported by Ouvrard et al.
112
, the redetermined values from a more recent 
paper by Jones et al.
129
 are chosen. Thermal ellipsoids of the selected complexes are 




Table (3.14.1) Geometric parameters of selected N···I-Cl halogen bonded complexes, 
adapted from ref.
106,112
, data reported in this work is marked bold 










2.246 2.562 179.24 117.93 





2.290 2.510 178.72 119.83 









2.336 2.459 179.32 119.82 




2.337 2.488 179.40 119.75 
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Figure (3.14.1) Ball and stick representation plots of selected literature complexes 
 
According to Table (3.14.1), it has been observed that there is a relationship between the base 
strength and the N···I and I-Cl distances and C-N-C angle. Base strength can be described as 
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the ability of a base to donate a free electron pair to other species in order to accept a proton. 
The greater the ability to donate the electrons, the greater the base strength is. Generally, the 
base strength is known by the pKa values of their conjugate acids (the higher the pKa value 
of the conjugate acid, the stronger the base is). 128 Conjugate acids are species that form when 
bases acquire a proton, while a pKa value is a negative logarithm of the acid dissociation 
constant. Several factors affect the base strength of organic species. The first and the most 
important one is the electronegativity of an element on which the free electron pair is located. 
The less the electronegative the element is, the stronger the base because the free electron 
pair will be more available for the interaction with the protons. Other factors affecting the 





electronegative element being attached to electron-withdrawing or -donating groups (the 
latter increase the basicity) and stabilisation of an electron pair either by conjugation or being 
involved in the preservation of aromaticity (the less stabilised the electron pair is, the stronger 
the base). In the complexes prepared in this work and the literature reported ones, it was 
observed that as the base strength increases, N···I distance and the C-N-C angle in the 
pyridine ring decrease (with some exceptions), while the elongation of I-Cl distance 
increases, too. This trend can be correlated with the electron-donating or electron-
withdrawing properties of the groups on the pyridine ring. It is well known that in organic 
chemistry in electrophilic aromatic substitution these properties are related to so-called 
activation or deactivation of the ring.
128
 The general trend is, if just a hydrogen atom is taken 
as a reference, groups prone to π-donation (alkoxy-, amino-, amides) are strongly activating 
and alkyl groups with no electron-withdrawing groups are moderately activating due to the 
inductive effect. On the other hand, halogens are moderately deactivating due to their high 
electronegativity, while groups like cyano-, nitro-, carbonyl-, haloalkyl- and ammonium are 
highly deactivating because of their π-acceptor properties.
128
 For the selected N···I-Cl 
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halogen bond systems, this trend could be observed through the N···I interaction distance, 
because the more electrons are donated to the pyridine ring, the higher the electron density 
could be expected on the ring N atom, which can further interact with the ζ-hole of the iodine 
atom from ICl. Subsequently, the more electron density on the nitrogen atom, the stronger the 
N···I interaction should be. This is manifested by the shortening of the N···I distance, while 
at the same time by elongation of the I-Cl bond, as well. For the prepared and literature-based 
complexes, the mentioned trend is observed. If the pyridine-ICl complex is taken as a 
reference point, then electron-donating methoxy- and dimethylamino- groups expectedly 
have shorter N···I distance, while the halo- groups longer interaction distance. The position 
of the group on the ring relative to the pyridine N atom should be noted too, methoxy- and 
dimethylamino- groups are in para-position, bearing in mind that both of them are ortho- and 
para-activating, this surely contributed to increasing the electron density on the N atom. In 
contrary, halo- groups are all except the 2-chloroquinoline in meta-positon relative to the 
pyridine N atom, and since they are meta- activating, all the halo-groups in meta-position 
have similar N···I distance, while for 2-chloroquinoline, where chlorine atom is in the ortho-
position, the distance is noticeably greater. Therefore, it would be reasonable to expect from 
the complexes where no suitable crystalline material is observed that values for 2,6-
dimethoxypyridine halogen bonded complex should be similar to values of 4-
methoxypyridine-ICl. Quinoxaline and 1,10-phenanthroline complexes would be similar to 
the values observed in N, N-bis(ICl)-2,2-bipyridine complexes, while for the halo-complexes 
(3-fluoropyridine-ICl, 2-fluoro-3-iodopyridine-ICl, 2-fluoro-4-iodopyridine-ICl, 2-fluoro-5-
iodopyridine-ICl and 2,6-dichloropyridine) the measured values to be close to the already 
observed halo-complexes. Due to the strongest π-acceptor properties, the longest N···I 
interaction should be expected in the 2-cyanopyridine-ICl complex. The other two mentioned 
parameters follow the same trend, but with some exceptions. For the I-Cl bond length, a 
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slight exception is observed in trans-N, N-bis(ICl)-2,2-bipyridine (2) complex, while for the 
C-N-C angle there are three noticeable outliers, 3,5-difluoropyridine-ICl, trans-N, N-bis(ICl)-
2,2-bipyridine (1) and 2-chloroquinoline-ICl. 





). Instead of co-crystallising the 
starting materials, the formation of pyridinium ions and ICl2
–
 could be observed. There are 
several suggested mechanisms which could explain the formation of polyhalogen anions. One 
of the mechanisms suggests that these ions could be formed due to the presence of water in 
the reaction system. As reported by Philbrick
130
 upon hydrolysis of ICl (equations 1, 2), ICl2
–
 
anion is present as the main form of iodine in concentrated solution.  
 
The occurrence of polyhalogen anions in the final complexes and therefore in the reaction 
system is most likely to occur due to the traces of water present in the solvent (ethanol) used 
in the preparation of the product. To compensate for the negative charge, the corresponding 
pyridinium complexes are occurring. 
Among the complexes in this subgroup, the main difference that can be observed is that for 
the 2,6-dimethoxypyridinium- ICl2
–
 there is a hydrogen bond between the pyridinium cation 
and the polyhalogen anion, while in the 2-cyanopyridinium complex, there are no hydrogen 
bonds between the organic cations and the corresponding anion.  The variation in the bond 
distance for I-Cl1, I-Cl2 in 2,6-dimethoxypyridinium- ICl2
–
 is due to the presence of N1-
H1···Cl1 hydrogen bond. This hydrogen bond causes the elongation of the bond length in I-
Cl1, while the I1-Cl2 bond is shorter because Cl2 is not included a hydrogen bond or in any 
of the non-covalent interactions. (Table 3.14.2) 
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The bond distance between iodine and both of chlorine atoms in 2-cyanopyridinium- ICl2
–
 is 
approximately equal. This is the result ICl2
- 
not involved in any kind of supramolecular 
interactions, rather an N-H···N hydrogen bond links two organic bases, from which one is 
positively charged and the other is neutral. 
Table (3.14.2) Geometrical parameters of ICl2
– 





 complexes  
Crystalline complexes I-Cl1 I-Cl2 
2,6-dimethoxypyridinium- ICl2
–
 2.6041(5) 2.5177(6) 
2-cyanopyridinium- ICl2
–-
 2.5531(6)  2.5540(6) 
  
The third subgroup (crystalline complexes from the starting material) consists of only one 
sample. Instead of the expected halogen-bonded complex, only the starting material 
crystallised from the reaction solution. The absence of the complex could be explained by 
several possible reasons. First of which attributed to two chlorine atoms in 2,6-
dichloropyridine, which are considerably strong electron-withdrawing groups and hence they 
reduce the electron density on N atom of the pyridine ring. Besides, the ortho- positions of 
chlorine atoms also assist to prevent N atom of the pyridine ring from attacking ICl by the 
steric hindrance. 
Complexes in which no suitable crystalline material was obtained could be 
characterised by other techniques to determine the presence of the halogen bond in the 
complex. In this work, UV-VIS and ATR-FTIR spectroscopy were used. Even though the 
new bond is formed between the iodine from ICl moiety and the nitrogen from pyridine ring, 
which can be observed using IR spectroscopy below 500 cm
-1
, the complexes were not 




Therefore, the research has been focused on the influence of addition ICl to the starting 
material by comparison of the pyridine ring vibrations generally, and N=C bond particularly, 
to determine whether ICl interacts with the pyridine N atom. If the N atom is involved in a 
non-covalent or supramolecular interaction then part of its electron density should be 
transferred into that interaction, thus weakening the bonds already present in the compound. 
In FTIR spectrum it would mean that wavenumber corresponding to C=N bond should be 
moved toward lower wavenumbers (Table 3.14.3) and for UV-VIS spectroscopy that band 
characteristic for an organic base should be shifted towards higher wavelengths because XB 
acceptors are electron donors (Lewis bases), some of the electron density is redistributed into 




Table (3.14.3) Wavenumbers of selected bands in ATR-FTIR spectra correlated with specific 
bonds of the starting materials (St. m.) and the corresponding ICl complexes (C.) 




 ν(C-H), cm-1 
St. m C. St. m C. St. m. C. 
3,5-difluoropyridine 1577 1561 1476 1437 3101 3072 
3,5-dichloropyridine 1423 1407 1555 1535 3070 3039 
2,6-dimethoxypyridine 1530 1483 1545 1548 3102 3011 
4-methoxypyridine 1547 1500 1616 1604 3110 3098 
3-fluoropyridine 1576 1557 1645 1605 3054 3036 
2-fluoropyridine-3-iodopyridine 1556 1511 1579 1585 3024 3083 
2-fluoropyridine-4-iodopyridine 1578 1540 1645 1583 3056 3082 
2-fluoropyridine-5-iodopyridine 1557 1568 1579 1592 3055 3045 
2-cyanopyridine 1462 1434 1578 1587 3060 3062 
1,10-phenanthroline 1502 1496 1586 1545 3058 3052 
Quinoxaline 1530 1494 1630 1608 3038 3021 
2-chloroquinoline 1493 1449 1585 1564 3054 3058 
 
As known from the complexes characterised by X-ray diffraction, two different types of 
interactions were observed, halogen bond and hydrogen bond. In systems like  
3,5-fluoropyridine-ICl where the halogen bond is present, the band of the starting material 
was shifted from 1577 cm
-1
 to 1561 cm
-1 
and this shift confirms the bonding between  
3,5-fluoropyridine and ICl. On the other hand, using the starting material such as  
2,6-dimethoxypyridine the shift was also observed (from 1530 cm
-1
 to 1483 cm
-1
) upon the 
addition of ICl to the starting material, but this was due to the presence of N-H···Cl hydrogen 
bond. The same shift occurs with C=C band and C-H band, respectively. This shifting 
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towards lower wavelengths refers to an interaction of the interhalogens (ICl) with N atom of 
the pyridine ring, which as result of the resonance and the conjugation on the pyridine ring 
and this leads to a decrease of the double bond feature and due to the presence of the 
electron-withdrawing group on the ring which caused decreasing the electron density 
reducing bond order.
 131,132 
Table (3.14.4) Wavelengths of selected bands in UV-VIS spectra of the starting materials (St. 
m.) and the corresponding ICl complexes (C.) 
Starting material λ(Starting material) /nm λ(Complex) /nm 
3,5-difluoropyridine 303 451 
3,5-dichloropyridine 335 458 
2,6-dimethoxypyridine 316 - 
4-methoxypyridine 328 442 
3-fluoropyridine 303 386 
2-fluoropyridine-3-iodopyridine 316,445 369, 469 
2-fluoropyridine-4-iodopyridine 351 326, 438 
2-fluoropyridine-5-iodopyridine 317,448 434 
2-cyanopyridine 305 346, 440 
1,10-phenanthroline 308 343, 435 
Quinoxaline 323, 460 440 
2-chloroquinoline 319, 460 439 
 
This new band confirms the formation of the halogen bonded complex. Even though in the 
IUPAC list of features it is listed that the formation of the halogen bonds usually moves the 
absorption bands to lower wavelengths, for these systems, the opposite effect is noticed. In 
other words, λmax of the starting material was shifted towards higher wavelengths, which is 
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called a bathochromic or a red shift. This shift could be observed because of adding the 
saturated groups such as amine, hydroxyl and halogens to the chromophores. It should be 
noted that there is a possibility of observing peaks below 300 nm, but since the spectra were 
collected from 300 to 800 nm, only peaks appearing in this region will be used for 
interpretation of structural features. Complexes that had the structure characterised by single 
crystal X-ray diffraction, have distinctive UV-VIS spectra. Samples that contain a N···I-Cl 
halogen bond (3,5-difluoropyridine-ICl, 3,5-dichloropyridine-ICl and 4-methoxypyridine-





). This peak intensity 
could be correlated with the charge-transfer feature of the halogen bond. When either halogen 
or a hydrogen bond are present in the sample, the charge transfer component is more 
significant than just the electrostatic interactions that can be observed in ionic complexes. 
The position of the peak could also be correlated with observed interaction strength, in case 
of 4-methoxypyridine complex, the peak is at 386 nm, while for the 3,5-difluoropyridine-ICl 
and 3,5-dichloropyridine-ICl where the XB interactions are much weaker, the peaks are 
positioned at 451 and 458 nm, respectively. For the ICl2
–
 containing complexes, it has been 
observed that the peak is of a much lower intensity and positioned from 440-450 nm. These 
peak positions could be attributed to an equilibrium between ICl2
–
 and iodide ions, as 
reported by Kazantseva et al.
133
 The exception to this trend is observed in 2-cyanopyridine- 
ICl2
–
 where two intense peaks can be observed. These peaks could be explained by the 
presence of hydrogen bonds which have the charge transfer component, as well. Based on 
peak shapes, positions and intensities in their UV-VIS spectra, it would be reasonable to 
assume that 3-fluoropyridine-ICl, 2-fluoro-3-iodopyridine-ICl, 2-fluoro-4-iodopyridine-ICl, 
2-fluoro-3-iodopyridine-ICl and quinoxaline-ICl complexes are halogen-bonded, Figure 
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(3.14.2). On the other hand, 1,10-phenantroline should contain ICl2
–
 ion in the structure 
(Figure 3.14.3). 
 
Figure (3.14.2) UV-VIS spectra of 3,5-difluoropyridine-ICl (Blue), 3,5-dichloropyridine-ICl 
(Orange), 2-fluoro-3-iodopyridine-ICl (Green), 2-fluoro-4-iodopyridine-ICl (Gold), 2-fluoro-
5-iodopyridine (Brown), Quinoxaline-ICl (Silver), 2-chloroquinoline-ICl (Red), the spectra 

























Figure (3.14.3) UV-VIS spectra of 2,6-dimethoxypyridine-ICl2
–
 (Blue) and  
1,10-phenantroline- ICl2
–
 (Orange), the spectra were collected using methanol as the solvent, 































Heteronuclear interhalogens can form a variety of compositions (XY, XY3, XY5, XY7). All 
the dinuclear interhalogens are known, as well as their thermal stabilities. ClF is very stable, 
IBr and ICl moderately, while BrCl dissociates easily. Compounds with more than one Y 
atom are fluorides, except for ICl3.
126,134
 Iodine monobromide is formed by the direct 
combination of the comprising elements. In the gas phase, IBr bond distance determined by 
microwave spectroscopy is 2.4691 Å.
27
 At room temperature, IBr is a black crystalline 
material with a melting point of 41 °C and boiling point of 116 °C.
126,134
  
Recently, Jones et al.
129
 reported a rare phenomenon of colossal negative thermal expansion 
when they redetermined the structure of a pyridine-IBr complex. That system has positive 
thermal expansion along a and c axes and a negative one along the b axis. Such a 
phenomenon is observed due to the temperature-induced weakening of C-H···Br hydrogen 
bond, which then causes the rearrangement in the packing of the complexes.  
The IBr containing XB complexes are much less represented in the literature than the 
corresponding ICl and I2 ones.
112,106
 Some of the reasons for this could be that IBr the charge 
separation is in between of the I-X (Cl, Br, I) dihalogens, with ICl having the better charge 
separation because of the higher electronegativity of a chlorine atom and thus higher 
possibility of forming XB complexes in borderline systems. On the other hand, even if I2 is a 
non-polar and has no charge separation at all, it is often used because it is a homonuclear 
molecule. Moreover, Montis et al.
135
 reported that they experienced problems regarding the 
IBr reactivity, frequently leading to scarce reproducibility and formation of unexpected 
products, which was observed in this work, as well. Even though XB complexes containing 
IBr with a variety of XB acceptors (P, S, As, Se) have been reported,
112
 only the ones 
containing N···IBr introduction will be presented in Table 4.0.1. 
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REFCODE Complex name N···I (Å) I-Br (Å) N···I-Br (°) 
TAGNIZ
118
 Cis N, N-bis (Bromoiodo)-2,2-
bipyridine 


















2.279 2.678 178.17 
ZESSAU
135
 2-arylselanyl pyridine-IBr 2.411 2.623 178.74 
 
It can be observed that five complexes containing N···I-Br have been reported. The average 
N···I distance is 2.376 Å, while the value for I-Br bond is 2.621 Å. A complex with refcode 
SOWDOZ
137
 has the shortest N···I value (2.279 Å) that indicates the strongest XB, and the 
most elongated bond (2.678 Å) is observed in the same system, as well. All the N···I-Br 






This chapter aims to prepare and characterise crystalline complexes that contain N···I 
halogen bond. A range of pyridine derivatives is chosen as XB acceptor, while iodine 
monobromide serves as XB donor. The organic starting materials are chosen because of the 
wide range of base strength, which is going to be correlated with the strength of the XB 
interaction. All the crystalline complexes are going to be characterised by ATR-FTIR 
spectroscopy, UV-Vis spectroscopy and if the crystal of a suitable size is obtained, single-
crystal X-ray diffraction. From the structures obtained by X-ray diffraction the halogen bond 





4.3 Investigation of halogen bonded complexes 
4.3.1 3,5-difluoropyridine- IBr  
 
 
UV-Visible Spectra for 3,5-difluoropyridine-IBr solution  
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 3,5-difluoropyridine absorbs at 303 nm while IBr displays two main 
absorption bands at 317 nm and 454 nm. When the starting materials are mixed the new band 
appears at 384 nm. That band is not attributed to the 3,5-difluoropyridine or IBr. Rather, it 
indicates that the reaction between the starting materials occurred because λmax at 303 nm for 
3,5-difluoropyridine was shifted 80 nm toward higher wavelengths (red shift), Figure (4.1.1). 
Starting material and the resulting complex are also characterised by ATR-FTIR, Figures 





Figure (4.1.1) UV- Visible Spectra of 3,5-difluoropyridine -IBr: 3,5-difluoropyridine (Blue), 
IBr(Orange), 3,5-difluoropyridine - IBr (Green), the spectra were collected using methanol as 





























Figure (4.1.2) ATR-FTIR spectrum of 3,5-difluoropyridine-IBr.   
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UV-Visible Spectra for 3,5-dichloropyridine-IBr solution  
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 3,5-dichloropyridine absorbs at 335 nm and iodine monobromide IBr at 
317 nm and 454 nm. The new band appears at 388 nm when the two above starting materials 
are mixed. This band, which is not attributed to the 3,5-dichloropyridine or IBr suggests the 
formation of the halogen bonded complex, λmax for 3,5-dichloropyridine was shifted 53 nm 
toward higher wavelengths, Figure (4.2.1). Starting material and the resulting complex are 
also characterised by ATR-FTIR, Figures (3.2.2, 4.2.2). 
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Figure (4.2.1) UV- Visible Spectra of 3,5-dichloropyridine-IBr: 3,5-dichloropyridine (Blue), 
IBr (Orange), 3,5-dichloropyridine- IBr (Green), the spectra were collected using methanol as 



































4.3.3 2,6-dichloropyridine- IBr  
 
 
UV-Visible Spectra for 2,6-dichloropyridine-IBr solution 
All the spectra were collected using methanol as the solvent, the concentration of the samples 
was 10
-3 
M. The base 2,6-dichloropyridine absorbs at 335 nm and IBr absorbs at 317 nm and 
454 nm. The new band appears at 434 nm when the two above starting materials are mixed 
which is not attributed to the 2,6-dichloropyridine or IBr. λmax for 2,6-dichloropyridine was 
shifted 99 nm toward higher wavelength because of XB interaction with IBr Figure 
(4.3.1).Starting material and the resulting complex are also characterised by ATR-FTIR, 
Figures (3.3.1, 4.3.2). 
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Figur (4.3.1) UV-Visible Spectra of 2,6-dichloropyridine-IBr : 2,6-dichloropyridine (Blue), 
IBr(Orange), 2,6-dichloropyridine- IBr (Green), the spectra were collected using methanol as 


































4.3.4 2,6-dimethoxypyridine- IBr  
 
UV-Visible Spectra for 2,6-dimethoxypyridine-IBr solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2,6-dimethoxypyridine absorbs at 316 nm and iodine monobromide absorbs at 317 
nm and 454 nm. The new band appears at 440 nm when the two above starting materials are 
mixed which is not attributed to the 2,6-dimethoxypyridine or IBr. λmax for 2,6-
dimethoxypyridine was shifted 124 nm toward higher wavelengths, Figure (4.4.1) Starting 





Figure (4.4.1) UV- Visible Spectra of 2,6-dimethoxypyridine -IBr : 2,6-dimethoxypyridine 
(Blue), IBr (Orange), 2,6-dimethoxypyridine - IBr (Green), the spectra were collected using 






























Figure (4.4.2) ATR-FTIR spectrum of 2,6-dimethoxypyridine -IBr 
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4.3.5 4-methoxypyridine- IBr 
 
 
UV-Visible Spectra for 4-methoxypyridine -IBr solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 4-methoxypyridine absorbs at 328 nm and iodine monobromide IBr absorbs at 317 
nm and 454 nm. A new band appears at 435 nm when the two above starting materials are 
mixed which is not attributed to the 4-methoxypyridine or IBr. This new band confirms the 
formation of the halogen bonded complex. That means λmax for 4-methoxypyridine were 
shifted 107 nm and for IBr were shifted 121 nm toward higher wavelength. Figure (4.5.1). 






Figure (4.5.1) UV- Visible Spectra of 4-methoxypyridine -IBr : 4-methoxypyridine (Blue), 
IBr(Orange), 4-methoxypyridine - IBr (Green), the spectra were collected using methanol as 






































UV-Visible Spectra for 3-fluoropyridine -IBr solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 3-fluoropyridine absorbs at 303 nm and iodine monobromide IBr absorbs at 317 nm 
and 454 nm. A new band appears at 387 nm when the two above starting materials are mixed 
which is not attributed to the 3-fluoropyridine or IBr. This new band confirms the formation 
of the halogen bonded complex. That means λmax for 3-fluoropyridine was shifted 73 nm 
toward higher wavelength which is called bathochromic shift or red shift, Figure (4.6.1.) 




Figure (4.6.1) UV- Visible Spectra of 3-fluoropyridine -IBr : 3-fluoropyridine (Blue), 
IBr(Orange), 3-fluoropyridine - IBr (Green), the spectra were collected using methanol as the 






























Figure (4.6.2) ATR-FTIR spectrum of 3-fluoropyridine –IBr. 
Crystal Structure of 3-fluoropyridine -IBr 
Crystallographic data for 3-fluoropyridine are given in Table (4.1), and selected bond lengths 
and angles in Table (4.2). A thermal ellipsoid plot of the structure together with the 
numbering scheme used is given in Figure (4.6.3). 
 
Figure (4.6.3) Thermal ellipsoid plot of 3-fluoropyridine-IBr with atom labelling scheme. 
3-fluoropyridine-IBr crystallises in the monoclinic space group P21/c. The molecule 
possesses no exact crystallographic symmetry because the pyridine ring shows 
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crystallographic disorder, with the fluorine atoms being disordered about a pseudo mirror 
plane, and with refined occupancies of 0.78(1) and 0.22(1). 
The 3-fluoropyridine and the IBr moiety interact via N1···I1-Br1 halogen bond. The N1···I1 
interaction distance is 2.369(3) Å, which is less than the sum of van der Walls radii of these 
atoms (3.53 Å).
121
 The distance between the iodine atom and bromine atom is 2.6222(5) Å, 
which is longer than the distance of the starting material (IBr) in gas phase 2.4691 Å
27
 and 
the N1···I1-Br1 angle is 178.93(6). Complexes are packed in pairs, with units within the 
same pair staying almost in the same plane (Figure 4.6.4), and the adjacent pair in the 
different plane that intersects the first one at 27.77°. The vertical distance between two 
parallel planes is 3.456 Å, while the distance between two centroids of pyridine rings is 4.377 
Å (Figures 4.6.5 and 4.6.6) No other non-covalent interactions are observed. Even though 
some (C-H···Br) short contact can be detected (between adjacent pairs C-Br 3.910 Å, and 









Figure (4.6.5): Packing diagram of 3-fluoropyridine –IBr approximately along to b axis 
 
 
Figure (4.6.6) View showing the distance between the centroids of 




Table 4.1: Crystallographic data for the complex 3-fluoropyridine-IBr. 
Crystal data  
Chemical formula C5H4BrFIN 
Mr 303.90 
Crystal system, space group Monoclinic, P21/c 
T/K 150 
a, b, c (Å) 4.3767 (7), 14.401 (2), 12.2961 (19) 
β  (°) 97.698 (5) 
V/ (Å
3
) 768.0 (2) 
Z 4 




Crystal size/ (mm) 0.32 × 0.15 × 0.12 
  
Data collection  
Diffractometer Bruker APEX-II CCD 
Absorption correction Multi-scan  
Tmin, Tmax 0.400, 0.747 
No. of measured, independent and 
observed [I > 2ζ(I)] reflections 















), S 0.033, 0.068, 1.18 
No. of reflections 3215 
No. of parameters 92 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin /(e Å
−3
) 0.86, −1.20 
 
Table (4.2): Selected interatomic contacts /Å and /
o
 for the complex 3-fluoropyridine-IBr. 
Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 Br1 2.6222(5) Br1 I1 N1 178.93(6) 
I1 N1 2.369(3) I1 N1 C5 119.9(2) 
N1 C5 1.331(4) I1 N1 C1 118.5(2) 
N1 C1 1.325(4) C5 N1 C1 121.5(3) 
F1 C2 1.289(5) C4 C3 C2 117.3(4) 
C3 C4 1.363(6) C3 C4 C5 120.3(3) 
C3 C2 1.376(6) N1 C5 C4 120.3(3) 
C4 C5 1.382(5) F1 C2 C3 118.7(4) 
C2 C1 1.378(5) F1 C2 C1 119.7(3) 
   C3 C2 C1 121.6(4) 
   N1 C1 C2 119.0(3) 
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4.3.7 2-fluoro- 3-iodopyridine- IBr 
 
UV-Visible Spectra for 2-fluoro-3-iodopyridine -IBr solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-fluoro-3-iodopyridine absorbs at 316 nm and iodine monobromide IBr absorbs at 
317 nm and 454 nm. A new band appears at 436 nm when the two above starting materials 
are mixed which is not attributed to the 2-fluoro-3-iodopyridine or IBr. λmax for 2-fluoro-3-





Figure (4.7.1) UV- Visible Spectra of 2-fluoro-3-iodopyridine -IBr : 2-fluoro-3-iodopyridine 
(Blue), IBr(Orange), 2-fluoro-3-iodopyridine - IBr (Green), the spectra were collected using 



























4.3.8 2-fluoro- 4-iodopyridine- IBr 
 
UV-Visible Spectra for 2-fluoro-4-iodopyridine -IBr solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-fluoro-4-iodopyridine absorbs at 351 nm and iodine monobromide IBr absorbs at 
317 nm and 454 nm. The new band appears at 378 nm when the two above starting materials 
are mixed which is not attributed to the 2-fluoro-4-iodopyridine or IBr. λmax for 2-fluoro-4-
iodopyridine were shifted more than 27 nm toward higher wavelength, Figure (4.8.1). 







Figure (4.8.1) UV- Visible Spectra of 2-fluoro-4-iodopyridine -IBr : 2-fluoro-4-iodopyridine 
(Blue), IBr(Orange), 2-fluoro-4-iodopyridine - IBr (Green), the spectra were collected using 


































4.3.9 2-fluoro- 5-iodopyridine- IBr 
 
 
UV-Visible Spectra for 2-fluoro-5-iodopyridine -IBr solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-fluoro-5-iodopyridine absorbs at 317 nm and iodine monobromide IBr absorbs at 
317 nm and 454 nm. The new band appears at 385 nm when the two above starting materials 
are mixed which is not attributed to the 2-fluoro-5-iodopyridine or IBr. λmax for 2-fluoro-5-




Figure (4.9.1) UV- Visible Spectra of 2-fluoro-5-iodopyridine -IBr : 2-fluoro-5-iodopyridine 
(Blue), IBr(Orange), 2-fluoro-5-iodopyridine - IBr (Green), the spectra were collected using 





























UV-Visible Spectra for 1,10-Phenanthroline -IBr solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 1,10-Phenanthroline absorbs at 308 nm and iodine monobromide IBr absorbs at 317 
nm and 454 nm. The new band appears at 429 nm when the two above starting materials are 
mixed which is not attributed to the 1,10-Phenanthroline or IBr. λmax for 1,10-Phenanthroline 
were shifted 121 nm toward higher wavelength, Figure (4.10.1). Starting material and the 






Figure (4.10.1) UV- Visible Spectra of 1,10-phenanthroline -IBr : 1,10-phenanthroline 
(Blue), IBr (Orange), 1,10-phenanthroline-IBr (Green), the spectra were collected using 






























Figure (4.10.2) ATR-FTIR spectrum of 1,10-phenanthroline –IBr. 
XRD measurements for 1,10-Phenanthroline –IBr  
1.Crystal Structure of 1,10-Phenanthroline –IBr  
Crystallographic data for 1,10-Phenanthroline –IBr are given in Table (4.3), and selected 
bond lengths and angles in Table (4.4). A thermal ellipsoid plot of the structure together with 
the numbering scheme used is given in Figure (4.10.3). 
 
Figure (4.10.3) Thermal Ellipsoid plot for the 1,10-phenanthroline complex. 
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The complex crystallises in the monoclinic crystal system; space group P21/c. The 
asymmetric unit consists of two protonated 1,10-phenanthroline ions, one molecule of iodine, 
IBr2
–
 and bromide ion. The possible mechanisms of polyhalogen ions formation are discussed 
above. The Br3-I1-Br2 angle is 178.95°, which is very close to being completely linear, but 
even though the bond lengths in the IBr2
–
 ion are not symmetrical (I1-Br2 2.691(2) Å, I1-Br3 
2.702(1) Å), it cannot be concluded that the ion is involved in any of the non-covalent 
interactions that could cause this length difference. The observed short contact distances 
(C13···Br3 3.658 Å, C23···Br3 3.814 Å, C10···Br2 3.813 Å, C5···Br2 3.721 Å, C1···Br2 
3.655 Å) are significantly longer than the reported values for C-H···Br HB (3.376 Å).
138
 
However, the bromide ion is involved in several interactions. Firstly, the iodine molecule 
forms a bridging halogen bond interaction with two bromide ions, thus forming an infinite 
chain. The Br1···I2-I3 XB has the Br1···I2 interaction length of 3.136(1) Å, while for the 
Br1···I3-I2 XB, the distance between Br1 and I3 is 3.181(1). Both distances are less than the 
sum of Van der Walls radii (3.83 Å).
121
 The I2-I3 distance is elongated, when compared to 
the distance of the iodine molecule in the gas phase (2.6663 Å),
27
 and the corresponding 
angles of these halogen bonds are 171.93° and 169.88°, respectfully. (Figure 4.10.4) 
Moreover, there are two kinds of N-H···Br hydrogen bonds present. (Figure 4.10.5) In the 
N1-H1···Br1 HB, the distance between N atom and Br atom is 3.279 Å, and the N1-H1-Br1 
angle is 149.84°, while for the N3-H3A···Br1, N3···Br1 distance is 3.308 Å and the N3-
H3A-Br1 angle is 150.36. (Figure 4.10.5) Both distance values are close to the literature 







Figure (4.10.4) View showing Br1···I3-I2 and Br1···I2-I3 halogen bonds and IBr2
–
  
with the corresponding geometric parameters,  
1,10-phenanthroline molecules are omitted for clarity 
The distance between the centroids of two adjacent protonated 1,10-phenanthroline ions is 
3.609 Å. (Figure 4.10.6) The mentioned non-covalent interactions cause the packing of a 
complex to resemble the three-fold axis formed around the Br··· I-I chain. (Figure 4.10.7) 
 
Figure (4.10.5) View showing N-H···Br hydrogen bonds 1,10-phenanthroline-IBr complex 




Figure (4.10.6) View showing the distance between the centroids of 
 two 1,10-phenantrolinium ions 
 
 
Figure (4.10.7) View showing the packing 1,10-phenanthroline-IBr complex  





Table 4.3: Crystallographic data for the 1,10-Phenanthroline –IBr complex. 
Crystal data  
Chemical formula Br2I·I2·Br·2(C12H9N2) 
Mr 982.85 
Crystal system, space group Monoclinic, P21/c 
T/K 195 
a, b, c (Å) 9.0428 (10), 15.9337 (17), 20.083 (2) 
β (°) 99.896 (4) 
V/ (Å
3
) 2850.6 (5) 
Z 4 




Crystal size/ (mm) 0.29 × 0.21 × 0.16 
Data collection  
Diffractometer Bruker APEX-II CCD 
Absorption correction Multi-scan  
SADABS2016/2 (Bruker,2016/2) was used 
for absorption correction. wR 
Tmin, Tmax 0.463, 0.746 
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No. of measured, independent and 
observed [I > 2ζ(I)] reflections 












), S 0.066, 0.239, 1.03 
No. of reflections 6867 
No. of parameters 315 
No. of restraints 20 
H-atom treatment H atoms treated by a mixture of independent 
and constrained refinement 






 + 20.P]  





Δρmax, Δρmin (e Å
−3





Table 4.4: Selected interatomic contacts /Å and /
o
 for the complex 1,10-Phenanthroline –IBr 
Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 Br2 2.691(2) Br2     I1   Br3 178.95(5)   
I1 Br3 2.702(1) H1 N1 C1 114(5) 
I2 I3 2.753(1) H1 N1 C9 123(5) 
N1 H1 0.96(7) C1 N1 C9 123(1) 
N1 C1 1.336(14) C8 N2 C12 115(1) 
N1 C9 1.359(14) N1 C1 H1A 121 
N2 C8 1.334(16) N1 C1 C2 119(1) 
N2 C12 1.337(17) C1 C2 H2 119 
C1 C2 1.383(17) C1 C2 C3 121(1) 
C2 C3 1.346(17) C2 C3 H3 120 
C3 C4 1.416(16) C2 C3 C4 120(1) 
C4 C5 1.405(17) C3 C4 C5 124(1) 
C4 C9 1.399(15) C3 C4 C9 117(1) 
C5 C6 1.349(19) C5 C4 C9 119(1) 
C6 C7 1.443(19) C4 C5 H5 120 
C7 C8 1.391(17) C4 C5 C6 120(1) 
C7 C10 1.409(18) H5 C5 C6 120 
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C8 C9 1.434(15) C5 C6 H6 119 
C10 C11 1.36(2) C5 C6 C7 121(1) 
C11 C12 1.39(2) H6 C6 C7 119 
N3 H3A 1.0(1) C6 C7 C8 120(1) 
N3 C13 1.300(13) C6 C7 C10 122(1) 
N3 C21 1.355(14) C8 C7 C10 118(1) 
N4 C20 1.36(2) N2 C8 C7 125(1) 
N4 C24 1.315(15) N2 C8 C9 118(1) 
C13 C14 1.378(17) C7 C8 C9 117(1) 
C14 C15 1.390(18) N1 C9 C4 120(1) 
C15 C16 1.400(16) N1 C9 C8 118(1) 
C16 C17 1.416(17) C4 C9 C8 122(1) 
C16 C21 1.417(16) C7 C10 H10 121 
C17 C18 1.336(18) C7 C10 C11 118(1) 
C18 C19 1.435(17) H10 C10 C11 121 
C19 C20 1.408(14) C10 C11 H11 120 
C19 C22 1.383(16) C10 C11 C12 120(1) 
C20 C21 1.437(15) H11 C11 C12 120 
C22 C23 1.381(19) N2 C12 C11 124(1) 
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C23 C24 1.377(18) N2 C12 H12 118 
 C11 C12 H12 118 
H3A N3 C13 112(7) 
H3A N3 C21 124(7) 
C13 N3 C21 124(1) 
C20 N4 C24 118(1) 
N3 C13 H13 120 
N3 C13 C14 120(1) 
C13 C14 H14 120 
C13 C14 C15 120(1) 
C14 C15 H15 120 
C14 C15 C16 120(1) 
C15 C16 C17 125(1) 
C15 C16 C21 118(1) 
C17 C16 C21 117(1) 
C16 C17 H17 119 
C16 C17 C18 122(1) 
H17 C17 C18 119 
C17 C18 H18 119 
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C17 C18 C19 122(1) 
H18 C18 C19 119 
C18 C19 C20 118(1) 
C18 C19 C22 125(1) 
C20 C19 C22 117(1) 
N4 C20 C19 123(1) 
N4 C20 C21 118(1) 
C19 C20 C21 119(1) 
N3 C21 C16 119(1) 
N3 C21 C20 120(1) 
C16 C21 C20 121(1) 
C19 C22 H22 121 
C19 C22 C23 119(1) 
C22 C23 C24 120(1) 
N4 C24 C23 123(1) 
N4 C24 H24 118 










UV-Visible Spectra for 2-cyanopyridine -IBr solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-cyanopyridine absorbs at 305 nm and iodine monobromide IBr absorbs at 317 nm 
and 454 nm. The new band appears at 438 nm when the two above starting materials are 
mixed which is not attributed to the 2-cyanopyridine or IBr. λmax for 2-cyanopyridine was 
shifted 87 nm toward higher wavelength, Figure (4.11.1). Starting material and the resulting 





Figure (4.11.1) UV- Visible Spectra of 2-cyanopyridine-IBr: 2-cyanopyridine (Blue), 
IBr(Orange), 2-cyanopyridine -IBr (Green), the spectra were collected using methanol as the 
























Figure (4.11.2) ATR-FTIR spectrum of 2-cyanopyridine –IBr. 
XRD measurements for 2-cyanopyridine –IBr 
1.Crystal Structure of 2-cyanopyridine -IBr 
Crystallographic data for 2-cyanopyridine-IBr are given in Table (4.5), and selected bond 
lengths and angles in Table (4.6). A thermal ellipsoid plot of the structure together with the 
numbering scheme used is given in Figure (4.21). 
 
Figure (4.11.3) Thermal Ellipsoid plot for 2-cyanopyridine-IBr. 
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2-cyanopyridine-IBr crystallises in the Triclinic crystal system and the space group is P-1 
The asymmetric unit consists of one 2-cyanopyridine and one IBr molecule. The two moieties 
are connected by N···I-Br halogen bond. The distance between N1 and I1 is 2.466(6) Å, 
which is less than the sum of Van der Walls radii of the corresponding atoms (3.53Å),
121
 
while the distance between the iodine atom and bromine atom is 2.566(1) Å. This is longer 
than the distance for the starting material (IBr) in gas phase 2.4691 Å
27
 and the measured  
N1-I1-Br1 angle is 178.8(2)°, Figure (4.11.4). Complexes are further connected via C-H···N 
hydrogen bonds and Br···Br interactions to form a step-like pattern, Figures (4.11.5, 4.11.6) 
 
Figure (4.11.4) View showing halogen bond geometrical information  
of 2-cyanopyridine-IBr complex 
 





Figure (4.11.6) Top-view of the step-like packing pattern of 2-cyanopyridine-IBr complex  
The cyano-group nitrogen atom is a bifurcated HB acceptor. The two types of C-H···N 
hydrogen bonds are C3-H3···N2 where the C3···N2 distance is 3.378 Å and the C3-H3-N2 
angle is 136.78°, and C4-H4···N2 hydrogen bond, in which the C4···N2 distance is 3.454 Å 
and the C4-H4-N2 angle is 147.13°, Figure (4.11.7). Both distances are shorter than the 
reported values for C-H···N hydrogen bond in similar systems (3.521 Å)
140
, while the 
measured angles are greater (134.41°). These halogen bonds form two types of graph-set 
motifs, two C4-H4···N2 are a part of   
 (  ) motif, while two C4-H4···N2 and two C4-
H4···N2 HBs form a   
 (  ) motif, (Figure 4.11.7). As it was mentioned, apart from the 
hydrogen bonds, type I halogen interactions
1,125
 between the two bromine atoms, can be 
observed. The Br···Br distance is 3.470 Å, which is shorter than the sum of Van der Waals 
radii (3.70 Å), while the I-Br···Br angles are both 165.12°, Figure (4.11.8). These are 
characteristic properties for this kind of short contacts which can be observed as a result of 
close packing of complexes. 
1,125
 The distance between the centroids of the pyridine rings of 




Figure (4.11.7) View of the hydrogen bonds in 2-cyanopyridine-IBr complex with the 
corresponding graph-set motif notation  
 




Figure (4.11.8) View showing the distance between the two centroids  




Table 4.5: Crystallographic data for the 2-cyanopyridine –IBr complex. 
Crystal data  
Chemical formula C6H4BrIN2 
Mr 310.92 
Crystal system, space group Triclinic, P-1 
T/K 195 
a, b, c (Å) 7.941 (2), 7.974 (2), 8.266 (2) 
α, β, γ (°) 76.275 (8), 65.978 (8), 61.910 (7) 
V/ (Å
3
) 421.11 (19) 
Z 2 




Crystal size/ (mm) 0.29 × 0.21 × 0.08 
Data collection  





Tmin, Tmax 0.322, 0.746 
No. of measured, independent and 
observed [I > 2ζ(I)] reflections 














), S 0.056, 0.147, 1.17 
No. of reflections 2529 
No. of parameters 91 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 2.98, −2.42 
 
 
Table 4.6: Selected interatomic contacts /Å and /
o
 for the complex 2-cyanopyridine-IBr. 
Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 Br1 2.5663(11) Br1 I1 N1 178.8(2) 
I1 N1 2.466(6) I1 N1 C1 119.2(6) 
N1 C1 1.296(10) I1 N1 C5 119.8(5) 
N1 C5 1.341(10) C1 N1 C5 120.8(8) 
N2 C6 1.126(12) N1 C1 H1 120 
C1 C2 1.391(13) N1 C1 C2 120.9(9) 
C2 C3 1.367(14) H1 C1 C2 120 
C3 H3 0.95 C1 C2 C3 119(1) 
C3 C4 1.368(12) H2 C2 C3 121 
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C4 H4 0.95 C2 C3 C4 120(1) 
C4 C5 1.382(10) H3 C3 C4 120 
C5 C6 1.429(11) C3 C4 C5 117.5(9) 
 
H4 C4 C5 121.3 
N1 C5 C4 121.6(8) 
N1 C5 C6 118.9(8) 
C4 C5 C6 119.5(8) 







Instead of the expected halogen bonded quinoxaline-IBr complex, two other complexes are 
obtained (quinoxaline - IBr2
–
, quinoxaline -I2). Since the latter one contains N···I-I halogen 
bond, it is discussed in the chapter (5).  
UV-Visible Spectra for Quinoxaline - IBr2
–
 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base Quinoxaline absorbs at 323 nm and iodine monobromide IBr absorbs at 317 nm and 
454 nm. A new band appears at 439 nm when the two above starting materials are mixed 
which is not attributed to the Quinoxaline or IBr. λmax for Quinoxaline was shifted 131 nm 
toward higher wavelength, Figure (4.12.1). Starting material and the resulting complex are 





Figure (4.12.1) UV- Visible Spectra of Quinoxaline-IBr2
–
: Quinoxaline (Blue), IBr(Orange), 
Quinoxaline- IBr2
–
 (Green), the spectra were collected using methanol as the solvent, the 




























Figure (4.12.2) ATR-FTIR spectrum of Quinoxaline – IBr2
–
. 
XRD measurements for Quinoxaline-IBr2
–
 
Crystallographic data for quinoxaline-IBr2
–
 are given in Table (4.7), and selected bond 
lengths and angles in Table (4.8). A thermal ellipsoid plot of the structure together with the 
numbering scheme used is given in Figure (4.12.3), packing diagram of Quinoxaline-IBr2
–
 
approximately along to the b axis is shown in Figure( 4.12.4). 
 





 crystallises in the Triclinic system, and the space group is P-1. The 
asymmetric unit consists of two molecules of quinoxaline, and IBr2
–
 ion. The unit cell 
consists of 2 asymmetric units, Figure (4.12.4). The iodine is bonded to 2 bromine atoms to 
produce the IBr2
–
 ion. Of the two molecules of quinoxaline is protonated, while the other is 
neutral. Moreover, two quinoxaline molecules are connected by an N1-H1···N3 hydrogen 
bond. The N···N distance is 2.704 Å, and N-H-N angle is 172.00°, Figure (4.12.5). Despite a 
difference in bond lengths, I-Br 2.677 Å and I-Br2 is 2.716 Å, IBr2
–
 ion is not involved in a 
halogen bond, nor any other non-covalent interaction, but serves only for the charge 
compensation within the complex. The observed short contacts (C12···Br2 3.880 Å, C1···Br2 
3.719 Å, C10···Br3 3.675 Å, C4···Br3 3.820 Å) are significantly longer than the reported C-
H···Br hydrogen bond length (3.376 Å).
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 The distance between the two adjacent 
quinoxaline molecules is 4.377 Å, Figure (4.12.6). 
 
Figure (4.12.4) Packing diagram of quinoxaline-IBr2
–















Table 4.7: Crystallographic data for the Quinoxaline- IBr2
–
 complex. 
Crystal data  
Chemical formula Br2I·C8H7N2·C8H6N2 
Mr 548.02 
Crystal system, space group Triclinic, P1 
T/K 180 
a, b, c (Å) 7.3002 (18), 11.243 (3), 12.079 (3) 
α, β, γ (°) 72.322 (10), 75.31 (1), 73.318 (9) 
V/ (Å
3
) 889.7 (4) 
Z 2 




Crystal size/ (mm) 0.29 × 0.26 × 0.07 
Data collection  
Diffractometer Bruker APEX-II CCD 
Absorption correction Multi-scan  
 
Tmin, Tmax 0.526, 0.747 
No. of measured, independent and 
observed [I > 2ζ(I)] reflections 














), S 0.043, 0.117, 1.04 
No. of reflections 7843 
No. of parameters 211 
No. of restraints 1 
H-atom treatment H atoms treated by a mixture of independent 
and constrained refinement 
Δρmax, Δρmin (e Å
−3





Table 4.8: Selected interatomic contacts /Å and /
o
 for the complex Quinoxaline-IBr2
–
. 
Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 Br1 2.6773(9) C1 N1 C8 113.7(7) 
I1 Br2 2.7161(9) C2 N2 C3 114.9(7) 
N1 H1 0.98(2) N1 C1 C2 124.2(8) 
N1 C1 1.314(4) H1 C1 C2  117.9 
N1 C8 1.369(5) N2 C2 C1 123.5(8) 
N2 C2 1.310(5) N2 C3 C4 119.6(7) 
N2 C3 1.362(4) N2 C3 C8 121.9(7) 
C1 C2 1.405(6) C4 C3 C8 118.5(7) 
C3 C4 1.412(5) C3 C4 C5 120.6(8) 
C3 C8 1.409(4) H4 C4 C5 119.7 
C4 C5 1.366(6) C4 C5 C6 120.7(8) 
C5 C6 1.402(7) H5 C5 C6 119.6 
C6 C7 1.369(6) C5 C6 C7 120.5(8) 
C7 C8 1.413(4) H6 C6 C7 119.6 
N3 C9 1.313(5) C6 C7 C8 119.8(8) 
N3 C16 1.371(6) H7 C7 C8 120.1 
N4 C10 1.311(6) N1 C8 C3 121.7(7) 
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N4 C11 1.363(5) N1 C8 C7 118.5(7) 
C9 C10 1.405(6) C3 C8 C7 119.7(7) 
C11 C12 1.407(7)  
C11 C16 1.410(4) 
C12 C13 1.361(6) 
C13 C14 1.411(6) 
C14 C15 1.365(7) 





4.3.13 2-ethoxyquinoline -IBr 
 
UV-Visible Spectra for 2-ethoxyquinoline -IBr2
–
 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-chloroquinoline absorbs at 319 nm and iodine monobromide IBr absorbs at 317 
nm and 454 nm. The new band appears at 436 nm when the two above starting materials are 
mixed which is not attributed to the 2-chloroquinoline or IBr. λmax for 2-chloroquinoline were 
shifted 114 nm toward higher wavelength, Figure (4.13.1). Starting material and the resulting 





Figure (4.13.1) UV- Visible Spectra of 2-chloroquinoline -IBr : 2-chloroquinoline (Blue), 
 IBr (Orange), 2-chloroquinoline -IBr (Green), the spectra were collected using methanol as 





























Figure (4.13.2) ATR-FTIR spectrum of 2-ethoxyquinoline - IBr2
–
 
XRD measurements for 2-ethoxyquinoline –IBr2
–
 
Crystallographic data for 2-ethoxyquinoline - IBr2
–
 are given in Table (4.9), and selected 
bond lengths and angles in Table (4.10). A thermal ellipsoid plot of the structure together 
with the numbering scheme used is given in Figure (4.35). 
 





Even though 2-chloroquinoline and IBr were used as starting materials, instead of the 
expected 2-chloroquinoline-IBr halogen bonded complex, 2-ethoxyquinoline-IBr2
–
 was 
obtained as a crystalline product. 2-ethoxyquinoline-IBr2
–
 crystallises in the monoclinic 
crystal system and the space group is, C 2/c. The asymmetric unit contains one molecule of 
protonated ethoxyquinoline, a half of IBr2
–
 ion and a half of chloride ion. Packing of 2-
ethoxyquinoline –IBr2
–
 within the unit cell approximately along to the a-axis is shown in 
Figure (4.13.4). The formation of polyhalide anion could stem from one of the previously 
discussed mechanisms. I-Br distances in the IBr2
–
 ion are equal (2.671 Å) and the measured 
Br-I-Br angle is 180.00° (Figure 4.13.5), which indicates that the IBr2
–
 ion is not involved in 
any of the non-covalent interactions. There is N1-H1···Cl1 hydrogen bond present between 
the protonated 2-ethoxyquinoline and the chloride ion, Figure (4.13.5). The distance between 
N1 and Cl1 is 3.05(3) Å which less than the sum of Van der Waals radii (3.30 Å)
121
 for these 
atoms, the N1-H1-Cl1 measured angle is 173.48°, as well. The distance between two adjacent 
protonated 2-ethoxyquinoline molecules is 5.108 Å, Figure (4.13.6) 
Forming of 2-ethoxyquinoline in the resulting complex, rather than 2-chloroquinoline, which 
was used as a starting material could be explained by Williamson reaction, Figure (4.13.7). 
This kind of reaction includes the reaction of an organohalide with alkoxide (in this system 
coming from ethanol, which is the solvent) to produce a corresponding ether. The chloride 
ion, that observed in the structure, is a product of substitution between 2-chloroquinoline and 
ethoxy anion.  
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 Figure (4.13.4) Packing diagram of 2-ethoxyquinoline –IBr2
–
 approximately along to a-axis. 
 
Figure (4.13.5) View showing the geometrical parameters of IBr2
–
 and N1-H1···Cl1 






Figure (4.13.6) View showing the distance between two centroids of adjacent 2-








Table (4.9) Crystallographic data for the product formed for 2-ethoxyquinoline –IBr2
–
. 
Chemical formula Br2I·Cl·2(C11H12NO) 
Mr 670.60 
Crystal system, space group Monoclinic, C2/c 
T/K 180 
a, b, c (Å) 26.495 (7), 5.1241 (14), 22.276 (7) 
β (°) 122.864 (8) 
V/ (Å
3
) 2540.2 (12) 
Z 4 




Crystal size/ (mm) 0.22 × 0.16 × 0.1 
Chemical formula Br2I·Cl·2(C11H12NO) 
Data collection  
Diffractometer Bruker APEX-II CCD 
Absorption correction Multi-scan  
Tmin, Tmax 0.572, 0.746 
No. of measured, independent and 
observed [I > 2ζ(I)] reflections 














), S 0.045, 0.091, 1.01 
No. of reflections 3949 
No. of parameters 143 
No. of restraints 1 
H-atom treatment H atoms treated by a mixture of independent 
and constrained refinement 
Δρmax, Δρmin (e Å
−3






Table 4.10: Selected interatomic contacts /Å and /
o
 for the complex 2-ethoxyquinoline –IBr2
–
. 
Atom 1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 Br1 2.6714 Br1 I1 Br1 180 
I1 Br1 2.6714 C9 O1 C10 118.8(4) 
O1 C9 1.309(7) H1 N1 C1 117(2) 
O1 C10 1.453(7) H1 N1 C9 120(2) 
N1 H1 0.92(3) C1 N1 C9 123.3(4) 
N1 C1 1.376(7) N1 C1 C2 120.0(4) 
N1 C9 1.317(5) N1 C1 C6 118.6(4) 
C1 C2 1.396(6) C2 C1 C6 121.4(4) 
C1 C6 1.401(6) C1 C2 H2 120.9 
C2 C3 1.36(1) C1 C2 C3 118.4(4) 
C3 C4 1.393(8) C2 C3 H3 119.3 
C4 C5 1.348(8) C2 C3 C4 121.3(5) 
C5 C6 1.406(9) H3 C3 C4 119.4 
C6 C7 1.407(7) C3 C4 C5 120.2(5) 
C7 C8 1.350(9) H4 C4 C5 119.9 
C8 C9 1.408(6) C4 C5 C6 121.1(5) 
C10 H10B  0.99 C1 C6 C5 117.5(4) 
 C1 C6 C7 117.4(4) 
C5 C6 C7 125.1(4) 
C6 C7 C8 122.5(4) 
H7 C7 C8 118.7 
C7 C8 C9 118.2(4) 
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H8 C8 C9 120.9 
O1 C9 N1 113.4(4) 
O1 C9 C8 126.5(4) 
N1 C9 C8 120.1(4) 
O1 C10 C11 106.9(5) 
H10A C10 C11 110.3 





Table 4.11: Distance between atoms, measured angles, λmax and melting point for IBr 
complexes. 
Compound N---I Å I-Br Å N---I-Br 
o
 
λmax /nm Mp /°C 
3,5-difluoropyridine-IBr. --- --- --- 381 Mrt 
3,5-dichloropyridine- IBr. --- --- --- 388 Mrt 
 2,6-dichloropyridine-I IBr. --- --- --- 434 77-80 
2,6-dimethoxypyridine- IBr --- --- --- 440 52-55 
4-methoxypyridine- IBr --- --- --- 435 38-40 
3-fluoropyridine- IBr 2.369(3) 2.6222(5) 178.93(6) 387 58-61 
2-fluoropyridine-3-iodopyridine- IBr --- --- --- 436 76-79 
2-fluoropyridine-4-iodopyridine- IBr --- --- --- 378 88-91 
2-fluoropyridine-5-iodopyridine- IBr --- --- --- 385 96-99 
2-cyanopyridine-IBr 2.466(6) 2.566(1) 178.8(2) 438 94-96 
1,10-phenanthroline- IBr --- --- --- 429 191-194 
Quinoxaline- IBr --- --- --- 439 56-59 
2-chloroquinoline- IBr --- --- --- 436 131-133 






Iodine monobromide complexes can be classified into two groups, the first characterised only 
by UV-VIS and ATR-FTIR spectroscopy, while the second is characterised by single-crystal 
X-ray diffraction and UV-VIS and ATR-FTIR spectroscopy. The latter consists of two main 
subgroups: 
(1) complexes with N···I-Br halogen bond (2-cyanopyridine-IBr and 3-fluoropyridine-IBr). 
Table 4.12 contains geometric properties of these two complexes, as well as the similar 
aromatic sp
2
 N-based halogen bonds with iodine monobromide. Based on this dataset, some 
conclusions regarding the correlation of halogen bonds strength with the functional groups on 
the aromatic ring could be made. If the pyridine-IBr complex, is taken as a reference point 
because it does not have any functional groups attached, it can be seen that amongst the 
available compounds, this system has the shortest N-I distance, which indicates the strongest 
N···I-Br halogen bond. This is also confirmed by the biggest elongation of the I-Br bond, 
2.653 Å, as compared to 2.4691 Å
27
 in the starting material.  
From the complexes prepared in this work, it has been observed that the N-I halogen bond 
distance in 2-cyanopyridine-IBr (2.466 Å) which is considerably longer than the 
corresponding distance in 3-fluoropyridine-IBr (2.368 Å). This difference could be correlated 
with the electron-withdrawing properties of the functional groups on the pyridine ring. 
Cyano- group is stronger electron-withdrawing group than the fluorine atom and withdraws 
more electrons from the N atom of the pyridine ring and reduces the electron density. As a 
result, there is a decrease in the interaction between N and I hence, the halogen bond formed 
is weaker and the N···I distance is longer. Since the fluoro- group is the weaker electron-
withdrawing group, XB in 3-fluoropyridine-IBr complex is shorter than the N···I halogen 
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bond distance in the 2-cyanopyridine-IBr complex. The literature-reported N···I distances are 
between the values of the two complexes within this work, Figure (4.14.1) 
Table 4.12 Geometric parameters of selected N···I-IBr halogen bonded complexes, adapted 
from ref.106
,
112, data reported in this work is marked bold. 





2.304 2.653 178.57 119.46 
3-fluoropyridine-IBr  2.368 2.622 178.93 121.53 
2,5-bis(2-Pyridiniumyl)-3,6-bis(2-pyridyl) 










2.410 2.588 173.99 118.75 




2.411 2.623 178.74 120.29 




2.461 2.577 175.84 120.32 


















Figure (4.14.1) Thermal ellipsoid plots of selected literature complexes, Å. 
 
(2) The second group contains ionic complexes containing polyhalogen ions, (IBr2
–
). In this 







). Instead of co-crystallising the starting materials, the 
formation of pyridinium ions with IBr2
–
 is obtained. As discussed previously, one of the 
mechanisms suggests that these ions could be formed due to the presence of water in the 
reaction system.
130
  Among the complexes in this group, the main difference that can be 
observed is that for 1,10-phenanthroline- IBr2
–
 and quinoxaline- IBr2
–
 the I-Br distances are 
not identical, while in the 2-chloroquinoline- IBr2
–
 complex, the IBr2
– 
ion is symmetrical and 
both of the distances are equal (2.671(4) Å), Table 4.13. The difference in the I-Br bond 
lengths in the former two complexes should indicate that at least one side of the ion is 
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involved in non-covalent interactions since the I-Br bond lengthening occurs when involved 
in a halogen bond. However, no such contacts can be detected. Several C-H···Br short 
contacts are observed, but their distances are significantly longer than the literature ones, so 
this option is excluded. Most likely this bond length difference occurs due to the close 
packing of complexes. 
Table (4.13) Geometrical parameters of IBr2
–








Crystalline complexes I-Br1(Br3*) (Å) I-Br2 (Å) 
1,10-phenanthroline-IBr2
–
 2.691 2.702 
Quinoxaline- IBr2
–
 2.677 2.716 
2-chloroquinoline- IBr2
–
 2.671 2.671 
*In 1,10-phenanthroline-IBr2
– 
because the labelling scheme is different (Br3-I-Br2) 
In this chapter, the focus was put on the impact of the addition of dihalogens (IBr) to a range 
of organic starting materials. In cases when crystals of suitable size could not be obtained, the 
presence of interaction between the organic bases and iodine monobromide was determined 
by comparison of the pyridine ring vibrations in the IR part of the spectrum. N=C bond was 
of specific interest since if there is an interaction between the pyridine N atom and IBr, there 
should be a redistribution of electron density. If the N atom is included in a non-covalent or 
supramolecular interaction then part of its electron density should be transferred into that 
interaction, thus weakening the bonds already present in the compound. In FTIR spectrum it 
would mean that wavenumber corresponding to C=N bond should be moved towards lower 




Table (4.14) Wavenumbers of selected bands in ATR-FTIR spectra correlated with specific 
bonds of the starting materials (St. m.) and the corresponding IBr complexes (C.) 




 ν(C-H), cm-1 
St. m C. St. m C. St. m. C. 
3,5-difluoropyridine 1476 1461 1577 1538 3101 3065 
3,5-dichloropyridine 1423 1414 1555 1551 3070 3054 
2,6-dichloropyridine 1467 1414 1584 1556 3142 3087 
2,6-dimethoxypyridine 1545 1457 1629 1609 3102 3003 
4-methoxypyridine 1547 1560 1616 1604 3110 3097 
3-fluoropyridine 1557 1537 1645 1603 3054 3063 
2-fluoropyridine-4-iodopyridine 1578 1554 1645 1578 3056 2974 
2-cyanopyridine 1578 1568 1602 1581 3060 3015 
1,10-phenanthroline 1561 1505 1617 1594 3058 2988 
Quinoxaline 1530 1499 1630 1612 3102 3038 
2-chloroquinoline 1561 1539 1617 1608 3054 2978 
 
In the complexes characterised by X-ray diffraction, interaction like halogen bond was 
observed, for example in the system of 3-fluoropyridine-IBr where the halogen bond is 
present, the band of the starting material was shifted from 1557 cm
-1
 to 1537 cm
-1 
and this 
shift confirms the bonding between 3-fluoropyridine and IBr. Moreover, 2-cyanopyridine -
IBr where the halogen bond is present as well, the band of the starting material was shifted 
from 1578cm
-1
 to 1568 cm
-1
. Also, the same shift occurs with C=C band and C-H band
 
and 
these shifts confirm the bonding between 2-cyanopyridine and IBr. This shifting towards 
lower wavelengths (with some exception) refers to an interaction of IBr with the N atom of 
the pyridine ring, which leads to a decrease of the conjugated double bond features.




Table (4.15) Wavelengths of selected bands in UV-VIS spectra of the starting materials and 
the corresponding IBr complexes  
Starting material λ(Starting material) /nm λ(Complex) /nm 
3,5-difluoropyridine 303 384 
3,5-dichloropyridine 335 388 
2,6-dichloropyridine 316 434 
2,6-dimethoxypyridine 328 440 
4-methoxypyridine 303 435 
3-fluoropyridine 316,445 387 
2-fluoropyridine-3-iodopyridine 351 436 
2-fluoropyridine-4-iodopyridine 317,448 378 
uy2-fluoropyridine-5-iodopyridine 305 385 
2-cyanopyridine 308 438 
1,10-phenanthroline 323, 460 383, 450 
Quinoxaline 319, 460 439 
2-chloroquinoline 303 436 
 
Despite in the IUPAC list of features, where it is listed that the formation of the halogen 
bonds usually moves the absorption bands to lower wavelengths, for these systems, the 
opposite influence is noticed, i.e. λmax for both starting materials were shifted towards higher 
wavelengths, which is called a bathochromic or a red shift. Complexes, where the structure is 
characterised by single crystal X-ray diffraction, have several distinctive features in their UV-
VIS spectra. Halogen bonded complexes (3-fluoropyridine-IBr, 2-cyanopyridine-IBr) have a 
single and a more intense peak when compared to complexes containing polyhalogen ions. 
This peak intensity could be correlated with the charge-transfer feature of the halogen bond. 
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When there is a non-covalent interaction present, either halogen or a hydrogen bond, the 
charge transfer component is more significant than just the electrostatic interactions.
142
 The 
position of the peak could also be correlated with observed interaction strength, in case of 3-
fluoropyridine, the peak is at 387 nm, while for the 2-cyanopyridine-IBr where the XB 
interaction is much weaker, the peak is observed at 438 nm. For the IBr2
– 
containing 
complexes, it has been observed that the peak is of a much lower intensity and positioned 
from 440-450 nm. These peak positions could be attributed to an equilibrium between IBr2
– 




 Also, 1,10-Phenantroline- IBr2
– 
complex contains both the IBr2
– 
ion and a halogen bond (Br···I-I) and in the UV-VIS 
spectrum, wide peak containing a shoulder can be observed, which indicates two unresolved 
peaks, 383 nm peak should stem from the XB and ~450 nm shoulder that corresponds to 
IBr2
–
. Based on peak shapes, positions and intensities in their UV-VIS spectra, it would be 
reasonable to assume that 3,5-difluoropyridine-IBr, 2-fluoro-4-iodopyridine-IBr and 2-fluoro-
5-iodopyridine-IBr complexes are halogen-bonded, Figure (4.14.2), 3,5-dichloropyridine- 
IBr2
–
 contains both the IBr2
–














 contain just the IBr2
–





Figure (4.14.2) UV-VIS spectra of 3,5-difluoropyridine-IBr (Blue), 3-fluoropyridine-IBr 
(Orange), 2-fluoro-4-iodopyridine-IBr (Silver), 2-fluoro-5-iodopyridine-IBr (Green), the 





Figure (4.14.3) UV-VIS spectra of 3,5-dichloropyridine- IBr2
–
 (Blue),  
1,10-phenantroline- IBr2
–
(Orange), the spectra were collected using methanol as the solvent, 














































Figure (4.14.4) UV-VIS spectra of 2-ethoxyquinoline- IBr2
–





 (Silver), 4-methoxypyridine- IBr2
–
 (Yellow),  
2,6-dimethoxypyridine- IBr2
–
 (Purple), 2,6-dichloropyridine- IBr2
–
 (Green), the spectra were 




































Iodine is the heaviest stable halogen. At room temperature, it exists as a lustrous purple-black 
solid. The melting and boiling points of iodine are 144 °C and 184 °C, respectively. 
However, it is well known that even with the light heat, iodine sublimes easily.
126,134
 In the 
gas phase, the I-I bond length was determined by Raman spectroscopy 2.6663 Å.
27
 
Iodine as an element is of crucial importance for halogen bonding since it has the best XB 
donor properties. As it was mentioned in the general introduction, the molecular iodine is 
found in the first reported XB adduct H3N···I2 
5
 and the benzene··· I2 adduct was studied by 
Benesi and Hildebrand in their pioneering spectroscopic work.
9
 
 Nowadays, it is being discovered that halogen bonding is an important factor in many 
biochemical systems, but particularly in thyroid biochemistry, which is iodine dependent. 
Research is focused on elucidating XB interactions with thyroid enzymes
107,143
 and the 
interaction of antithyroid drugs with molecular iodine.
108
 
Depending on a variety of factors (steric effects, XB acceptor atom, other non-covalent 
interactions), several different structural interaction modes are observed in dihalogen XBs.
106
 
Electron donors which interact at only one end of the X2 or XY molecule form discrete 
adducts (Figure 5.0.1, A). Except for these simple adducts, in systems with halogen bonded 
diiodine, bridging mode (Figure 5.0.1, B) where both iodine atoms are involved in XB 
interaction, is observed for diazines (pyrazine and derivatives,
144





 and the diiodine with hexamethylenetetramine 
complex.
147
 Apart from the mentioned two modes, amphoteric adducts (Figure 5.0.1, AA) 
and amphoteric bridging mode (Figure 5.0.1, BA) are observed. In the former, polarization on 
the X2 is sufficient enough to make X atom which is not interacting with XB acceptor act as a 
Lewis base to adjacent dihalogens, while in the latter, both the amphoteric effect and bridging 




Figure 5.0.1 Dihalogen XB interaction modes, adapted from 
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Most N···I2 complexes, and all N···IBr, and N···ICl complexes are discrete adducts (mode 
A). However, from the above-mentioned modes, the bridging mode is observed in this work, 
as well. Since the XB iodine chemistry is abundant and with many reported complexes, only 








REFCODE Complex name N···I 
(Å) 






 9-cyclohexyladenine diiodine 2.520 2.764 177.14 
GAWXEH
149
 N-iodine-2,3-diazabicyclo (2.2.2) oct-2-ene 2.431 2.807 175.49 
HMCPZI
150
 Hexamethylcyclotriphosphazene diiodine 2.418 2.823 177.80 
HXMIOD
147








 2,3-bis (2-pyridyl) quinoxaline diiodine 2.530 2.759 173.80 
NULBIF
145












 2,3,5,6-Tetrakis (2-pyridyl) pyrazine bis 
(diiodine) 
2.563 2.750 173.02 
PICOLI
151
 4-picoline diiodine 2.322 2.823 175.51 
QIHBOY
152
 1,2-Bis (4-pyridyl) ethylene bis (diiodine) 2.422 2.802 178.78 
TMEAMI
153





2.432 2.833 178.93 
YUYNUB
155
 1,3,5,7-Tetraazatricyclo (3.3.1.13,7) decane 
tris (diiodide) 
2.593 2.746 177.58 
HMTNTI
156
 Hexamethylenetetramine tri-iodo-nitrogen 2.475 2.808 175.41 
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diiodine 3.247 178.10 
HXMTDI
147




























2.358 2.818 176.08 
VUHDIN
160
 Pyridine diiodine 2.425 2.804 176.44 
YIPCEG
161
 Isonicotinamide iodine 2.439 2.790 178.04 
BULJUP
162
 (E)-1,2-bis(pyridine-4-yl) diazene 
bis(iodine) 
2.477 2.773 179.58 
ZESQUM
135
 bis(2,6-bis(phenylselanyl) pyridine) di-
iodine 
2.936 2.722 175.76 
DARZAY
163










 2,2'-Bipyridine diiodine 2.604 2.746 179.41 
ZESQOG
135
 2-[(4-chlorophenyl) selanyl] pyridine di-
iodine 
2.497 2.769 178.18 
SUBWEU
165




It can be observed that 28 complexes containing N···I-I have been reported. The average 
N···I distance is 2.610 Å, while the value for I-I bond is 2.779 Å. A complex with refcode 
TMEAMI
153
 has the shortest N···I value (2.271 Å) that means the strongest XB, and the most 
elongated bond (2.833 Å) is noticed in the same system, as well. Also, it can be observed that 






Preparation and characterisation of N···I halogen bonded crystalline complexes is the aim of 
this chapter. The strength of the N···I XB is going to be studied on iodine (XB donor) 
adducts with a series of pyridine derivatives (XB acceptor). The impact of functional groups 
of the nitrogen-containing organic starting materials is going to be correlated with the 
strength of the halogen bond interaction. All the crystalline complexes are going to be 
characterised by ATR-FTIR and UV-Vis spectroscopy, and single-crystal X-ray diffraction, if 
the suitable crystal is obtained. From the structures obtained by X-ray diffraction the halogen 






5.3 Investigation of halogen bonded complexes 




UV-Visible Spectra for 3,5-difluoropyridine –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 3,5-difluoropyridine absorbs at 303 nm and iodine absorbs at 304 nm. A new band 
appears at 362 nm when the two above starting materials are mixed. This band is not 
attributed to the 3,5-difluoropyridine or iodine. λmax for 3,5-difluoropyridine was shifted 59 
nm toward higher wavelength which is called bathochromic shift or redshift, Figure (5.1.1). 






Figure (5.1.1) UV- Visible Spectra of 3,5-difluoropyridine-I2: 3,5-difluoropyridine (Blue),  
I2 (Orange), 3,5- difluoropyridine-I2 (Green), the spectra were collected using methanol as the 


































5.3.2 3,5-dichloropyridine - I2  
 
 
UV-Visible Spectra for 3,5-dichloropyridine –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 3,5-dichloropyridine absorbs at 335 nm and iodine absorbs at 304 nm. A new band 
appears at 360 nm when the two above starting materials are mixed. This new band is not 
attributed to the 3,5-dichloropyridine or I2. λmax for 3,5-dichloropyridine was shifted 25 nm 
toward higher wavelength, Figure (5.2.1). Starting material and the resulting complex are also 






Figure (5.2.1) UV- Visible Spectra of 3,5-dichloropyridine-I2: 3,5-dichloropyridine (Blue), 
 I2 (Orange), 3,5-dichloropyridine-I2 (Green), the spectra were collected using methanol as 
































UV-Visible Spectra for 2,6-dichloropyridine –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2,6-dichloropyridine absorbs at 335 nm and iodine absorbs at 304 nm. The new 
band appears at 359 nm when the two above starting materials are mixed which is not 
attributed to the 2,6-dichloropyridine or iodine. λmax for 2,6-dichloropyridine was shifted 24 
nm toward higher wavelength, Figure (5.3.1). Starting material and the resulting complex are 






Figure (5.3.1) UV- Visible Spectra of 2,6-dichloropyridine-I2: 2,6-dichloropyridine (Blue),  
I2 (Orange), 2,6-dichloropyridine-I2 (Green), the spectra were collected using methanol as the 

































 UV-Visible Spectra for 2,6-dimethoxypyridine –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2,6-dimethoxypyridine absorbs at 316 nm and iodine absorbs at 304 nm. The new 
band appears at 358 nm when the two above starting materials are mixed which is not 
attributed to the 2,6-dimethoxypyridine or I2. λmax for 2,6-dimethoxypyridine was shifted 42 
nm toward higher wavelength, Figure (5.4.1). Starting material and the resulting complex are 





Figure (5.4.1) UV- Visible Spectra of 2,6-dimethoxypyridine -I2: 2,6-dimethoxypyridine 
(Blue), I2 (Orange), 2,6-dimethoxypyridine -I2 (Green), the spectra were collected using 





































UV-Visible Spectra for 4-methoxypyridine –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 4-methoxypyridine absorbs at 328 nm and iodine absorbs at 304 nm. The new band 
appears at 359 nm when the two above starting materials are mixed which is not attributed to 
the 4-methoxypyridine or I2. λmax for 4-methoxypyridine was shifted 31 nm toward higher 
wavelength, Figure (5.5.1). Starting material and the resulting complex are also characterised 





Figure (5.5.1) UV- Visible Spectra of 4-methoxypyridine-I2: 4-methoxypyridine (Blue), 
 I2 (Orange), 4-methoxypyridine -I2 (Green), the spectra were collected using methanol as the 



































UV-Visible Spectra for 3-fluoropyridine –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 3-fluoropyridine absorbs at 303 nm and iodine absorbs at 304 nm. The new band 
appears at 361 nm when the two above starting materials are mixed which is not attributed to 
the 3-fluoropyridine or I2. λmax for 3-fluoropyridine was shifted 58 nm toward higher 
wavelength, Figure (5.6.1). Starting material and the resulting complex are also characterised 





Figure (5.6.1) UV- Visible Spectra of 3-fluoropyridine -I2: 3-fluoropyridine (Blue), 
 I2 (Orange), 3-fluoropyridine -I2 (Green), the spectra were collected using methanol as the 





































UV-Visible Spectra for 2-fluoro-3-iodopyridine –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-fluoro-3-iodopyridine absorbs at 316 nm and iodine absorbs at 304 nm. The new 
band appears at 359 nm when the two above starting materials are mixed which is not 
attributed to the 2-fluoro-3-iodopyridine or I2. λmax for 2-fluoro-3-iodopyridine was shifted 43 





Figure (5.7.1) UV- Visible Spectra of 2-fluoro-3-iodopyridine -I2: 2-fluoro-3-iodopyridine 
(Blue), I2 (Orange), 2-fluoro-3-iodopyridine -I2 (Green), the spectra were collected using 




























UV-Visible Spectra for 2-fluoro-4-iodopyridine –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-fluoro-4-iodopyridine absorbs at 351 nm and iodine absorbs at 304 nm. The new 
band appears at 356 nm when the two above starting materials are mixed which is not 
attributed to the 2-fluoro-4-iodopyridine or I2. λmax for 2-fluoro-4-iodopyridine was shifted 5 
nm toward higher wavelength Figure (5.8.1). Starting material and the resulting complex are 





Figure (5.8.1) UV- Visible Spectra of 2-fluoro-4-iodopyridine -I2: 2-fluoro-4-iodopyridine 
(Blue), I2 (Orange), 2-fluoro-4-iodopyridine -I2 (Green), the spectra were collected using 

































UV-Visible Spectra for 2-fluoro-5-iodopyridine –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-fluoro-5-iodopyridine absorbs at 317 nm and iodine absorbs at 304 nm. A new 
band appears at 353 nm when the two above starting materials are mixed which is not 
attributed to the 2-fluoro-5-iodopyridine or I2. λmax for 2-fluoro-5-iodopyridine was shifted 36 




Figure (5.9.1) UV- Visible Spectra of 2-fluoro-5-iodopyridine -I2: 2-fluoro-5-iodopyridine 
(Blue), I2 (Orange), 2-fluoro-5-iodopyridine -I2 (Green), the spectra were collected using 





























UV-Visible Spectra for 2-cyanopyridine –I2 solution  
 All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-cyanopyridine absorbs at 305 nm and iodine absorbs at 304 nm. A new band 
appears at 361 nm when the two above starting materials are mixed which is not attributed to 
the 2-cyanopyridine or I2. λmax for 2-cyanopyridine was shifted 10 nm toward higher 
wavelength, Figure (5.10.1). Starting material and the resulting complex are also 





Figure (5.10.1) UV- Visible Spectra of 2-cyanopyridine -I2: 2-cyanopyridine (Blue), I2 
(Orange), 2-cyanopyridine -I2 (Green), the spectra were collected using methanol as the 





























XRD measurements for 2-cyanopyridine –I2 
Crystallographic data for 2-cyanopyridine- I2 are given in Table (5.1), and selected bond 
lengths and angles in Table (5.2). A thermal ellipsoid plot of the structure together with the 
numbering scheme used is given in Figure (5.10.3). 
 
Figure (5.10.3) Thermal Ellipsoid plot for 2-Cyanopyridine- I2. 
2-cyanopyridine- I2 crystallises in the triclinic, the space group is P-1. The asymmetric unit is 
one molecule of 2-cyanopyridine and one molecule of I2. The organic base and iodine are 
connected via N1···I1-I1 halogen bond. N1···I1 bond length is 2.872 (4) Å, which is less than 
the sum of van der Waals radii of nitrogen and iodine (3.53 Å).
121
 The I-I distance (2.7149 
(6) Å) is longer compared to the same distance for the iodine in the gas phase (2.663 Å)
27
 and 
the measured angle for N1-I1-I1 is 177.28 (8)°. One iodine molecule is involved in two 
N1···I1-I1 halogen bonds with two 2-cyanopyridine molecules. Thus, it forms a bridged 
adduct,
106
 Figure (5.10.4). Apart from this type of interactions, the complexes are further 
connected by the C-H···N hydrogen bonds to form ribbons, Figure (5.10.5, 5.10.6). The 
nitrogen atom of the cyano-group is a bifurcated HB acceptor. The two types of C-H···N 
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hydrogen bonds linking the complexes are C3-H3···N2 where the C3···N2 distance is 3.397 
Å and the C3-H3-N2 angle is 137.23°, and C4-H4···N2 hydrogen bond, in which the 
C4···N2 distance is 3.505 Å and the C4-H4-N2 angle is 154.39°, Figure (5.10.5). Both 
distances are shorter than the reported values for C-H···N hydrogen bond in similar systems 
(3.521 Å)
140
, while the measured angles are greater (134.41°)
140
 These halogen bonds form 
two types of graph-set motifs, two C4-H4···N2 are a part of   
 (  ) motif, while two C4-
H4···N2 and two C3-H3···N2 HBs form a   
 (  ) motif, (Figure 5.10.5).  
 





Figure (5.10.5) View showing 2-cyanopyridine –I2 with the corresponding hydrogen bonds 
labelled according to graph set motif nomenclature. 
 
 





Table 5.1: Crystallographic data for the 2-cyanopyridine –I2 complex. 
Crystal data  
Chemical formula I2·2 (C6H4N2) 
Mr 462.02 
Crystal system, space group Triclinic, P1 
T/K 160 
a, b, c (Å) 4.4377 (10), 6.3823 (13), 12.689 (3) 
α, β, γ (°) 83.580 (8), 83.081 (9), 84.521 (9) 
V/ (Å
3
) 353.32 (13) 
Z 1 




Crystal size/ (mm) 0.17 × 0.04 × 0.04 
Data collection  
Diffractometer Bruker APEX-II CCD 
Absorption correction Multi-scan  
Tmin, Tmax 0.612, 0.746 
No. of measured, independent and 
observed [I > 2ζ (I)] reflections 














), S 0.035, 0.061, 1.03 
No. of reflections 1912 
No. of parameters 82 
H-atom treatment H-atom parameters constrained 
Δρmax, Δρmin (e Å
−3
) 0.72, −0.73 
 
Table (5.2): Selected interatomic contacts /Å and /
o
 for the complex 2-cyanopyridine-I2 
Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 I1 2.7149 (6) C1 N1 C5 116.9 (4) 
N1 C1 1.327 (6) N1 C1 C2 122.8 (4) 
N1 C5 1.336 (5) C1 C2 C3 119.1 (4) 
N2 C6 1.137 (6) C2 C3 C4 119.2 (4) 
C1 C2 1.387 (6) C3 C4 C5 117.4 (4) 
C2 C3 1.373 (7) N1 C5 C4 124.6 (4) 
C3 C4 1.378 (7) N1 C5 C6 116.3 (3) 
C4 C5 1.378 (5) C4 C5 C6 119.1 (3) 





5.3.11 1,10-Phenanthroline –I2 
 
 
UV-Visible Spectra for 1,10-Phenanthroline –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 1,10-Phenanthroline absorbs at 308 nm and iodine absorbs at 304 nm. The new 
band appears at 355 nm when the two above starting materials are mixed which is not 
attributed to the 1,10-Phenanthroline or I2. λmax for 1,10-Phenanthroline was shifted 47 nm 
toward higher wavelength, Figure (5.11.1). Starting material and the resulting complex are 




Figure (5.11.1) UV- Visible Spectra of 1,10-Phenanthroline -I2: 1,10-Phenanthroline (Blue), 
I2 (Orange), 1,10-Phenanthroline -I2 (Green), the spectra were collected using methanol as the 





























5.3.12 quinoxaline– I2 
 
 
UV-Visible Spectra for quinoxaline –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base quinoxaline absorbs at 323 nm and iodine absorbs at 304 nm. A new band appeared 
at 354 nm with the shoulder at 442 nm. When the two above starting materials are mixed 
which is not attributable to the quinoxaline or I2. λmax for quinoxaline was shifted toward 
higher wavelengths, Figure (5.12.1). Starting material and the resulting complex are also 




Figure (5.12.1) UV- Visible Spectra of quinoxaline -I2: quinoxaline (Blue), I2 (Orange),  
1,10- quinoxaline -I2 (Green), the spectra were collected using methanol as the solvent, the 

































XRD measurements for quinoxaline –I2 
Crystallographic data for quinoxaline-I2 are given in Table (5.3), and selected bond lengths 
and angles in Table (5.4). A thermal ellipsoid plot of the structure together with the 
numbering scheme used is given in Figure (5.12.3).  
 
Figure (5.12.3) Thermal ellipsoid plot for quinoxaline –I2 
quinoxaline-IBr2– crystallises in the Orthorhombic, space group is Pbca. The asymmetric 
unit is one molecule of quinoxaline and one molecule of I2. Even though iodine 
monobromide was used as a starting material, iodine is observed as an XB donor in this 
complex. The crystallisation of iodine instead of iodine monobromide could be explained by 
the previously discussed formation of polyhalogen ions. Complexes are connected in one-
dimensional chains by N···I-I halogen bonds. Similar to 2-cyanopyridine-I2 complex, bridged 
adduct mode is observed. However, the N···I distances are not equal, Figure (5.12.4). The 
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N1···I1 distance is 2.857 (7) Å and N2···I2 is 2.875 (8) Å, which are both less than the sum 
of van der Waals radii of nitrogen and iodine (3.53 Å),
121
 Figure (5.12.4). The bond length in 
the molecule of iodine is 2.725 (1)Å, which is an elongation compared to the distance for the 
iodine in gas phase 2.6663 Å,
27
 Figure (5.12.4). The N-I-I angles also are not equal, N1-I1-I2: 
179.1 (1)° and N2-I2-I1: 177.0 (1)°. This difference in XB feature should indicate that there 
are some other non-covalent interactions present, but none could be observed. The distance 
between the centroids of the adjacent molecules is 4.295 Å, Figure (5.12.5) 
 
Figure (5.12.4) View showing an infinite chain of halogen bond connected complexes of 
quinoxaline-I2  
 
Figure (5.12.5) View showing the distance (Å) between the two centroids  
of quinoxaline molecules in quinoxaline-I2 complexes  
280 
 
Table 5.3: Crystallographic data for the quinoxaline –I2 
Crystal data  
Chemical formula I2·C8H6N2 
Mr 383.95 
Crystal system, space group Orthorhombic, Pbca 
T/K 180 
a, b, c (Å) 21.564 (3), 11.3419 (18), 8.1360 (11) 
V/ (Å
3
) 1989.8 (5) 
Z 8 




Crystal size/ (mm) 0.23 × 0.07 × 0.07 
Data collection  
Diffractometer Bruker APEX-II CCD 
Absorption correction Multi-scan  
 
Tmin, Tmax 0.539, 0.746 
No. of measured, independent and 
observed [I > 2ζ (I)] reflections 




 (sin θ/λ)max /(Å
−1
) 0.703 
No. of measured, independent and 
observed [I > 2ζ (I)] reflections 








), S 0.048, 0.108, 1.17 
No. of reflections 2888 
No. of parameters 109 







 + 42.509P] 





Δρmax, Δρmin (e Å
−3





Table 5.4: Selected interatomic contacts /Å and /
o
 for the complex quinoxaline –I2. 
Atom1 Atom2 Length Atom1 Atom2 Atom3 Angle 
I1 I2 2.725 (1) C1 N1 C8 113.7 (7) 
N1 C1 1.33 (1) C2 N2 C3 114.9 (7) 
N1 C8 1.41 (1) N1 C1 C2 124.2 (8) 
N2 C2 1.32 (1) N2 C2 C1 123.5 (8) 
N2 C3 1.39 (1) N2 C3 C4 119.6 (7) 
C1 C2 1.42 (1) N2 C3 C8 121.9 (7) 
C3 C4 1.42 (1) C4 C3 C8 118.5 (7) 
C3 C8 1.42 (1) C3 C4 C5 120.6 (8) 
C4 C5 1.36 (1) H4 C4 C5 119.7 
C5 C6 1.41 (1) C4 C5 C6 120.7 (8) 
C6 C7 1.37 (1) H5 C5 C6 119.6 
C7 C8 1.41 (1) C5 C6 C7 120.5 (8) 
 
H6 C6 C7 119.6 
C6 C7 C8 119.8 (8) 
H7 C7 C8 120.1 
N1 C8 C3 121.7 (7) 
N1 C8 C7 118.5 (7) 
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5.3.13 2-chloroquinoline - I2: 
 
 
 UV-Visible Spectra for 2-chloroquinoline –I2 solution  
All the spectra were collected in methanol, the concentration of all the samples was 10
-3
 M. 
The base 2-chloroquinoline absorbs at 319 nm and iodine absorbs at 304 nm. Two new bands 
appear at 364 and 443 nm when the two above starting materials are mixed which is not 
attributed to the 2-chloroquinoline or I2. λmax for 2-chloroquinoline was shifted toward higher 
wavelengths, Figure (5.13.1).Starting material and the resulting complex are also 




Figure (5.13.1) UV- Visible Spectra of 2-chloroquinoline-I2: 2-chloroquinoline (Blue), I2 
(Orange), 2-chloroquinoline -I2 (Green), the spectra were collected using methanol as the 
































Most Iodine complexes were characterized only by UV-VIS and ATR-FTIR spectroscopy, 
except the 2-cyanopyridine-I2 and quinoxaline- I2 complexes that were characterised by 
single-crystal X-ray diffraction and UV-VIS and ATR-FTIR spectroscopy. Also, 
quinoxaline-I2 complex resulted from adding iodine monobromide to the quinoxaline and 
quinoxaline-IBr was the expected product. However, halogen bonded co-crystalline 
quinoxaline-I2 is obtained instead.  
Because this chapter involves only two prepared halogen bond complexes (2-cyanopyridine-
I2 and quinoxaline-I2) XB geometrical properties of these compounds are compared with the 
selected literature data in Table (5.5). From 28 complexes listed in Table (5.1), in 16 of them 
sp
2
 nitrogen atom in N···I-I halogen bond is observed. In addition, the labelling scheme of 
the reported complexes was adapted, and ball-stick representations along with halogen bond 
geometric parameters are listed in Figure (5.14.1) for better clarity. Pyridine-I2 (VUHDIN)
160
 
with the N···I distance of 2.425 Å and I-I bond length of 2.804 Å, can be taken as a reference 





Table (5.5) Geometric parameters of selected N···I-I halogen bonded complexes, adapted 
from ref.
106,112
 Data reported in this work are marked bold. 
Complex name (REFCODE) N···I (Å) I-I (Å) N···I-I (°) C-N-C (°) 




2.322 2.823 175.51 119.24 
4-(2-(4-(octyloxy)phenyl)vinyl)pyridine 




2.353 2.83 177.19 116.44 
3,3'-(1,4-Phenylenediethyne-2,1-




2.358 2.818 176.08 119.75 




2.421 2.801 178.78 118.48 




2.425 2.804 176.44 119.83 




2.439 2.79 178.04 120.88 




2.477 2.773 179.58 118.97 




2.497 2.769 178.18 119.62 




2.498 2.76 174.46 118.35 















2.554 2.750 175.50 118.03 









2.604 2.746 179.41 113.58 
Quinoxaline-I2 2.857 2.725 179.11 113.75 
2-cyanopyridine-I2 2.872 2.7149  177.28  116.89 
Quinoxaline-I2 2.875 2.725 176.99 114.88 









2.936 2.722 175.76 117.68 




2.949 2.724 178.77 122.72 
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Figure (5.14.1) Ball-stick representations of selected literature complexes. 
The 4-picoline-I2 (PICOLI)
151
 complex has the shortest N···I interaction distance, indicating 
the strongest halogen bond among the reported compounds. All the complexes that have the 
N···I interaction shorter than in the Pyridine-I2 contain electron-donating groups, thus 
supporting the previously stated hypothesis that the XB interaction strength is correlated with 
electron-donating or -withdrawing properties of the functional groups of the pyridine ring. 
The exception to the rule is found in isonicotinamide - I2 (YIPCEG)
161
 that has an amide 
group in para- position to the N atom of the pyridine ring. Since amide groups are very good 
electron-donating groups (better than alkyl- groups) it should be expected to have the 
strongest XB interaction among all the complexes in Table (5.5). However, it is falling short 
after the pyridine-I2 N···I distance. A possible explanation for this discrepancy could be 
found in the two N-H···O hydrogen bonds that link two adjacent complexes, Figure (5.14.2). 
Having these two types of in non-covalent interactions should redistribute the electron 






Figure (5.14.2) View showing the N-H···O hydrogen-bonded isonicotinamide - I2 complexes 
In addition to HBs in isonicotinamide - I2 complex, the type I interaction between the two 


























Figure (5.14.3) View showing type I interactions in selected literature complexes 
Apart from type I interaction, bridged adducts are observed both in prepared and literature 
complexes. The main difference among these complexes is that they could be either just 
discrete adducts or linked into infinite chains via halogen bonds. It is impossible to make a 
general statement since only several complexes are reported, but based on the current data 
set, it could be concluded that in discrete adducts XB geometrical parameters are 
symmetrical. In the other hand, systems where they are in infinite chains, the difference 




Table 5.6 Geometrical parameters of halogen bonded complexes with bridged adduct 
patterns, complexes prepared in this work are marked bold 
Complex name (REFCODE) N···I (Å) N···I (Å) N···I-I (°) N···I-I (°) 
2-cyanopyridine-I2 2.872 2.872 177.28 177.28 









2.936 2.936 175.76 175.76 
Quinoxaline-I2 2.875 2.857 176.99 179.11 














      QARGUL
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Figure (5.14.4) Ball-stick representations and geometrical parameters of selected literature 











Figure (5.14.5) Ball-stick representations and geometrical parameters of selected literature 
complexes containing infinite chain bridged adduct mode 
From Table (5.5) can be observed that the N···I interaction distances in N···I-I halogen bonds 
that are connected only via one iodine atom of the iodine molecule are significantly shorter 
than the complexes where both iodine atoms are involved in XBs. A good example of this 
can be seen when the prepared 2-cyanopyridine-I2 complex (2.872 Å) is compared to 
literature reported 4-cyanopyridine-I2 (NULBIF),
145
 2.543 Å. Since these two complexes are 
constitutional isomers, some difference should be attributed to the steric hindrance effect due 





, where for ZESQOG, only the singly halogen 
bonded iodine atom N···I distance is 2.497 Å and for ZESQUM where bridged adduct occurs 
N···I distance is 2.936 Å. Here, the steric hindrance effect should be considered too, since the 
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second bulky functional group is added, but the difference of 0.439 Å seems to significant to 
stem only from the steric effects. On the other hand, I-I bond length for 2-cyanopyridine-I2 is 
2.714 Å that is slightly shorter than the corresponding distance for 4-cyanopyridine diiodine 
(NULBIF) 2.745Å.  
The prepared quinoxaline-I2 complex has stronger halogen bonds, N···I distances are 2.857 
Å, 2.875 Å, which are shorter than the corresponding distances for the literature reported 
quinoxaline-I2 (NULBUR),
145
 2.949Å and 2.918 Å. However, it is interesting to note that I-I 
bond length for prepared quinoxaline-I2 is 2.725 Å is nearly equal to the distance for complex 
with refcode NULBUR 2.724 Å. 
This chapter also has been focused on the influence of addition I2 to the starting material by 
comparison of the pyridine ring vibrations since they could be observed on the available 
instrument, and N=C bond especially, to determine whether I2 interacts with the pyridine N 
atom. If the N atom is involved in a non-covalent or supramolecular interaction then part of 
its electron density should be moved into that interaction, thus weakening the bonds already 
present in the compound. In FTIR spectrum it would mean that wavenumber corresponding 
to C=N bond should be moved toward lower wavenumbers (Table 5.7). and for UV-VIS 
spectroscopy that band characteristic for an organic base should be shifted towards higher 




Table (5.7) Wavenumbers of selected bands in ATR-FTIR spectra correlated with 
specific bonds of the starting materials (St. m.) and the corresponding I2 complexes (C.) 
Starting material ν (C=N), cm
-1
 ν (C=C), cm
-1
 ν (C-H), cm-1 
St. m C. St. m C. St. m. C. 
3,5-difluoropyridine 1476 1438 1577 1549 3101 3055 
3,5-dichloropyridine 1423 1418 1555 1549 3070 3024 
2,6-dichloropyridine 1467 1414 1584 1555 3142 3086 
2,6-dimethoxypyridine 1545 1455 1629 1608 3102 3061 
4-methoxypyridine 1547 1501 1616 1604 3110 3090 
3-fluoropyridine 1557 1472 1645 1585 3054 3062 
2-fluoropyridine-4-iodopyridine 1578 1539 1645 1568 3056 3052 
2-cyanopyridine 1578 1461 1602 1577 3060 2973 
1,10-phenanthroline 1561 1541 1617 1591 3058 3049 
quinoxaline 1530 1462 1630 1580 3102 3045 
2-chloroquinoline 1561 1538 1617 1584 3054 3059 
 
Various types of interactions were observed in the complexes characterised by X-ray 
diffraction such as halogen bond and hydrogen bond in systems like 2-cyanopyridine-I2 
where the halogen bond is present, the band of the starting material was shifted from 1578 
cm
-1
 to 1461 cm
-1 
and this shift confirms the bonding between 2-cyanopyridine and I2. 
Simultaneously using the starting material such as quinoxaline, the shift was also observed 
(from 1530 cm
-1
 to 1462 cm
-1
) upon the addition of iodine to the starting material. The same 
shift occurs with C=C band and C-H band, respectively. This shifting towards lower 
wavelengths refers to an interaction of the I2 with N atom of the pyridine ring, which as result 
of the resonance and the conjugation on the pyridine ring and this leads to a decrease of the 
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double bond feature and due to the presence of the electron-withdrawing group on the ring 
which caused decreasing the electron density reducing bond order.
 141,123 
Table (5.8) Wavelengths of selected bands in UV-VIS spectra of the starting materials and 
the corresponding I2 complexes 
Starting material λ(Starting material) /nm λ(Complex) /nm 
3,5-difluoropyridine 303 362 
3,5-dichloropyridine 335 360 
2,6-dichloropyridine 316 359 
2,6-dimethoxypyridine 328 358 
4-methoxypyridine 303 359 
3-fluoropyridine 316,445 361 
2-fluoropyridine-3-iodopyridine 351 359 
2-fluoropyridine-4-iodopyridine 317,448 356 
2-fluoropyridine-5-iodopyridine 305 353 
2-cyanopyridine 308 361 
1,10-phenanthroline 323, 460 355 
quinoxaline 319, 460 354, 442 
2-chloroquinoline 303 364, 443 
 
Contrary to the XB features listed by IUPAC, where it is listed that the formation of the 
halogen bonds usually moves the absorption bands to lower wavelengths, for these 
complexes, the opposite influence is noticed, i.e. λmax is shifted towards higher wavelengths, 
which is called a bathochromic or a redshift. Complexes that were characterised by single-
crystal X-ray diffraction, have several distinctive features in their UV-VIS spectra. Similar to 
halogen bonded compounds observed in previous chapters, both complexes prepared in this 
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chapter have a single intense peak. This peak intensity could be correlated with the charge-
transfer feature of the halogen bond. When there is a non-covalent interaction present, either 
halogen or a hydrogen bond, the charge transfer component is more significant than just the 
electrostatic interactions.
142
 The 361 nm peak for the 2-cyanopyridine-I2 could be attributed 
to N···I-I XB interaction. Peaks at similar wavelengths are observed in most of the prepared 
complexes in this chapter, Figures (5.14.5, 5.14.6). Spectra are split in two figures for clarity. 
The intensity of 2-cyanopyridine peak is the lowest among the complexes in Figure (5.14.5), 
which could be linked to the strongest electron-withdrawing feature of the cyano- group. 
However, the trend following the electron-donating or withdrawing properties of functional 
groups could not be observed. The possible explanation for this discrepancy could be found 
in possibility that there are other factors affecting the electron density involved in 
interactions, hydrogen bonds like in isonicotineamide-I2 where the XB interaction is much 
weaker than expected, or due to different bonding patterns (discrete adducts or bridged 
adducts). The big exception to the trend of a single peak from 355-365 nm is found 2-
chloroquinoline-I2 complex, where two intensive peaks occur. Without the crystal structure of 
the complex, it is impossible to predict the XB or HB bonding features, because nothing 
similar is observed in known complexes. Due to the high intensity of the second peak, it 
could be speculated that two types of halogen bonds are present. For the quinoxaline -I2 
complex, where iodine monobromide was used as a starting material, and I2 was formed due 
to dissociation of IBr, apart from the 354 nm peak associated with halogen bond formation, a 
characteristic low-intensity shoulder peak at 442 nm stemming from IBr2
–








Figure (5.14.6) UV-VIS spectra of 3,5-difluoropyridine-IBr (Blue), 3,5-dichloropyridine-IBr 
(Orange),2,6-dichloropyridine-IBr(Silver),2,6-dimethoxypyridine-IBr(Gold),4-
methoxypyridine -IBr (Red), 2-cyanopyridine-IBr (Green), the spectra were collected using 




Figure (5.14.7) UV-VIS spectra of 3-fluoropyridine-IBr (Blue), 2-fluoropyridine-3-
iodopyridine-IBr (Orange), 2-fluoropyridine-4-iodopyridine-IBr (Silver), 2-fluoropyridine-5-
iodopyridine-IBr (Gold), 1,10-phenanthroline-IBr (Red), 2-chloroquinoline-IBr (Green), the 























































During the preparation of crystalline complexes, the following points can be noted. It was 
found that with the majority of ICl compounds the crystals formed immediately, with few 
exceptions that needed to be placed in the freezer to produce crystals (2-fluoro-3-
iodopyridine-ICl, 2-fluoro-4-iodopyridine-ICl, quinoxaline-ICl). In the case of compounds 
formed using IBr, for most of the complexes, crystals were formed immediately as well. 
However, some of them needed to be placed in a freezer for more than 12 hours (3,5-
difluoropyridine-IBr, 3,5-dichloropyridine-IBr, quinoxaline-IBr), but even so, the products 
formed more easily than for I2, where for some of them it was necessary to cool the reaction 
mixture down to -75 °C or to put it in the fume hood for more than two weeks. In some cases, 
it was needed to add a minimum amount of suitable solvent and to cool the reaction mixture 
down or evaporate and leave in the fume hood for a long time. These additional steps would 
influence the economic cost in future practical applications. 
Percentage yields: 
In general, ICl products have the best yields among the prepared complexes, such as 3,5-
difluoropyridine-ICl (76%). The average yields decreased from ICl (60%) over IBr 
complexes (45%) to I2 containing complexes (38%). This trend could be affected by the 
solubility of the complexes, but also since it took a long time for IBr and I2 containing 
complexes to precipitate, some side-reactions not leading to the formation of crystals could 
be happening in parallel and thus reducing the yield of the obtained complexes. 
Crystals size and morphology 
 Most ICl crystals have a diamond or cubic morphologies which made the XRD investigation 
the samples more straightforward compared to the with IBr and I2 samples. This was 
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especially pronounced for the iodine-containing products that were either needle-like or 
microcrystalline.   
Halogen bond features 
As it was mentioned in previous chapters, prepared samples could be divided in can be 
separated into four categories (A, B, C, D). The first three ones are characterised by single-
crystal X-ray diffraction, UV-VIS and ATR-FTIR spectroscopy, while for the latter one, 
samples are characterised only by UV-VIS and ATR-FTIR. 
A- Complexes which contain N···I-X (X= Cl, Br, I) halogen bond. In this work, seven 
complexes of that kind were prepared. Their geometrical features are listed in Table (6.1). 
Apart from the trend of increasing the N···I interaction length by using the organic bases with 
electron-donating groups to electron-withdrawing groups with a single dihalogen, it can be 
noticed that the N···I distance increase is ICl<IBr<I2. The more electronegative the atom 
covalently bonded to iodine is, the more charge separation will occur.
 106,112
 Thus, the sigma 
hole on the iodine atom will be more prominent and the XB interaction stronger.
1
 This trend 




Table (6.1) Geometric parameters of halogen-bonded complexes prepared in this work 




3,5-difluoropyridine-ICl 2.358(6) 2.470(2) 178.69(1) 
3,5-dichloropyridine-ICl 2.341(3) 2.4872(9) 180.00 
4-methoxypyridine-ICl 2.2717(12) 2.5305(4) 177.76(3) 
IBr complexes 
3-fluoropyridine-IBr 2.368 2.622 178.93 
2-cyanopyridine-IBr 2.466 2.566 178.79 
I2 complexes 
2-cyanopyridine-I2 2.872 2.7149 177.28 
Quinoxaline-I2 2.857, 2.875 2.725 179.11, 176.99 
 
Table (6.2) Geometric parameters of selected literature complexes 
Organic base N···I, ICl Å N···I, IBr Å N···I, I2 Å 
Pyridine
160
 2.284 2.304 2.425  
2,2-bipyridine
164










- 2.411 2.497  




Among the analogous compounds similar packing and non-covalent bonding patterns can be 
observed, Figures (4.11.6), (5.10.6), (6.0.1). In both IBr and I2 complexes the same hydrogen 
bonds (C-H···N) and motifs can be observed, Figures (4.11.7), (5.10.5). The HB C-N lengths 
are slightly longer in iodine complex than in the iodine monobromide one (3.505 Å, 3.397 Å 
for I2 complex and 3.454 Å, 3.378 Å for IBr complex, respectively). Even though two IBr 
complexes are linked via type I halogen interactions, while in the iodine-containing system, 
the bridged adduct is present, both complexes are packed in a similar stepwise manner, 
Figure (6.0.1). This indicates that the corresponding ICl complex, whose structure is still not 
elucidated, should have the same structural features. 
 
Figure (6.0.1) View showing non-covalent interactions of  
2-cyanopyridine-IBr (left) and 2-cyanopyridine I2 (right) 
In addition to the impact of the position of the group on the ring relative to the pyridine N 
atom, electron-donating act to activate N atom of the pyridine ring. However, these groups 
become more activating when are substituted in ortho- and para- positions on pyridine ring 




In all cases, the halogen bond should be located along the axis of a free electron pair.
106,112
 
The great advantage of dihalogens or interhalogens for studying this feature is their compact 
size, having no steric hindrance. In the definition of halogen bond, where this type of 
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interactions is described by R-X···Y, for dihalogens or interhalogens, when iodine atom acts 
as XB donor (X), the one possible variability for the R group is the type of the atom bonded. 
Thus, the nature of XB interactions can be studied at an elementary level, where donors are 
not affected by any other effect except the polarisation of the bond due to the change in atoms 





 and Ouvrard et al.
112
 reported that the hybridisation of the halogen bond 
acceptor atom affects the XB length. Also, sp
3
 hybridised atoms should have longer N···I 
distance than sp
2
 and sp hybridised, respectively. In this work, nor the literature, sp nitrogen 
atom involved in the halogen bond has not been prepared. In addition, there are only several 
cases of sp
3





). In Table (6.3) and Figure (6.0.2) are shown 
geometrical features of these compounds compared to pyridine-I-X (X=Cl, I), which could be 
considered as a representative sample of dihalogen or interhalogen complexes containing sp
2
 
hybridised nitrogen atom. While the N-I-X (X=Cl, I) angles are all very similar, both the 
N···I distances, and I-X bond lengths are shorter for sp
2
- than in sp
3
 nitrogen containing 




Table (6.2) Geometric parameters of selected literature complexes 
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Figure (6.0.2) Ball-stick representations of selected literature complexes 










 and 2-ethoxyquinoline- IBr2
–
). Instead of co-crystallising the starting materials, the 









 and 1,10-phenanthroline- IBr2
– 
the 
polyhalogen ions are not symmetrical. While for the 2,6-dimethoxypyridinium-ICl2
–
 there is a 
hydrogen bond between the pyridinium cation and the polyhalogen anion, for the IBr2
–
 
containing complexes, the distances that are significantly longer than the literature reported 
values. On the other hand, the bond distance between iodine and both of chlorine atoms in 2-
cyanopyridinium-ICl2
–
 and iodine and both of bromine atoms in quinoxaline- IBr2
–
 is nearly 
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 are not included in any type of supramolecular interactions, 
rather an N-H···N hydrogen bond links two organic bases, from which, one is positively 
charged and the other is neutral. (Table 6.3) 







Crystalline complexes I-Cl1 I-Cl2 
2,6-dimethoxypyridine-ICl2
–
 2.6041(5) 2.5177(6) 
2-cyanopyridine-ICl2
–
 2.5531(6)  2.5540(6) 
Crystalline complexes I-Br1(Br3*) I-Br2 
1,10-phenanthroline-IBr2
–
 2.702 2.691 
Quinoxaline- IBr2
–
 2.677 2.716 
2-ethoxyquinoline- IBr2
–
 2.671 2.671 
 
C- The third group has only one sample. Instead of 2,6-dichloropyridine-ICl halogen-bonded 
complex, just the organic starting material crystallised from the reaction solution. However, 
the structure of 2,6-dichloropyridine was still not reported in Cambridge Structural database. 
As possible reasons for not obtaining the XB complex, the electron-withdrawing property of 
chlorine atoms in 2,6-dichloropyridine that reduce the electron density on N atom of the 
pyridine ring, as well as the ortho- positions on the pyridine ring act to prevent N atom of the 
pyridine ring from interacting with iodine monochloride by the steric hindrance.  
The product of adding IBr to 2-chloroquinoline should be 2-chloroquinoline –IBr. However, 
2-ethoxyquinoline-IBr2
–
 is observed instead of the expected complex. Due to Williamson 
reaction, 2-ethoxyquinoline was formed from the 2-chloroquinoline, that was used as an 
organic starting material and ethoxy species stemming from ethanol used as a solvent, Figure 
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(6.0.3). Furthermore, the formation of polyhalide anions in this and the other mentioned 
samples was observed.  
 
             Figure (6.0.3) - Scheme for the formation of ether and halide ion.  
Because these products were observed in crystalline materials, as well as quinoxaline-I2 
complex, where iodine monobromide was used as starting material, it was difficult to predict 
the structural properties of complexes where crystals were not of a suitable size for single-
crystal X-ray diffraction.  Therefore, based on known features from the structure of 
elucidated structures and linking them to peak positions and intensities observed in FTIR and 
UV-VIS spectra the unknown structures were predicted. 
D-Complexes in which no suitable crystalline material was obtained could be characterised 
by other techniques like UV-VIS and ATR-FTIR spectroscopy to determine the presence of 
the halogen bond or polyhalogen ions in the complex. Since the spectrometer with a range 
wide enough to observe N···I and I-X (X=Cl, Br, I) was not available, FTIR spectrum 
analysis has been focused on the impact of addition ICl, IBr and I2 to the starting material. 
XB interactions were studied through comparison of the pyridine ring vibrations generally, 
and N=C bond specifically, to determine whether interhalogens or dihalogens interact with 
the pyridine N atom. If there is an interaction between the organic base and a dihalogen, the 
wavenumber corresponding to the C=N bond should be moved toward lower wavenumbers. 
Tables (3.14.3), (4.14.3), (5.7).  
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 In FTIR the big difference in a characteristic band wavenumber between the starting material 
and the complex indicates that the interaction is strong, and the halogen bond is short. For 
example, in the 4-methoxypyridine-ICl complex that has the shortest N···I interaction 
distance (2.227 Å), the C=N band is moved toward lower wavenumbers, from 1547 cm
-1 
for 
the organic starting material to 1500 cm
-1
 for the complex, as shown in Table (3.14.3). In 
contrary, 2-cyanopyridine-I2 complex, where N···I halogen bond distance is 2.872 Å which is 
the longest among the prepared complexes, the difference in wavenumbers between the 
starting material and the complex is almost negligible, the wavenumbers for the starting 
material and the I2 complex are 1578 cm
-1
 and 1577 cm
-1 
respectively. 
For UV-VIS spectra, based on peak intensities observed in spectra of structures characterized 
by single-crystal X-ray diffraction, structural properties can be predicted. Peaks of higher 
intensity are attributed either to halogen or hydrogen bonds since they have a strong charge-
transfer component in the interaction, which should be visible in this part of the 
electromagnetic spectrum. On the other hand, peaks of low intensity are associated with the 
presence of equilibrium between halogen (I
–




) in the 
sample solution,133 Table (6.4). Complexes, where the structure was characterized by single-
crystal X-ray diffraction, are marked bold. Complexes that should have halogen-bonded 
structures are marked with an asterisk (*), while the structures where the polyhalogen ion and 
ionic complex is expected, are marked with an octothorpe (
#
). Correlation of peak positions 
and intensities among the same dihalogen or interhalogen used, with the electron-donating or 
withdrawing properties has not been observed. Since multiple non-covalent interactions in the 
structure could be present and interfere with the halogen bond strength. As a general trend, it 
could be observed that the peaks attributed to halogen bonded complexes move from 340-390 




Table (6.4) Wavelengths of selected bands in UV-VIS spectra of the starting materials (St.m.) 
and the corresponding interhalogen or dihalogen complexes (C.), Complexes that should have 
halogen-bonded structures are marked with an asterisk (*), while the structures where the 
polyhalogen ion and ionic complex is expected, are marked with an octothorpe (
#
). 
Starting material λ(St. m.) /nm λ(ICl C.) /nm λ(IBr C.) /nm λ(I2 C.) /nm 
3,5-difluoropyridine 303 451* 384* 362* 
3,5-dichloropyridine 335 458* 388, 441*
,# 
360* 










4-methoxypyridine 303 386* 435
#
 359* 
3-fluoropyridine 316,445 369, 469* 387* 361* 
2-fluoropyridine-3-
iodopyridine 





317,448 434* 378* 356* 
2-fluoropyridine-5-
iodopyridine 
305 346, 440* 385* 353* 
2-cyanopyridine 308 343, 435
#
 438* 361* 


























   In this work, the aim was to prepare crystalline halogen-bonded complexes of dihalogens 
(iodine monochloride, iodine monochloride and iodine) with a range of aromatic nitrogen-
containing compounds. Dihalogens as a class of compounds have an advantage over other 
XB donors for studying halogen bonds. Due to their compact size, no steric hindrance is 
present and except the polarisation of the bond that is dependent on the atom that bonded to 
an XB donor, there are no other effects presents.  
Complexes were prepared by dissolving the appropriate organic starting material and 
dihalogen or interhalogen in 1:1 molar ratio. The minimum amount of ethanol used as a 
solvent. In total 13 organic nitrogen-containing compounds and three dihalogens were used. 
The crystalline material was prepared in all cases. However, due to the size and morphology 
of the crystals, only 13 complexes were suitable for characterisation by single-crystal X-ray 
diffraction. For all the complexes crystal size, colour, yield percentage and melting points are 
noted, as well as they have been characterised FTIR and UV-VIS spectra. 
The products formed by iodine monochloride were generally well-formed clear crystals that 
formed easily and in high yields which aid in their characterisation.  
Iodine monobromide products have similar properties to iodine monochloride products, 
however, they were more difficult to crystalize and required cooling. Also, several of these 
complexes have melting points below room temperature, which made them more difficult to 
handle.  
The products formed with iodine were even more difficult to crystalize than IBr ones, with 
cooling down to -75 °C required in some cases. The crystal colours were between brown to 
dark brown.  
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Based on the X-ray diffraction characterisation of the products from this work, they can be 
divided into four types: 








In this class of complexes, the halogen bond strength with the single dihalogen or 
interhalogen compound could be tuned by changing the electron-withdrawing and electron-
donating properties of functional groups of nitrogen-containing aromatic compounds. The 
more electron-donating the group is, the stronger the interaction will be. The opposite 
correlation is observed when increasing the electron-withdrawing properties of the functional 
group. The position regarding the nitrogen atom of the pyridine ring plays an important role, 
as well. The ortho- and para- positions enhance the effect of the donating groups, while the 
meta- positions favour the electron-withdrawing properties. The hybridisation of the XB 
acceptor atom, nitrogen in these systems, affects the halogen bond strength as well. The 
longest and weakest bonds are for sp
3
, followed by sp
2 
and sp hybridised acceptor atoms. 
Additionally, the XB interaction strength is increasing as an effect of changing the XB donor 
used (I2> IBr> ICl). Finally, other non-covalent interactions, like hydrogen bonds affect the 
XB strength through possible charge redistribution. 
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 Contrary to the formation of expected halogen-bond connected samples, the ionic complexes 
containing protonated organic starting materials and polyhalogens ions are obtained in five 
cases. In 2-cyanopyridine-ICl2
–
 and 2-ethoxyquinoline- IBr2
–
 complexes, polyhalogen ions 
are symmetrical, while for the other three samples, a difference between the bond lengths 
form the central to the terminal atoms is present. This difference indicates that at least one 
terminal atom of the ion is involved in non-covalent interactions. Also, 2-ethoxyquinoline-
IBr2
–
 complex resulted from the addition of 2-chloroquinoline and iodine monobromide. This 
substitution could be explained by the Williamson ether synthesis mechanism. 
C -Recrystallised starting materials: 
2,6-dichloropyridine 
The product that should have crystallised from the reaction between ICl with 2,6-
dichloropyridine should have been 2,6-dichloropyridine-ICl. Rather than that complex, only 
2,6-dichloropyridine, which was the starting material, formed crystals. 
D- Complexes characterised only by FTIR and UV-VIS 
spectroscopy: 
All the samples were characterised using FTIR spectrometer from 600 to 4000 cm
-1
 and UV-
VIS spectrometer from 300 to 900 nm. Due to the limitation of the FTIR instrument, 
complexes were studied indirectly. The bonds of the pyridine ring adjacent to the point of XB 
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interaction (C=N, C=C, C-H) were compared with the corresponding bands in the starting 
material. Due to the redistribution of electron density from the pyridine ring, these bands 
should be shifted toward lower wavenumbers.  UV-VIS spectra were interpreted based on 
peak intensities observed in spectra of structures characterized by single-crystal X-ray 
diffraction. Peaks of higher intensity were attributed either to halogen or hydrogen bonds 
since they have a strong charge-transfer component in the interaction. On the other hand, 
peaks of low intensity were associated with the presence of equilibrium between halogen (I
-
) 








Goals and recommendations for further work: 
- To obtain the crystals of the suitable size for single-crystal X-ray diffraction, of complexes 
where no such crystals are obtained, by changing the reaction conditions. For example, to 
choose another solvent or solvent mixtures, or to conduct a reaction on higher temperatures, 
or utilising mechanochemistry followed by recrystallisation in a solvent. 
- To obtain halogen bonded crystals of systems where ionic complexes and unexpected 
products are obtained. 
-To study the conditions of polyhalogen ions formation. For example, by conducting 
reactions in conditions of controlled humidity or with distilled and dried solvents. Also, to 
study systems where a fixed amount of water is added, to possibly discover the threshold 
percentage, after which ions are preferred over XB adducts.  
-To use iodine monobromide or iodine monochloride as sources of iodine for samples, where 
there are difficulties for obtaining iodine-containing complexes. This method was observed 
with quinoxaline and IBr were mixed, but iodine crystallised in the complex.  
- To use the aliphatic nitrogen compounds (e.g. piperidine derivatives) to compare the 
properties with the aromatic nitrogen compounds. 
-To prepare polymorphs with different bonding modes (discrete adducts, bridged adducts…) 
to study this effect on halogen bond interaction strengths. 
-To conduct computational calculations of systems containing halogen bonded dihalogens or 
interhalogens to elucidate interaction features and to provide a better insight in FTIR spectra 
interpretation. 
-To study potential real-life applications of these systems. For example, to utilise the colossal 
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